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Summary
Plants as sessile organisms are constantly attacked by pathogens and have evolved a complex
immune system to cope with this challenge. The first inducible layer of plant immunity recognises
pathogens outside each plant cell and activates a resistance response that is usually sufficient
to halt pathogen infection. Many pathogens, however, produce effector molecules that suppress
these defences and thus allow successful invasion of the plant. A second layer of plant immunity
relies on the specific recognition of these effectors through intracellular immune receptors, the
so-called R (resistance) proteins. Effector recognition triggers a fast and strong immune response
that is often associated with localised cell death at the site of infection. To prevent spreading
cell death and to reduce the cellular costs of an activated immune system, these activities have
to be tightly regulated.
The nucleo-cytoplasmic protein EDS1, which exists in all higher plant species, has emerged
as a central regulator downstream of effector recognition. EDS1 physically interacts with two
sequence-related proteins, PAD4 and SAG101, that share an organisation into an N-terminal
domain that is related to eukaryotic lipases and a C-terminal domain that has no obvious sequence
homologs. The EDS1 protein family, as defined by this organisation, is involved in multiple plant
stress signalling pathways. While recent studies have helped to genetically position EDS1, PAD4
and SAG101, their biochemical mode of action remained elusive.
To gain mechanistic insights into their functions, the structures of EDS1-containing complexes
should be elucidated by means of X-ray crystallography. This thesis describes the preparation of
recombinant proteins, their characterisation and the de novo structure solution of a functional
complex between EDS1 and SAG101.
I found that EDS1, despite being closely related to eukaryotic lipases at sequence and structure
level, does not utilise conserved lipase features to bind or process a (lipid-derived) signalling
molecule in central immune pathways of the model plant Arabidopsis. The lipase-like half of the
protein is rather optimised for protein-protein interactions within the EDS1 family.
The interactions between EDS1 and SAG101 were characterised in vitro and in vivo and used
to infer a homology model of PAD4. EDS1, PAD4 and SAG101 loss-of-interaction variants
were proposed on the basis of this structural information and could be verified experimentally.
These will help to further discriminate between the functions of single components and protein
complexes within EDS1-dependent pathways.
While interactions within the EDS1 protein family are largely driven by the lipase-like half, the
C-terminal EP domain is sequentially and structurally unique but reveals a distant relation to
proteins that exist in multi-protein complexes. This domain potentially acts as a binding platform
for proteins outside the EDS1 family and could gain importance as the number of experimentally
characterised EDS1 interactors is constantly growing.
1
Zusammenfassung
Als sessile Organismen sind Pflanzen ständigen Attacken durch Pathogene ausgesetzt und haben
als Antwort darauf ein komplexes Immunsystem entwickelt. Die erste Ebene pflanzlicher Immu-
nität erkennt Pathogene noch außerhalb der Zelle und aktiviert Resistenzmechanismen die in der
Regel ausreichen, einen Befall durch das Pathogen zu verhindern. Eine Vielzahl von Pathogenen
synthetisiert allerdings sogenannte Effektormoleküle, die diese Resistenzmechanismen aushebeln
und so den Befall der Pflanze ermöglichen. Eine zweite Ebene des pflanzlichen Immunsystems
erkennt solche Effektoren mittels intrazellulärer Immunrezeptoren, den sogenannten R (Resis-
tenz) Proteinen. Erkennung des Effektors führt zu einer Immunantwort, die häufig mit lokalem
Zelltod am Ort der Infektion assoziiert ist und deshalb strikt reguliert werden muss.
Das nukleo-zytoplasmatische Protein EDS1, das ist allen höheren Pflanzen existiert, übernimmt
eine zentrale regulatorische Rolle nach Effektor-Erkennung. EDS1 wechselwirkt mit den sequenz-
verwandten Proteinen PAD4 und SAG101, die, ebenso wie EDS1, in eine N-terminale Domäne
mit Ähnlichkeit zu eukaryotischen Lipasen und eine C-terminale Domäne organisiert sind, für die
sich keine offensichtlichen Sequenzhomologe finden. Die EDS1 Proteinfamilie ist durch diese Or-
ganisation charakterisiert und spielt eine zentrale Rolle in unterschiedlichsten Stress-Signalwegen
der Pflanze. Während genetische Analysen geholfen haben, die EDS1 Familie in diese Signalwege
einzuordnen, blieb ihre biochemische Funktion unbekannt.
Um mechanistische Einblicke in ihre Funktion zu erlangen, sollten die Strukturen von EDS1-
assoziierten Proteinkomplexen mittels Röntgenstrukturanalyse gelöst werden. In dieser Arbeit
ist die Präparation von rekombinanten Proteinen, deren Charakterisierung und eine neuartige
Struktur des funktionalen Komplexes aus EDS1 und SAG101 beschrieben.
Ich konnte zeigen, dass EDS1 trotz seiner strukturellen Verwandtschaft zu Lipasen in zen-
tralen Immunsignalwegen der Modellpflanze Arabidopsis weder ein (lipidähnliches) Kleinmolekül
bindet noch umsetzt. Die lipase-ähnliche Domäne ist vielmehr optimiert, um Protein-Protein
Wechselwirkungen innerhalb der EDS1 Familie zu vermitteln. Die Wechselwirkungen zwischen
EDS1 und SAG101 wurden in vitro und in vivo charakterisiert und dazu benutzt, ein Homologie-
Modell von PAD4 zu erstellen. Interaktionsdefiziente Varianten von EDS1, PAD4 und SAG101
wurden auf Basis dieser Strukturen vorgeschlagen und experimentell validiert. Diese stellen wert-
volle Werkzeuge dar, um zwischen den biologischen Funktionen von einzelnen Proteinen und
Protein-Komplexen innerhalb EDS1-abhängiger Signalwege zu unterscheiden.
Während die Interaktionen innerhalb der EDS1 Proteinfamilie vor allem von der lipase-ähnlichen
Domäne bestimmt werden, scheint die C-terminale EP Domäne auf Sequenz- und Strukturebene
einzigartig zu sein. Eine entfernte strukturelle Verwandtschaft zu Proteinen aus Multiprotein-
Komplexen bedeutet möglicherweise, dass diese Domäne Interaktionen außerhalb der EDS1-
Familie vermittelt. Dieser Aspekt könnte in Zukunft an Bedeutung gewinnen da zunehmend
mehr EDS1 Interaktoren charakterisiert werden.
2
1. Introduction
"The extent of land is limited – that is perfectly true. But the labour power to be
employed on this area increases along with the population; and even if we assume
that the increase in yield due to this increase does not always rise in proportion to the
labour, there still remains a third element – which the economists, however, never
consider as important – namely, science, the progress of which is just as unceasing
and at least as rapid as that of populations."
— Friedrich Engels, Outlines of a Critique of Political Economy, 1843
1.1. The Need For Resistant Plants
Almost 50 years before Friedrich Engels published his "Outlines of a Critique of Political Econ-
omy", the British reverend Thomas Malthus already discussed the dangers of population growth
in his "Essays on the Principle of Population" [Malthus, 1798]. With a world population that was
only reaching one billion people at the beginning 19th century, Malthus could have hardly imag-
ined the world would accommodate seven times more people by 2012. Pointed out by Engels,
scientific progress in agriculture has ever since impacted the attainable yields of food crops and
provides the basis for today’s world nutrition. Yet, given that the world population is projected
to reach more than 9 billion people by 2050, food security remains a challenge. As agricultural
crops have further gained importance as a source of renewable energy, the optimisation of crop
yields is of worldwide concern.
Recently reviewed by Oerke [2006], crop losses are due to abiotic (irradiation, water supply,
temperature, nutrients) or biotic factors. Analysing 19 worldwide regions, he estimated that the
potential loss to competing weeds, animal pests and pathogens exceeds 50% of the attainable
crop yield. While established crop protection such as mechanical weeding and the use of pesticides
improved the situation, farmers still loose about one third of their yield as a consequence of biotic
stress [Oerke, 2006].
1.1.1. Genetically Engineered Crop Resistance
Since the first plant genome of Arabidopsis thaliana (hereafter referred to as Arabidopsis) was
published in 2000 [Arabidopsis Genome Initiative, 2000], sequencing techniques have become
more sophisticated and led to an exploding number of available genomes in recent years. Although
heavily debated, this information is and will be used to genetically engineer plants with desired
traits including the resistance to drought and pathogens.
Genetically modified crops have been dominated by two major traits: (1) the introduction of
tolerance against the herbicide glyphosate and (2) an endotoxin that confers resistance against
insect pests.
Glyphosate (or N-(phosphonomethyl)glycine) is a broad range herbicide that kills weeds which
would otherwise compete with crop plants. It inhibits the largely plant specific enzyme 5-enol-
pyruvylshikimate-3-phosphate synthase and thereby interferes with the synthesis of essential
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amino acids. Glyphosate became extremely popular in the United States after the commerciali-
sation of plants that carry a resistance against them in 1996. Since then, glyphosate has become
one of the most widely used herbicides (Fig. 1.1). The specificity of glyphosate led to the antic-
ipated decrease of herbicide application on U.S. acres during the first years after its introduction.
Yet, from 2001 until today the amount of herbicides used on U.S. acres has increased ever since
and was ultimately 70% higher in 2011 than it was in 1996 [Benbrook, 2012] (Fig. 1.1).
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Figure 1.1 | Popularity of genetically modified crops in the U.S. and their impact on pesticide
use. The area in the United States on which HR (herbicide resistant) and Bt (Bacillus thuringiensis)
crops were planted (red bars) and the annual in- or decrease of the amount of pesticides (herbicides
or insecticides) used on all U.S. acres (black lines) are plotted. Data are taken from Benbrook [2012].
The most important factor driving this trend is the occurrence of glyphosate-resistant weeds[1].
Reliance on a single herbicide creates a strong selection pressure towards the corresponding re-
sistance in weeds that these can develop relatively fast due to short generation times. Farm-
ers responded by increasing the herbicide application rates per year, leading to a doubling of
glyphosate consumption between 1996 and 2006 [Benbrook, 2012].
Herbicide resistant weeds promoted the popularity of a different genetically engineered trait
that enables crop plants to produce endotoxins that originate from the soil bacterium Bacillus
thuringiensis (Fig. 1.1). The transgenic plants are therefore termed Bt crops. These endotoxins
are insecticidal in that they, once activated, form pores in the membranes of insect gut cells that
lead to death of these cells and ultimately of the insect. The widespread use of Bt crops in
the United States indeed helped to constantly decrease the amount of insecticides sprayed on
U.S. acres since 1996 (Fig. 1.1). Although different insects species had been already shown to
develop a resistance against Bt endotoxins in the laboratory (those are reviewed in [Tabashnik
et al., 2003]), it was not until 2011 that also a field-evolved resistance was reported [Gassmann
et al., 2011].
The rise of pesticide ineffectiveness due to pathogen resistance underlines the importance to
develop new crop protection methods. Intensive research is necessary to introduce resistance at
[1]http://www.weedscience.org/ tries to keep track of emerging resistances. (request date: January, 2013)
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a faster rate than that by which the pests evolve counter-resistance. Instead of traits conferring
herbicide resistance or such originating from non-plant organisms, these may as well rely on the
innate immune systems that plants possess. For that, a comprehensive understanding of plant
immunity and its components is necessary.
1.2. How Plants Defend Themselves
Plants, like humans, have evolved a multi-layered immune system. Despite striking similarities
between them, they are differently organised.
The human immune system consists of three layers: (1) physical, chemical and biological
barriers, (2) an innate branch of immunity and (3) the adaptive immune system.
Physical, chemical and biological barriers like our skin, antibacterial enzymes or the gut flora
that competes with pathogenic bacteria, efficiently fend off attacks of most pathogens (see for
example [Turvey and Broide, 2010]).
If this first line of defence fails, invading pathogens are recognised by cells of the innate im-
mune system. These utilise a limited set of pattern recognition receptors that perceive microbial
components, which are conserved among large groups of pathogens, the so-called pathogen-
associated molecular patterns or PAMPs[2]. Upon PAMP recognition, complex signalling path-
ways become activated that culminate in the induction of a protective inflammatory response.
These pathways are also essential for the initiation of the third line of defence, the adaptive
immune system. This layer of immunity utilises highly specialised cells that travel through the
blood and lymphatic system and display structurally related receptors that are, however, ex-
tremely diverse regarding their capability to detect non-self molecules, the so-called antigens.
Antigen recognition does not only lead to the elimination of the pathogen but also establishes an
immunological memory that render the immune response upon recurrence of an antigen faster
and more efficient.
Plants as well have three layers of immunity that do partially overlap: (1) preformed barriers,
(2) a PAMP-triggered immune response and (3) the effector-triggered immunity [Jones and
Dangl, 2006]. Unlike humans, plants lack an adaptive immune system but rely solely on an
innate immune system whose components are present in every cell of the plant. Within the
next sections, I will present molecular and structural details of plant immunity and will position
the central immune regulator ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1) within plant
resistance signalling.
1.2.1. A First Layer of Inducible Plant Immunity Restricts Infection by Most
Pathogens
The first obstacle an invading plant pathogen has to overcome are preformed barriers. Like the
intact skin of humans, those include physical barriers such as the cell wall, leaf hairs (trichomes)
and the plant cuticles (waxy layers that cover most of the plants surface). The mechanical
[2]Instead of PAMPs the term microbial-associated molecular patterns or MAMPs has been suggested since both
pathogenic and non-pathogenic microbes produce MAMPs that would activate the immune response [Ausubel,
2005].
5
1. Introduction
barriers are complemented with a chemical barrier made of phytoanticipins [Nürnberger and
Lipka, 2005][3].
Pathogens that are able to overcome preformed defence mechanisms activate the first inducible
layer of plant defence. Similar to the innate immune system of humans, the invading pathogen is
recognised through conserved microbial molecules, the already introduced PAMPs. They include
bacterial flagellin, chitin from the fungal cell wall or specific glucans from oomycetes [Altenbach
and Robatzek, 2007]. The activated immune responses are collectively termed PAMP-triggered
immunity.
In plants, 10 pairs of PAMPs and their respective pattern recognition receptors have been
identified [Robatzek and Wirthmueller, 2012]. The probably best studied pair is bacterial flagellin
that is recognised by the FLAGELLIN SENSING 2 (FLS2) receptor. The membrane-anchored
FLS2 receptor comprises three domains: (1) an extracellular domain that consists of leucine-rich
repeats (LRRs), (2) a membrane-spanning domain and (3) an intracellular kinase domain. FLS2
perceives flagellin through the horseshoe-shaped LRR domain [Gòmez-Gòmez and Boller, 2000].
This leads to a dimerisation of FLS2 with the receptor kinase BAK1 and mutual phosphorylation
of BAK1 and the FLS2 kinase domains is thought to result in downstream signalling (Fig. 1.2 A)
although Robatzek and Wirthmueller [2012] point out that "the quest for FLS2 crystal structures
is open" and the precise mechanisms of FLS2 signal transduction are still elusive.
While the molecular details of pattern recognition receptor signalling are thus poorly under-
stood, the resulting responses are comparatively well studied. Reviewed by Nicaise et al. [2009],
these include strengthening of the preformed barriers through the deposition of callose into
the plant cell wall and the closure of stomatas that constitute an entry point for the invading
pathogens. Additionally, PAMP recognition leads to a complex genetic reprogramming of the
plant cell through miRNA-mediated gene silencing and an activation of MAP kinase cascades
that, in turn, regulate transcription factors of the WRKY-type. The sum of these outputs is in
most cases sufficient to stop pathogen invasion. They further prime the plant’s immune sys-
tem through the establishment of a systemic acquired resistance that helps to effectively stop
subsequent pathogen infection [Mishina and Zeier, 2007].
1.2.2. The Second Layer of Activated Plant Immunity Needs to Be Tightly
Regulated
In a simplified view, plant pathogens have phylogenetically evolved so-called effector molecules
that allow them to overcome a PAMP-triggered immunity through different strategies. One is
to directly target the pattern recognition receptors or their associated proteins.
The model bacterium Pseudomonas syringae pv. tomato (Pto) DC3000 for instance produces
a small protein, AvrPto, that directly interacts with the FLS2 receptor (see above) and prevents
receptor phosphorylation, thereby suppressing an FLS2-mediated immune response [Xiang et al.,
2008, 2011]. This leads to an effector-triggered susceptibility of the plant (Fig. 1.2 B).
[3]VanEtten et al. [1994] propose to define phytoanticipins as molecules that are present in plants before chal-
lenge by microorganisms whereas phytoalexins are antimicrobial compounds that are both synthesised by and
accumulated in plants after exposure to microorganisms.
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Plants, in turn, have co-evolved a class of intracellular receptors to specifically recognise
these effector molecules and activate another layer of immunity, the effector-triggered immune
response. The involved immune receptors are termed R (resistance) proteins. They exist in
every plant cell and belong almost exclusively to the NB-LRR class that generally comprises
three domains: a C-terminal leucine-rich repeat (LRR) domain that we already know from the
membranous pattern recognition receptors, a central nucleotide binding (NB) domain and N-
terminally either a coiled-coil (CC) or a Toll/Interleukin-1 receptor (TIR) domain.
While a CC- and TIR-domain from barley and flax have been analysed structurally [Maekawa
et al., 2011; Bernoux et al., 2011], the nucleotide binding and leucine-rich repeat domains of
plant R proteins still need to be computationally modelled. Takken and Goverse [2012] have
collected this fragmentary knowledge to propose a model for a functional plant R protein: the
C-terminal LRR domain is thought to recognise the effector molecule and accordingly exhibits
hypervariable amino acids that are under positive selection for effector perception [Seeholzer
et al., 2010]. This recognition can happen directly through physical interaction or indirectly by
detecting the modification(s) caused by the effector on its host target.
Although cases of direct effector recognition have been reported by Dodds et al. [2006] and
others, it is only hard to conceive that this is a general mechanism as Arabidopsis encodes only
149 NB-LRR proteins [Meyers et al., 2003] while the introduced Pseudomonas syringae isolate
Pto DC3000 already produces 39 effectors [Baltrus et al., 2011]. One of these Pto effectors,
the already introduced AvrPto, physically interacts with the intracellular protein kinase Pto that,
in turn, needs the NB-LRR R protein Prf to activate defence signalling (Fig. 1.2 C).
This indirect type of effector recognition by an R protein can be explained through different
models. In the guard model, Pto would be a general component of plant defence which is directly
attacked by the AvrPto effector that tries to shut down Pto-mediated immunity. The guarding
NB-LRR R protein Prf, however, would recognise the actions of AvrPto (instead of AvrPto
itself) and trigger an immune response. This hypothesis was proposed by Van der Biezen and
Jones [1998] and helps to explain how a limited set of R proteins can recognise a wide range of
effectors.
The guard model was modified by Van der Hoorn and Kamoun [2008] who argue that it results
in an evolutionary unstable situation as soon as populations of a plant species either possess or
lack an R protein for successful effector recognition. This would lead to an opposing selection
pressure on the guarded effector target (the guardee) if it is required for immune signalling:
in the plant population lacking the R protein, evolutionary selection would drive the guardee
to decrease affinity for the effector in order to evade detection and inhibition by the effector’s
action. Contrary, in a population where the R protein is present, evolutionary selection would
lead to an increased affinity between the guardee and effector to enhance pathogen perception.
They thus propose a decoy model in which the effector target (the decoy) is essential for effector
recognition, yet not for immune signalling. It rather mimics the actual effector target and acti-
vates downstream immune pathways upon effector recognition. Although experimental evidence
is lacking, the Pto kinase could in such a model act as a mimic for the FLS2 kinase domain.
Insights from a AvrPto/Pto complex crystal structure [Xing et al., 2007] have helped to
understand the subsequent signalling events. Pto, either as a guardee or a decoy, is assumed
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Figure 1.2 | PAMPs and effectors trigger different plant immune responses. (A) Bacterial flagellin
can be recognised as a PAMP by the pattern recognition receptor FLS2. This leads to a dimerisa-
tion of the receptor with the receptor kinase BAK1 and mutual phosphorylation events that activate
pathways leading to a PAMP-triggered immunity in an unknown way. (B) Pathogens have evolutionary
evolved effector molecules like AvrPto that are injected into the plant cell and inhibit components of
PAMP-triggered immunity (e.g. the FLS2 kinase domain). (C) These effectors are recognised by
intracellular immune receptors that usually contain a C-terminal leucine-rich repeat (LRR) domain, a
central nucleotide binding (NB) domain and varying types of N-terminal domains. AvrPro gets recog-
nised through the concerted actions of the Pro kinase and the NB-LRR protein Pfr that together
trigger an immune response. Figure adapted from [Chinchilla et al., 2009] and [Ntoukakis et al., 2013].
to act as a cofactor stabilising the inactive conformation of the NB-LRR protein Pfr. Upon the
formation of an AvrPto-Pto complex, a structural change within the Pto kinase domain leads to a
conformational rearrangement and activation of Pfr. Because there is neither ultimate evidence
for the guard model nor the decoy model, this bait-and-switch model, with Pto acting as a
bait that switches on Pfr upon AvrPto perception, has been proposed as a general mechanism
for indirect effector recognition [Collier and Moffett, 2009]. The different modes of effector
recognition are summarised in Figure 1.3.
The immune output following effector recognition differs significantly from a PAMP-triggered
immune response in being generally faster and more prolonged [Tsuda and Katagiri, 2010].
Although both pathways share common features and cellular machineries [Kim et al., 2012],
effector-trigger immunity is usually associated with a so-called hypersensitive response that is
rather uncommon (but possible, see [Naito et al., 2008]) for an immune response triggered by
PAMPs.
The hypersensitive response is characterised by local cell death at the site of pathogen infection,
a mechanism comparable to the scorched earth policy used in warfare: to fend off an attack,
anything that might be useful for the invader is destroyed. A hypersensitive response is thus only
effective against biotrophic (such living on host tissue) but not necrotrophic (such killing cells
and living from the remains) pathogens. Although plants are modular organisms that can kill
single leaves without further consequences, a hypersensitive response needs tight regulation to
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Figure 1.3 | Effector recognition models. Pathogen effectors can be recognised differently by intra-
cellular plant immune receptors of the NB-LRR class. As direct recognition is assumed to be rather
rare, the guard and decoy model have been proposed. In the guard model, the host target (blue) has
a function in plant immunity and is thus attacked by an effector. The effector’s activity (e.g. a mod-
ification of the host target) is perceived by an NB-LRR receptor that is able to guard more than one
guardee. In the decoy model, the guarded molecule is not active in immune signalling but rather mimics
a component of plant immunity luring the effector away from its actual target. In the bait-and-switch
model, a bait molecule (either a guardee or a decoy) resides in complex with an immune receptors and
resistance signalling is activated upon effector interaction.
prevent spreading cell death and to reduce the cellular costs of an induced resistance [McDowell
and Simon, 2006].
1.3. How EDS1 Is Involved in Plant Defence Signalling
As described above, the 149 Arabidopsis NB-LRR R proteins can be divided into two groups:
while CC-NB-LRR R proteins signal through the membrane-associated protein NDR1 (NON-
RACE SPECIFIC DISEASE RESISTANCE 1), TIR-NB-LRR R proteins generally use the nucleo-
cytoplasmatic protein EDS1 (ENHANCED DISEASE SUSCEPTIBILITY 1) as a signal trans-
ducer [Aarts et al., 1998].
1.3.1. EDS1 Forms Molecularly and Spatially Distinct Complexes Within Plant
Cells
EDS1 has been characterised in chemically mutagenised Arabidopsis plants that showed an en-
hanced disease susceptibility phenotype against an oomycete pathogen that causes downy mildew
[Parker et al., 1996], a plant disease common for grapevine, hop and other agricultural important
plants. In a similar screen, Glazebrook et al. [1996] identified PAD4 (PHYTOALEXIN DEFI-
CIENT 4) as another central immune component of Arabdidopsis against multiple pathogens and
Feys et al. [2001] could demonstrate that EDS1 and PAD4 interact directly in yeast two-hybrid
assays and in plant cells. Almost ten years after the identification of EDS1 and PAD4, another
protein of then unknown function, SAG101 (SENESCENCE ASSOCIATED GENE 101), was
shown to interact and function together with EDS1 in plant immunity [Feys et al., 2005].
Complexes of EDS1 with PAD4 are detectable inside the cytoplasm and nuclei of plant cells
while such of EDS1 and SAG101 exists predominantly in the nucleus [Feys et al., 2005; Zhu
et al., 2011]. EDS1 is further able to interact with itself in planta and does so primarily in
the cytoplasm as resolved by measuring FRET signals between transiently expressed fluorescent
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protein-tagged proteins in individual Arabidopsis cell compartments [Wiermer, 2005; Feys et al.,
2005]. Analysis of protein accumulation in plants that lack either EDS1, SAG101, PAD4 or
combinations of them revealed that the proteins are stabilised through their interaction partners
[Feys et al., 2005].
Analytical size exclusion chromatography using pathogen-unchallenged Arabidopsis leaf ex-
tracts suggests that EDS1 forms preferentially homodimers with itself (∼ 143 kDa) and het-
erodimers with SAG101 (∼ 133 kDa) [Feys et al., 2005]. Judging from these experiments, EDS1
exists additionally as a monomer (∼ 72 kDa) and in a higher molecular mass complex with PAD4
(∼ 200 kDa) that could consist of two EDS1 and one PAD4 molecules (or could include yet
unknown components).
A recent study further proposes a ternary complex in which EDS1 bridges between PAD4
and SAG101 if the proteins are transiently expressed in tobacco plants [Zhu et al., 2011]. In
contrast, a ternary complex could not be shown in yeast two-hybrid assays or in vitro between
recombinantly produced proteins [Rietz et al., 2011]. This illustrates that there are still open
questions concerning the assembly of EDS1-requiring complexes. The next paragraphs will
illustrate that these complexes, but additionally the single components, are involved in various
plant signalling pathways.
1.3.2. EDS1 Complexes Fulfil Different Functions in Plant Immunity
EDS1 Acts in Multiple Plant Resistance Types Both EDS1 and PAD4 were shown to be
required for Arabidopsis resistance conferred by R proteins of the TIR-NB-LRR type (e.g. RPP2,
RPP4, RPS4) but dispensable for immune signalling through CC-NB-LRR R proteins (e.g. RPS2,
RPS5) [Glazebrook et al., 1997; Parker et al., 1996; Zhou, 1998; Aarts et al., 1998]. This seems
to be conserved among higher plants as EDS1 is also required for immunity that is mediated
by the TIR-type R protein N but not the CC-type R protein Rx in tobacco plants [Peart et al.,
2002]. As a CC-NB-LRR protein, which confers resistance against the biotrophic turnip crinkle
virus, and an atypical R protein, which protects Arabidopsis from the powdery mildew plant
disease, additionally depend on EDS1, this discrimination might be an oversimplification [Xiao
et al., 2005; Chandra-Shekara et al., 2004].
RPP (RESISTANCE TO PERONOSPORA PARASITICA) and RPS (RESISTANCE TO PSEU-
DOMONAS SYRINGAE) TIR-NB-LRR R proteins recognise effectors of the biotrophic oomycete
Hyaloperonospora arabidopsidis (formerly Peronospora parasitica and hereafter referred to as
Hyaloperonospora) and of the biotrophic bacterium Pseudomonas syringae.
Phenotypically, Arabidopsis plants lacking EDS1 (eds1) show a complete loss of TIR-NB-LRR-
mediated resistance characterised by the absence of localised cell death after Hyaloperonospora
infection (Fig. 1.4). In contrast, mutant plants missing PAD4 (pad4) retain a limited hypersen-
sitive response that is, however, insufficient to halt pathogen growth completely. This leads to
a trailing necrosis along the path of pathogen growth (Fig. 1.4 and [Feys et al., 2001]).
An Arabidopsis pad4 mutant phenotype that is an intermediate between an immune response
of wild-type plants and such that lack EDS1 (eds1) can also be observed if the plants are infected
with Pseudomonas syringae bacteria expressing the effector AvrRps4 that is recognised by the
EDS1-dependent TIR-NB-LRR protein RPS4 (Fig. 1.4).
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(Pseudomonas) Figure 1.4 | Phenotypes of eds1
and pad4 mutant plants. Wild-
type Arabidopsis plants of accession
Landsberg erecta (Ler) were inoculated
with a Hyaloperonospora cell suspen-
sion. Leaves were photographed 6 d af-
ter inoculation. Trailing necrosis (tn) in
pad4-2 is indicated by an arrow. Leaves
were stained with Trypan Blue 5 days
after inoculation to visualise pathogen
mycelium (m) and dead plant cells (d).
For bacterial infection, leafs were dipped
in a cell suspension of Pseudomonas sy-
ringae pv. tomato (Pto) DC3000 ex-
pressing the effector AvrRps4 and pho-
tographed after 6 d. Figures taken from
[Feys et al., 2001].
In contrast, sag101 mutant plants show a wild-type like hypersensitive response in similar
assays [Feys et al., 2005]. However, a pad4/sag101 double mutant plant is as susceptible as
an eds1 plant arguing for a redundancy between PAD4 and SAG101 in TIR-NB-LRR R protein
mediated immune signalling [Feys et al., 2005]. The same is true for so-called basal resistance
[Feys et al., 2005].
As this will become important, I will briefly explain the different modes of interaction between
Arabidopsis and the oomycete Hyaloperonospora. As reviewed by Coates and Beynon [2010], the
interaction between Arabidopsis accessions and Hyaloperonospora isolates show extreme levels of
genotypic and phenotypic variation due to a constant co-evolution between host and pathogen.
One can discriminate between compatible and incompatible interactions and (if an Arabidopsis
plant from the same accession is used) between compatible and incompatible Hyaloperonospora
isolates. An incompatible isolate activates a hypersensitive response through the recognition of an
effector by the corresponding R protein and will be efficiently restricted in growth. The interaction
between Hyaloperonospora isolate Noco2 and Arabidopsis accession Landsberg erecta (Ler) in
Figure 1.4 is a perfect example. Absence of effector recognition through the respective R protein
results in a compatible interaction and allows pathogen growth. Importantly, residual defence
mechanisms remain active during an compatible interaction and result in a basal resistance of the
plant. Jones and Dangl [2006] define basal resistance as the additive effects of a PAMP-triggered
and weak effector-triggered immunity minus those of an effector-triggered susceptibility.
Both EDS1 and PAD4 have been shown to be required for the accumulation of the plant
hormone salicylic acid in an effector-triggered immune response mediated by TIR-NB-LRR (but
not CC-NB-LRR) R proteins [Falk et al., 1999; Feys et al., 2001; Zhou, 1998] and in basal
resistance. As transcription of both proteins is, in turn, upregulated by the application of salicylic
acid [Falk et al., 1999; Jirage et al., 1999], EDS1 and PAD4 are thought to act in a positive
feedback loop leading to increased salicylic acid levels. Salicylic acid is known to act in the
establishment of the systemic acquired resistance that primes the plant’s immune system against
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further pathogen attacks [Métraux et al., 1990; Vlot et al., 2009]. EDS1 thus functions in
effector-triggered, basal and systemic acquired resistance.
Spatially and Molecularly Distinct EDS1 Complexes Discriminate Between Functional
States Recent studies suggest that EDS1 and PAD4 exist in a complex and as separate entities
and that these states discriminate between individual functions [Rietz et al., 2011]. An EDS1
variant (EDS1L262P) that is unable to interact with PAD4 but still able to bind SAG101 was
therein used to show that physical interaction between EDS1 and PAD4 is necessary for a basal
and systemic immune response but not for TIR-NB-LRR-triggered resistance. The ability of in-
dividual EDS1 and PAD4 to establish a TIR-NB-LRR-triggered cell death is not due to SAG101
compensation as the same phenotypes have been shown in a sag101 mutant background [Rietz
et al., 2011].
Functions within EDS1-related complexes are further discriminated by cellular localisation:
García et al. [2010] demonstrated that EDS1 is actively shuttled between the cytoplasm and the
nucleus of plant cells through components of the nuclear pore complex. The authors could show
that EDS1 is accumulated in the nucleus upon pathogen infection and that nuclear EDS1 drives a
TIR-NB-LRR-mediated transcriptional reprogramming, including genes that are essential for the
synthesis and signalling of salicylic acid. While the role of a cytoplasmic EDS1 pool is less clear, it
may act in counterbalancing the actions of nuclear EDS1 [García et al., 2010]. Active transport
of EDS1 between both compartments and the restriction of SAG101 to the nucleus however
imply that proper protein localisation is required for full functionality. The inability of SAG101 to
fully compensate for the loss of PAD4 in TIR-NB-LRR-mediated and basal resistance (compared
to the vice versa, see above) might result from a cellular imbalance of EDS1 heterocomplexes
and further supports this claim. Proposed EDS1-containing complexes and their putative role in
TIR-NB-LRR-dependent immune signalling is schematically depicted in Figure 1.5.
1.3.3. Manifold Stress Pathways Rely on EDS1, PAD4 and SAG101
The role of localised cell death that is mediated by EDS1 and PAD4 extends beyond a plant’s
resistance against biotrophic pathogens (Pseudomonas, Hyaloperonospora and others). When
herbivorous insects deposit their eggs on Arabidopsis and other plants, these use a cell death
mechanism that shares similarities with a hypersensitive response triggered by effector recognition
[Little et al., 2007] and these mechanisms have recently been shown to depend on EDS1 [Gouhier-
Darimont et al., 2013].
Mateo et al. [2004], Rustérucci et al. [2001] and others observed that EDS1 and PAD4 are
moreover required in the regulation of cell death upon plant photo-oxidative stress that can
be caused by high light. The authors analysed Arabdiopsis lsd1 (lesions simulating disease 1)
mutant plants that fail to stop the initiation and propagation of cell death upon light stress
or application of superoxide ions and found that all traits (e.g. reduced catalase activity and
stomatal conductance) were dependent on EDS1 and PAD4. As Straus et al. [2010] could
reveal that cell death upon photo-oxidative stress in another Arabdiopsis mutant (nudt7) is as
well EDS1-dependent, they proposed that EDS1 has a "master" role in coordinating biotic but
also abiotic stress stimuli.
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Figure 1.5 | Hypothetical model of EDS1-related protein functions in TIR-NB-LRR-mediated re-
sistance. EDS1 is a nucleo-cytoplasmatic protein. Proposed by Feys et al. [2005], EDS1 dimers
exist alongside heterocomplexes with PAD4 inside the cytosol while the plant cell nucleus contains
EDS1/SAG101 and EDS1/PAD4 heterocomplexes. The authors further found EDS1 monomers but
did not analyse their cellular localisation. Zhu et al. [2011] proposed a nuclear EDS1/PAD4/SAG101
ternary complex for that, however, neither Feys et al. [2005] nor Rietz et al. [2011] found further
evidence. I tried to integrate the current literature into a very schematic EDS1 working model. Upon
effector recognition through an TIR-NB-LRR R protein, EDS1 and PAD4 (probably separated from
another) "kick-start" the resistance response and trigger a localised cell death at the infection site
[Rietz et al., 2011]. EDS1 in an unknown state is then actively shuttled into the nucleus through the
nuclear pore complex (NPC) and triggers transcriptional reprogramming of resistance genes [García
et al., 2010]. This leads to an accumulation of the plant hormone salicylic acid which establishes a
systemic acquired resistance in neighbouring cells that do not undergo programmed cell death [Rietz
et al., 2011].
In addition to EDS1-requiring complexes, the EDS1 binding partners SAG101 and PAD4 seem
to fulfil functions independent of EDS1. SAG101 has been shown to be essential for a de-
fence response of Arabidopsis against the biotrophic turnip crinkle virus [Zhu et al., 2011] and
PAD4 acts independently of EDS1 in the resistance of Arabidopsis plants against feeding of the
green peach aphid, an insect that is considered an agricultural pest as it transmits plant viruses
[Pegadaraju et al., 2007, 2005].
1.3.4. The Biochemical Role of the EDS1 Protein Family Remains Elusive
Interestingly, Louis et al. [2012] observed that some, yet not all, resistance functions of PAD4
against green peach aphid feeding seem to depend on potentially catalytic residues within the
N-terminal half of PAD4. Both, PAD4 and EDS1, had long before been shown to be sequentially
related to hydrolases (or, more precisely, lipases) [Falk et al., 1999; Jirage et al., 1999]. The
similarity of N-terminal EDS1 and PAD4 to eukaryotic lipases encompasses three conserved
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residues in Arabdiopsis EDS1 and PAD4 that may represent a catalytic serine-aspartate-histidine
(S-D-H) triad that is essential for the function of many hydrolytic enzymes. Louis et al. [2012]
exchanged the serine within the PAD4 triad to an alanine and expressed this protein variant
stably in Arabidopsis instead of wildtype PAD4. The authors observed that pathogenic green
peach aphid insects spent significantly more time feeding on these mutant plants, arguing for a
hydrolytic activity of PAD4 in this particular response. Apart from this finding, the role of EDS1,
PAD4 and SAG101 enzymatic activity is largely unknown.
In addition to the N-terminal lipase-like domain, Falk et al. [1999] and Jirage et al. [1999]
reported that EDS1 and PAD4 possess a C-terminal domain for which they found no sequence
homologues. Feys et al. [2001] recognised that the C-terminal domains of EDS1 and PAD4
are closely related to each other and coined the term EP-domain (for EDS1-PAD4 defined).
Already then, they reported that SAG101 is the only other Arabidopsis protein that is likewise
organised and after showing a physical interaction between EDS1 and SAG101, they propose a
domain organisation as depicted in Figure 1.6 [Feys et al., 2005]. As the EP domain seems to
be unique among plant and non-plant proteins, EDS1, PAD4 and SAG101 can be considered to
form a protein family and they will be thus collectively referred to as the EDS1 (protein) family
throughout this thesis.
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Figure 1.6 | Domain organisation within the EDS1 protein family. Boundaries of the lipase-like and
EP domain are shown for the Arabidopsis variants of EDS1, PAD4 and SAG101. Within the lipase-like
domains of EDS1 and PAD4, three conserved residues that might correspond to a Serine-Aspartate-
Histidine catalytic triad are marked. Figure adapted from [Feys et al., 2001].
1.3.5. Emergence of Further EDS1 Interactors
While the interactions within the EDS1 protein family have been intensively studied by yeast
two-hybrid assays and in planta [Feys et al., 2001, 2005; Rietz et al., 2011; Zhu et al., 2011],
recent studies have piled evidence that the family members could additionally interact with
other proteins. Heidrich et al. [2011] and Bhattacharjee et al. [2011] demonstrated that EDS1
physically interacts with different TIR-NB-LRR immune receptors (RPS4, RPS6 and SNC1)
and two corresponding, yet sequence-unrelated, effector proteins, AvrRps4 (perceived by RPS4)
and HopA1 (perceived by RPS6) that disrupt the EDS1/TIR-NB-LRR complexes. The authors
suggest that EDS1, possibly as an immune component in PAMP-triggered immunity (and thus
an effector target), is guarded by the interacting TIR-NB-LRR R protein (see Fig. 1.3) that
initiates an effector-triggered immune response upon EDS1/effector interaction.
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While the immune receptors RPS4 and RPS6 did not interact directly or indirectly with PAD4
[Bhattacharjee et al., 2011], another study by Kim et al. [2012] found that the TIR-NB-LRR R
protein VICTR (VARIATION IN COMPOUND TRIGGERED ROOT growth response) does not
only interact with EDS1 but also PAD4 (probably in a co-complex). Intriguingly, the interactions
between VICTR, EDS1 and PAD4 are important in the arrest of Arabidopsis root growth upon
perception of a small molecule that the authors identified by chemical screening. Although the
precise role of this small molecule needs to be determined, their work suggests that root growth
(probably in response to soil-born pathogens) is yet another plant signalling pathway regulated
in dependence of the EDS1 protein family.
1.4. Thesis Aims
The preceding paragraphs have shown that the EDS1 protein family is a central signalling hub
involved in a variety of plant processes including (1) effector-triggered immunity, (2) basal immu-
nity, (3) systemic acquired resistance, (4) regulation of cell death upon photo-oxidative stress,
(5) insect resistance and (6) root growth.
With a single exception – the role of PAD4 in insect resistance [Louis et al., 2012] – these
functions have not been linked to molecular details. Although the relation to lipases and the
possibility that any of the proteins transduces a lipid-derived molecule has been widely discussed
in the literature, this is not further supported by experimental evidence [Wiermer et al., 2005].
While sequence analysis additionally allowed to predict functional EDS1 family features including
nuclear localisation and nuclear export signals [Falk et al., 1999; García et al., 2010], it could
not further explain the biochemical mode of action and it is yet unclear how the EDS1 protein
family is activated (e.g. after effector recognition by TIR-NB-LRR R proteins) and how they
transduce downstream signals.
By analysing a limited set of proteins, Chothia and Lesk [1986] showed what has become a
dogma in structural biology, namely, that structure is generally more conserved than sequence.
This holds for more comprehensive analyses [Illergård et al., 2009] and implies that proteins
can adopt similar folds despite having different sequences. My ultimate goal was therefore a
comprehensive structure-function relationship of EDS1 and its signalling partners PAD4 and
SAG101. These structures should answer how closely the proteins are related to lipases at
the structural level and should yield insights into the unique EP domain that has no obvious
sequence homologues. To solve the structures, methods for the preparation of the proteins had
to be established. Stable variants of each protein and combinations of them should be used
in protein crystallisation experiments as a prerequisite for structure determination by means of
X-ray diffraction methods. Furthermore, the complexes should be characterised biophysically to
reveal insights into how they behave in solution and how they dynamically interact with each
other.
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"Every honest researcher I know admits he’s just a professional amateur. He’s doing
whatever he’s doing for the first time. That makes him an amateur. He has sense
enough to know that he’s going to have a lot of trouble, so that makes him a
professional."
— Charles F. Kettering
2.1. Materials
2.1.1. Chemicals
Laboratory grade chemicals and reagents were purchased from Sigma-Aldrich, Roth, Merck, Serva or
Applichem unless otherwise stated.
2.1.2. Enzymes
All enzymes used are listed in Table 2.1. These were stored at -20℃ and freshly thawed before use.
Table 2.1 | Enzymes and corresponding buffers.
Enzyme Buffer Supplier
DNase I See section 2.3.1 Boehringer
Gateway® BP Clonase™ II Mixture Supplied 10× reaction buffer Invitrogen/Life Technologies
Gateway® LR Clonase™ II Mixture Supplied 10× reaction buffer Invitrogen/Life Technologies
Lysozyme See section 2.3.1 Merck
PfuTurbo-DNA-Polymerase 10× PCR reaction buffer Stratagene
Mucor miehei lipase See section 2.4.8 Sigma-Aldrich
Restriction endonucleases Supplied 10× reaction buffer New England Biolabs
T4 DNA ligase Supplied T4 DNA ligation buffer Roche
Taq DNA polymerase 10× PCR reaction buffer MPIPZ, Köln
Trypsin Various Merck
2.1.3. Antibodies
Table 2.2 lists the primary and secondary antibodies used for immunoblot detection. Stock solutions of
antibodies that were not enzyme-conjugated were stored at -20℃ and freshly thawed before use while
enzyme-conjugates of antibodies were stored in dark vials at 4℃. Dilutions of antibodies were kept at
4℃ and used for several days while such that were not conjugated with horseradish peroxidase (HRP)
were preserved through the addition of sodium azide at a final concentration of 0.02% (w/v).
2.1.4. Oligonucleotides
Oligonucleotides were purchased from Sigma-Aldrich, Operon or Metabion. Lyophilised primers were
resuspended in bidistilled water to a final concentration of 100 µM. Working solutions were diluted to
10 pmol/µl (=10 µM).
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Table 2.2 | Used antibodies.
Primary antibody Source Dilution Supplier
α-c-Myc Mouse monoclonal 1:5000 Santa Cruz Biotechnology
α-EDS1 Rabbit polyclonal 1:1000 S. Rietz; J. Parker (MPIPZ)
α-HA 3F10 Rat monoclonal 1:5000 Roche
α-His Mouse monoclonal 1:2000 Roche
Secondary antibody Conjugated with Dilution Supplier
Goat anti-mouse IgG Alkaline phosphatase 1:5000-1:10000 Santa Cruz Biotechnology
Goat anti-rabbit IgG Alkaline phosphatase 1:5000-1:10000 Santa Cruz Biotechnology
Goat anti-rat IgG Alkaline phosphatase 1:5000-1:10000 Santa Cruz Biotechnology
Goat anti-mouse IgG Horseradish peroxidase 1:5000-1:10000 Santa Cruz Biotechnology
Goat anti-rabbit IgG Horseradish peroxidase 1:5000-1:10000 Santa Cruz Biotechnology
Goat anti-rat IgG Horseradish peroxidase 1:5000-1:10000 Santa Cruz Biotechnology
2.1.5. Buffers and Solutions
Buffers and solutions frequently used in this thesis are listed in Table 2.3 or given in the corresponding
text section if this is more appropriate. All buffers and solutions were prepared with bidistilled water and
such used for molecular biological experiments were generally autoclaved or sterile-filtered.
Table 2.3 | Solutions and buffers.
DNA gelelectrophoresis
10× running buffer 0.4M Tris, 0.2M acetic acid, 10mM EDTA, pH 8.5
6× loading buffer 40% (w/v) sucrose, 0.5M EDTA,
0.2% (w/v) bromophenol blue
DNA molecular weight marker 10% (v/v) 6× loading buffer, 5% (v/v) 1 Kb DNA
ladder (Roth)
PCR
dNTP mix 2.5mM dATP, 2.5mM dCTP, 2.5mM dGTP,
2.5mM dTTP
10× PCR reaction buffer 500mM KCl, 100mM Tris, 15mMMgCl2,
1% (v/v) Triton X-100, pH 9.0
Protein gelelectrophoresis
20× MES running buffer 1MMES, 1M Tris, 2% (w/v) SDS, 0.6% (w/v) EDTA
10× Tris-glycine running buffer 250mM Tris, 1.92M glycine, 1% (w/v) SDS
2× SDS sample buffer 60mM Tris pH 6.8, 4% (w/v) SDS, 200mM DTT,
20% (v/v) glycerol, 0.2% (w/v) bromophenol blue
6× SDS sample buffer 60mM Tris pH 6.8, 12% (w/v) SDS, 600mM DTT,
47% (v/v) glycerol, 0.6% (w/v) bromophenol blue
Staining solution [Fairbanks et al., 1971] 25% (v/v) isopropanol, 10% (v/v) acetic acid,
0.04% (w/v) Coomassie Brilliant Blue G-250
Destaining solution 25% (v/v) ethanol, 8% (v/v) acetic acid
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Staining solution [Kang et al., 2003] 10% (v/v) ethanol, 5% (w/v) aluminium sulfate,
2% (v/v) orthophosphoric acid, 0.02% (w/v) Coomassie
Brilliant Blue G-250
Destaining solution 10% (v/v) ethanol, 2% (v/v) orthophosphoric acid
Immunoblotting
TBS buffer 10mM Tris, 150mM NaCl, pH 7.5
TBS-T buffer 10mM Tris, 150mM NaCl, 0.05% (v/v) Tween 20,
pH 7.5
10× transfer buffer 250mM Tris, 1.92M glycine, 1% (w/v) SDS,
10% (v/v)Methanol
Ponceau S Dilution of ATX Ponceau concentrate (Fluka) 1:5 in
water
AP reaction buffer 50mM Tris, pH 9.5, 100mM NaCl, 0.5mMMgCl2
Protein purification
Anion exchange chromatography
AEC buffer A 50mM buffer substance (e.g. HEPES or BICINE),
1mM DTT, 0.5mM EDTA, pH 8.0
AEC buffer B 50mM buffer substance (e.g. HEPES or BICINE),
1mM DTT, 0.5mM EDTA, 1M NaCl, pH 8.0
Lysis and immobilized metal-affinity chromatography
IMAC lysis buffer 50mM HEPES, 150mM NaCl, 20mM imidazole,
1mM DTT, 10% (v/v) glycerol, pH 8.0
IMAC elution buffer 50mM HEPES, 150mM NaCl, 250mM imidazole,
1mM DTT, 10% (v/v) glycerol, pH 8.0
Protein purification from plants (adapted from [Witte et al., 2004])
Ex-Strep buffer 100mM Tris, pH 8.0, 5mM EGTA, 5mM EDTA,
150mM NaCl, 10mM DTT, plant protease inhibitor
cocktail (MPIPZ), 0.5% (v/v) Triton X-100, 100 µg/ml
avidin
W-Strep buffer 50mM Tris, pH 8.0, 2.5mM EDTA, 150mM NaCl,
2mM DTT, 0.05% (v/v) Triton X-100
Elu-Strep buffer 10mM Tris pH 8.0, 10mM desthiobiotin, 2mM DTT,
0.05% (v/v) Triton X-100
2.1.6. Recombinant Expression
Different strains of E. coli were used for plasmid transformation and protein expression. Frequently used
strains are given in Table 2.5.
Genes of interest were cloned into commercially available plasmids that are listed in Table 2.6 and often
allow to encode affinity-tag fusions of the corresponding protein product.
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Table 2.4 | Crystallisation screens.
Name No. of conditions Supplier
Crystal Screen 48 Hampton Research
Crystal Screen 2 48 Hampton Research
Crystal Screen Cryo 48 Hampton Research
Crystal Screen HT 48 Hampton Research
Grid Screen Ammonium sulfate 24 Hampton Research
Grid Screen MPD 24 Hampton Research
Grid Screen PEG/LiCl 24 Hampton Research
Grid Screen PEG6000 24 Hampton Research
Grid Screen Sodium chloride 24 Hampton Research
Grid Screen Sodium malonate 24 Hampton Research
JBScreen Classic 1-10 240 Jena Bioscience
JBScreen Kinase 96 Jena Bioscience
JCSG Core Suite I 96 Qiagen
JCSG Core Suite II 96 Qiagen
JCSG Core Suite III 96 Qiagen
JCSG Core Suite IV 96 Qiagen
PEG/Ion 48 Hampton Research
SaltRx 96 Hampton Research
Table 2.5 | Untransformed E.coli strains.
Name Supplier Genotype
E. coli BL21(DE3) Invitrogen F- ompT hsdS(rB- mB-) gal dcm (DE3)
E. coli DH5α Invitrogen F- endA1 thi-1 recA1 relA1 gyrA96 φ80dlacZ∆M15 ∆(lacZYA-argF)
U169 phoA supE44 hsdR17(rK-) mK+ λ-
E. coli DH10B Invitrogen F- endA1 recA1 galU galK nupG rpsL ∆lacX74 φ80lacZ∆M15 araD139
∆(ara leu)7697 mcrA ∆(mrr -hsdRMS-mcrBC) λ-
E. coli Rosetta™(DE3) Novagen F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE (CamR)
Table 2.6 | Empty plasmids for E.coli transformation.
Name Supplier Used for Resistance
pCDFDuet-1 Novagen Co-expression; expression as an N-terminal
6His-fusion
Streptomycin
pDEST™15 Invitrogen Expression as an N-terminal GST-fusion Ampicillin
pDEST™17 Invitrogen Expression as an N-terminal 6His-fusion Ampicillin
pET22b Novagen Expression of a C-terminal 6His-fusion Ampicillin
pET42a(+) Novagen Expression of a C-terminal 6His-fusion Kanamycin
pET59-DEST™ Invitrogen Expression as an N-terminal
6His-Trx-fusion
Ampicillin
pMAL-c2x New England Biolabs Expression as an N-terminal
MBP-FactorXa-fusion
Ampicillin
pRSFDuet-1 Novagen Co-expression; expression as an N-terminal
6His-fusion
Kanamycin
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Successfully transformed strains that were used to express frequently needed protein variants are sum-
marised in Table 2.7. The number (No.) refers to the "Stammsammlung E. coli" list used by the Niefind
group.
Table 2.7 | Selected transformed E. coli strains.
No. Strain Plasmid Insert Resistance
33 Rosetta™(DE3) pET22b EDS11-623-8His Chloramphenicol, ampicillin
35 Rosetta™(DE3) pET42a(+) EDS11-384-8His Chloramphenicol, kanamycin
45 Rosetta™(DE3) pRSF-Duet 6His-SAG1011-537 Chloramphenicol, kanamycin
47 Rosetta™(DE3) pRSF-Duet EDS11-623 w/o tag Chloramphenicol, kanamycin
56 Rosetta™(DE3) pET42a(+) EDS11-623L262P-8His Chloramphenicol, kanamycin
59 Rosetta™(DE3) pET42a(+) EDS11-616-8His Chloramphenicol, kanamycin
61 Rosetta™(DE3) pET42a(+) SAG101291-537-8His Chloramphenicol, kanamycin
64 Rosetta™(DE3) pCDF-Duet SAG1011-537 w/o tag Chloramphenicol, streptomycin
68 Rosetta™(DE3) pET59-DEST 6His-Trx-EDS11-623 Chloramphenicol, ampicillin
112 Rosetta™(DE3) pET42a(+) AaEDS11-623-8His Chloramphenicol, kanamycin
114 Rosetta™(DE3) pET22b EDS11-362-8His Chloramphenicol, ampicillin
118 Rosetta™(DE3) pET22b EDS11-384 w/o tag Chloramphenicol, ampicillin
Media that were used to cultivate E. coli cells are given in Table 2.8. All media were prepared with
deionised water and autoclaved before use. Non-autoclavable components were sterile-filtered. In most
cases, these media were supplemented with antibiotics that are listed in Table 2.9 and were stored at
-20℃ as 1000-fold concentrated stock solutions.
Table 2.8 | Media for E. coli cultivation.
Name Recipe for 1 litre
Lysogeny broth (LB) 10 g peptone, 10 g NaCl, 5 g yeast extract, pH 7.5
LB agar 10 g peptone, 10 g NaCl, 5 g yeast extract, 15 g agar, pH 7.5
Terrific broth (TB) 12 g peptone, 24 g yeast extract, 4 ml glycerol, 100 ml 0.17 M KH2PO4 and
0.72 M K2HPO4 (add sterile after autoclaving)
Table 2.9 | Antibiotics used in E.coli media.
Name Stock concentration
1000× ampicillin 100mg/ml ampicillin in water
1000× chloramphenicol 50mg/ml chloramphenicol in ethanol
1000× kanamycin 50mg/ml kanamycin in water
1000× streptomycin 50mg/ml streptomycin in water
For yeast two-hybrid studies, genes of interest were cloned into empty plasmids that were made Gateway®-
compatible by Johannes Stuttmann (MPIPZ, Köln) (Table 2.10). Successfully cloned plasmids were
transformed into yeast strain AH109 (Table 2.11).
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Table 2.10 | Empty plasmids for yeast transformation.
Name Supplier Used for Selection type Epitope
pGADT7-Rec Clontech Expression as a GAL4 AD fusion LEU2 HA
pGBKT7 Clontech Expression as a GAL4 BD fusion TRP1 c-Myc
Table 2.11 | Untransformed yeast strains.
Name Supplier Genotype
AH109 Clontech MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, LYS2 : :
GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3 : : MEL1UAS-MEL1TATA-lacZ,
MEL1
Yeast media (Table 2.12) were prepared using bidistilled water and were autoclaved before use. Non-
autoclavable components were added after being sterile-filtered.
Table 2.12 | Media for yeast cultivation.
Name Recipe for 1 litre
Synthetic defined (SD) 6.7 g nitrogen base w/o amino acids (Clontech), 20 g dexrose (add sterile
after autoclaving), pH 5.8
SD selection media 6.7 g nitrogen base w/o amino acids (Clontech), 20 g dexrose (add sterile
after autoclaving), a combination of dropout supplements (Clontech) and
amino acid stock solutions, pH 5.8
SD plates 6.7 g nitrogen base w/o amino acids (Clontech), 20 g dexrose (add sterile
after autoclaving), 15 g agar, pH 5.8
YPD 20 g peptone, 10 g yeast extract, 20 g dextrose (add sterile after
autoclaving)
2.1.7. Software
2.2. Molecular Biological Methods
2.2.1. Amplification of DNA
DNA molecules were amplified in vitro by polymerase chain reaction (PCR) adapted from Mullis
et al. [1986]. A PCR involves annealing of two oligonucleotide primers that are complementary
to the sense and anti-sense strands of a DNA template. Repeated cycles of DNA denaturing
at 94℃, primer annealing and primer elongation through a thermostable DNA polymerase allow
synthesis of major amounts of a desired DNA fragment with sizes of up to several kilobase pairs.
A typical reaction mix and thermal settings are shown below:
2.2.2. Purification of PCR Products
To remove contaminating proteins, components of the PCR reaction buffer, excessive dNTPs
etc., the PCR product was optionally cleaned using the QIAquick PCR Purification Kit (Qiagen)
21
2. Material and Methods
Table 2.13 | Used software.
Used for Software (package) Developer/Reference
Preparation of figures Adobe Illustrator Adobe Systems
Preparation of figures Adobe Photoshop Adobe Systems
Preparation of figures Inkscape http://inkscape.org/
Preparation of protein structure
figures
PyMOL [Schrödinger, LLC, 2010]
Preparation of graphs OriginPro Origin Lab
Preparation of text LaTeX Editor Adam Skórczyński and Sebastian
Deorowicz
Reference manager Mendeley Desktop http://www.mendeley.com/
DNA related software
Sequence data analysis LASERGENE® SeqMan Pro™ DNASTAR
Cloning LASERGENE® SeqBuilder™ DNASTAR
Protein related software
CD spectra analysis Spectra Manager™ JASCO
Chromatography systems FPLC/UNICORN Manager Pharmacia/GE Healthcare
Dynamic light scattering analysis DYNAMICS® Wyatt Technology
Gel documentation Image Lab™ Bio-Rad
Sequence alignments T-Coffee [Notredame et al., 2000]
Sequence alignments and
phylogenetic tree-building
SeaView [Gouy et al., 2010]
Thermofluor analysis CFX Manager™ Bio-Rad
Structural biology software
Data processing XDS [Kabsch, 2010]
Model building Coot [Emsley et al., 2010]
Molecular dynamics GROMACS [Van der Spoel et al., 2005]
Phasing CCP4 suite [CCP4, 1994]
Refinement Phenix suite [Adams et al., 2011]
Topology diagrams TopDraw [Bond, 2003]
Table 2.14 | A 50 µl PCR mix.
Component Volume
10× PCR reaction buffer 5 µl
dNTP mix 5 µl
Forward primer (10 µM) 1 µl
Reverse primer (10 µM) 1 µl
Taq DNA polymerase (4U/µl) 0.5 µl
Template DNA 1 - 50 ng
Water 37.5 µl
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Table 2.15 | Thermal setting for a standard PCR.
Stage Temperature (℃) Time No. of cycles
Initial denaturation 95 3min 1
Denaturation 95 30 sec
Annealing 50-60 30 sec 30-40
Extension 72 1min per kb
Final extension 72 3min 1
according to the manufacturer’s instructions. Purified DNA was eluted in bidistilled water or TE
buffer at pH 8.
2.2.3. Restriction Endonuclease Digestion of DNA
DNA was cut by endonucleases at specific recognition sites according to the manufacturer’s
instructions. All digests were carried out at the appropriate temperature for a minimum of 60
minutes.
2.2.4. Gel Electrophoresis of DNA Molecules
DNA molecules can be separated in agarose gels according to their size as they carry a negatively
charged phosphate backbone and migrate towards the positively charged anode in an electric field.
To prepare a 1% agarose gel that is suitable to resolve DNA fragments of a size between
500 and 10000 base pairs, 1% (w/v) agarose was boiled in TAE buffer, pH 8. Molten agarose
was cooled to approximately 50℃ before ethidium bromide was added at a final concentration
of 0.5 µg/ml. The agarose was poured and allowed to solidify before being placed in an elec-
trophoresis tank filled with TAE buffer, pH 8. Each DNA sample was mixed with 6× loading dye
before loading them onto the gel. After applying a voltage of approximately 5 V/cm distance
between tank electrodes and separation of DNA fragments, these were visualised by placing the
gel onto a UV transilluminator set to a wavelength of 312 nm.
2.2.5. Isolation of DNA Fragments from Agarose Gels
DNA fragments visualised on a UV transilluminator were excised from a separating agarose gel
using a cleaned razor blade and commercially available extraction kits following the manufac-
turer’s instructions.
2.2.6. Site-Specific Recombination of DNA in Gateway-Compatible Vectors
The Gateway® cloning system (Invitrogen/Life Technologies) allows fast and efficient transfer
of DNA fragments between plasmids. This makes it extremely helpful if many clonings are done
in parallel and in between different expression hosts of the desired gene product. It was developed
in the 1990s based on the recombination system that the λ phage uses naturally to integrate
DNA into the genome of E. coli cells [Hartley et al., 2000].
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In a first step, attB1 and attB2 (Gateway® nomenclature) recombination sites of 25 base
pairs have to be added by PCR to the 5’ and 3’ ends of the gene of interest. The PCR products
are then mixed with "Donor Vectors" and a "BP Clonase™" enzyme mix that catalyses the
recombination and insertion of the PCR product into the attP recombination sites within the
"Donor Vector" resulting in an "Entry Clone". The efficiency of recombination is dramatically
increased through the use of a ccdB gene that is lethal for E. coli as its gene product is a toxin
that targets the bacterial DNA gyrase. Successful recombination leads to an exchange of the
ccdB gene with the gene of interest (Fig. 2.1). When the reaction mixture is transformed into
E. coli (see section 2.2.12), cells that take up an unreacted vector carrying the ccdB gene or
by-product molecules retaining the ccdB gene will fail to grow.
The "Entry Clone" gene cassette with flanking attL recombination sites can then be efficiently
transferred into a set of commercially available "Destination Vectors" carrying attR recognition
sites by using an "LR Clonase™" mix. These allow to fuse the protein of interest to different
affinity tags including polyhistidine, thioredoxin, the maltose binding protein and many more.
The ccdB gene is again used to increase efficiency. The concept of Gateway® cloning is
illustrated in Figure 2.1.
Destination Vector
attR2attR1
attR1 attR2
ccdB gene
ccdB gene
Gene of interestattB1 attB2
PCR product
Gene of interestattL1 attL2
Entry Vector
attR1 attR2ccdB gene
by-product
Gene of interestattL1 attL2
Entry Vector
attR1 attR2ccdB gene
Destination Vectors
Expression vector
attB2attB1
attB1 attB2
Gene of interest
Gene of interest
attB1 attB2Gene of interest
Expression vectors
attP1 attP2ccdB gene
by-product
ccdB geneattP1 attP2
Donor Vector
+
+
+BP Clonase mix
1 h at RT
+LR Clonase mix
1 h at RT
A
B
Figure 2.1 | The principle of Gateway® cloning. (A) An "Entry Vector" is created through site-specific
recombination that is catalysed by a "BP Clonase™" enzyme mix as described in the text. (B) The "Entry
Vector" is used in a second step to recombine the gene of interest into one of many commercially available
"Destination Vectors", yielding Expression vectors in which the protein of interest is usually fused to
different affinity-tags.
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2.2.7. DNA Sequencing and Sequence Analysis
DNA fragments were sequenced either by the ADIS (Automatische DNA Isolierung und Se-
quenzierung) service at the MPIPZ (Köln) on Applied Biosystems Abi Prism® 377 and 3700 se-
quencers using the BigDye® Terminator technology or by the GATC Sequencing Service (GATC
Biotech AG) on Applied Biosystems 3730xl sequencers. Sequences were analysed with the
SeqMan™ program within the DNASTAR Lasergene® software suite.
2.2.8. Maintenance of Bacterial Cells
Laboratory strains of the gut bacterium E. coli have become a powerful tool for the heterologous
production of proteins as they are easily cultured and genetically manipulated. Genetic informa-
tion is usually transferred into and between E. coli cells through plasmids, small molecules of
DNA that are physically independent of chromosomal DNA and replicated autonomously. For
heterologous expression of a protein in bacterial cells, plasmids usually carry (1) an origin of
replication, (2) a multiple cloning site for the insertion of any gene that encodes for the protein
of interest, (3) elements required for protein expression including a promoter and terminator, a
ribosomal binding site (the Shine-Dalgarno sequence in E. coli) and system-specific elements and
(4) a selection marker. Genes encoding for proteins that provide resistance against otherwise
lethal antibiotics are commonly used as markers that allow to specifically select cells containing
the desired plasmids and to avoid contamination of bacterial cultures.
Unless otherwise stated, all liquid and solid media used for growth and maintenance of E. coli
were supplemented with antibiotics whenever cells carried the corresponding resistance genes at
final concentrations of:
• Ampicillin: 100 µg/ml
• Chloramphenicol: 50 µg/ml
• Kanamycin: 50 µg/ml
• Streptomycin: 50 µg/ml
For long term storage, glycerol stocks of E. coli cells were prepared by inoculating 5ml LB
medium with cells from a single colony grown on a selective LB-agar plate. This culture was
incubated at 30℃ over night while shaking at 220 rpm. On the next morning, 1ml of this culture
was mixed with 600 µl sterile 80% (v/v) glycerol and frozen at -80℃.
For mid term storage, 5ml LB medium were inoculated with either a single colony grown on
selective LB-agar or with cells from a glycerol stock. After incubation at 30℃ and 220 rpm over
night, a glass rod was dipped into this culture and cells were streaked out onto selective LB-agar
plates that were incubated over night at 37℃ and finally stored for several weeks at 4℃.
2.2.9. Plasmid Preparation
For preparation of DNA plasmids from E. coli cells, 5ml LB medium were inoculated with a single
colony grown on a selective LB-agar plate. This culture was incubated at 37℃ on a shaker at
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220 rpm and cells were harvested on the next day by 30 sec of centrifugation at 11000× g and
room temperature.
Cells were then treated with different commercially available plasmid extraction kits that gen-
erally involve an alkaline lysis of cells, the precipitation of cellular debris, proteins and genomic
DNA followed by adsorption of plasmid DNA to a silica membrane. Membrane-bound plasmid
DNA was then washed and finally eluted in either water or TE buffer, pH 8.
2.2.10. Determination of DNA Concentration
The concentration of DNA in solution can be measured photometrically as the aromatic nucle-
obases absorb light with a maximum absorbance near 260 nm wavelength. Using the Lambert-
Beer law that relates the absorption of light to the properties of the material through which the
light is travelling, the concentration of DNA can be calculated using the following formula:
c =
A260
ε260 × d
where c is the concentration of DNA (in M), ε260 is the absorption coefficient (in M-1 cm-1) and
d is the cell pathlength (in cm). Using the specific absorption coefficient for double-stranded
DNA (0.02 (µg/ml)-1 cm-1), the concentration can be calculated using this simplified formula:
ρ = A260 × 50µg/ml
While other specific absorption coefficients can be used for single-stranded DNA (0.027 (µg/ml)-1
cm-1) and single-stranded RNA (0.025 (µg/ml)-1 cm-1), the coefficient for short oligonucleotides
should be calculated using tools like OligoCalc[4] as it depends critically on the nucleobase com-
position. Proteins, in contrast, absorb light with a maximum absorbance near 280 nm and the
A260/A280-ratio can be used to analyse protein contamination. For double-stranded DNA, a
ratio lower than 1.8 indicates the presence of proteins and a ratio higher than 2.0 indicates a
probable contamination (e.g. by phenols).
2.2.11. Preparation of Chemically Competent Cells
E. coli cells can be treated such that they efficiently pick up plasmids from their environment. A
widespread method involves twovalent cations (calcium and magnesium) that alter the perme-
ability of bacterial membranes and allow DNA plasmids to enter the cells, especially when they
are shocked by heating.
Following a protocol established by Dagert and Ehrlich [1979], 100ml LB medium were in-
oculated with a single colony of an appropriate E. coli strain grown on a LB-agar plate. The
culture was incubated on a shaker at 37℃ until the cells reach an OD of 0.3 to 0.4 and then
harvested by centrifugation in pre-cooled tubes at 2500× g and 4℃ for 10min. Cell pellets were
resuspended on ice in 25ml (1/4 culture volume) of ice-cold MgCl2, taking 3 to 5 minutes for
this procedure. After centrifugation at 4℃ and 2000× g, pelleted cells were resuspended on ice
[4]http://www.basic.northwestern.edu/biotools/oligocalc.html
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in 5ml (1/20 culture volume) CaCl2 before an additional 45ml (9/20 culture volume) ice-cold
CaCl2 were added. This suspension was kept on ice for 20 minutes and subsequently pelleted by
10min of centrifugation at 2000× g and 4℃ in pre-cooled tubes. Finally, cells were resuspended
in 2ml (1/50 culture volume) of ice-cold 85mM CaCl2 in 15% (v/v) glycerol, dispensed in 100 µl
aliquots and frozen at -80℃.
2.2.12. Transformation of Chemically Competent Cells
For a single transformation, 50 µl chemically competent E. coli cells were briefly thawed on ice
before adding 1 to 10 ng of plasmid DNA. The cells were kept on ice for 20 minutes before
heatshocking them in a 42℃ water bath for 75 seconds. After putting the cells back on ice for
another 2 minutes, 600 µl LB medium were added and this small culture was incubated at 37℃
for 45-90 minutes on a shaker. Different volumes (25 to 100 µl) of this culture were then plated
on LB-agar and incubated over night at 37℃.
2.2.13. Colony PCR
To check for positive transformants, single colonies were directly picked with pipette tips into a
PCR reaction mix:
• 3 µl 10× PCR reaction buffer
• 3 µl dNTP mix
• 0.5 µl Taq polymerase
• 0.6 µl forward primer
• 0.6 µl reverse primer
• 23 µl H2O
2.3. Protein Biochemical Methods
2.3.1. Small-scale Expression of Recombinant Proteins
To test the level of expression dependent on different parameters (E. coli strain, composition
of the medium, inducer concentration, expression temperature and length of expression time),
single colonies for each E. coli strain were picked into 5ml LB medium and grown over night
while shaking at 37℃. On the next day, 10ml expression medium were inoculated in a sterile
tube with 200 µl of the starter culture and incubated at 37℃ until the cells reached an OD600
of 0.7 to 0.9. Expression of the target protein was then induced by the addition of IPTG in
varying concentrations and the cells were incubated at different temperatures between 18℃
and 37℃ for several hours or over night. IPTG (Isopropyl β-D-1-thiogalactopyranoside) is a
non-metabolised mimic of the disaccharide allolactose that triggers transcription of the bacterial
lac-operon. All expression plasmids used in this thesis do contain components of the lac-operon
and thus allow to turn on expression by the addition of IPTG. Following expression, cells were
yielded by centrifugation at 2500× g for 10 minutes at 4℃ and the cell pellets were either stored
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at -80℃ or used directly. To check for protein expression, each pellet was resuspended in 1ml
lysis buffer supplemented with 1mg/ml lysozyme, 10 µg/ml DNaseI and 1mM DTT and put
on ice for 30 minutes. Final cell lysis was achieved through sonification on ice applying 2min
pulse separated by pauses (40% on a 500 Watt VCX 500 sonicator; Sonics®). To pellet cell
debris, each cell suspension was centrifuged for 30min at 4℃ and 20.000× g. The supernatant
(soluble fraction) was kept in fresh tubes while the pellet (insoluble fraction) was resuspended in
1ml lysis buffer. Samples of each fraction were prepared for analysis on SDS-PAGE.
2.3.2. Small-scale Purification of His-tagged Proteins
Following the protocol for small-scale expression of recombinant proteins (see previous section),
50 µl preequilibrated Ni-NTA matrix (Qiagen) were added to the soluble fraction of proteins and
incubated at 4℃ for 1 h while gently shaking to allow for binding of His-tagged proteins to the
nickel ions. The matrix was then pelleted by centrifugation at 3000× g for 30 sec at 4℃. The
supernatant ("flow-through") containing unbound proteins was collected carefully and the Ni-
NTA resin was washed with 500 µl wash buffer and pelleted by centrifugation as described above.
This was repeated three times collecting the supernatants for later analysis by SDS-PAGE. To
elute His-tagged proteins, the Ni-NTA resin was either resuspended multiple times in 50 µl of
elution buffer (incubating 5min at 4℃ after adding the buffer, then spinning down the resin by
centrifugation and collecting the supernatants) or boiled after adding 100 µl 2× SDS sample
buffer. Samples of each fraction were prepared for SDS-PAGE analysis.
2.3.3. Large-scale Expression of Recombinant Proteins
Cells from LB-agar plates were used for the inoculation of a starter culture that was incubated in
a shaker at 37℃ over night using either TB or LB medium. For the expression culture, 500ml
medium were inoculated with 10ml starter culture and incubated at 37℃ while shaking until
they reached an OD600 of ∼ 0.2. The incubator was then set to cool to 18℃ and cells were
induced by the addition of IPTG at a final concentration of 0.2mM when they had reached an
OD600 of 0.7 to 0.9. These cultures were incubated over night at 18℃ and 180 rpm as low
expression temperatures have been shown to promote the production of soluble protein [Vera
et al., 2007]. On the next day, cells were harvested by centrifugation at 3300× g and 4℃ for
20 minutes, washed in 0.9% (w/v) NaCl and pelleted again by centrifuging them at 2500× g
and 4℃ for 10 minutes. The supernatant was discarded and cells were frozen at -80℃ or used
directly.
2.3.4. Large-scale Purification of His-tagged Proteins
Cell Lysis Cells from the freezer were thawed on ice for at least 30min and afterwards re-
suspended in an appropriate volume (approximately 5ml/g pellet) of lysis buffer supplemented
with 1mg/ml lysozyme, 10 µg/ml DNaseI and 1mM DTT and EDTA-free Complete™ Protease
Inhibitor Cocktail tablets (Roche). This suspension was incubated on ice for 30min and finally
lysed by ultrasonication for a total of 2 minutes at 40% output, separated by pauses on ice.
Cell debris was spun down by 30min of centrifugation at 4℃ and almost 120000× g in a XL70
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ultracentrifuge (Beckman Coulter). The lysate was cleared through a folded filter (Schleicher &
Schuell No. 589/5) before further use.
Immobilised Metal-Affinity Chromatography (IMAC) Metal-affinity chromatography was
first used by Porath et al. [1975] to purify recombinant proteins and uses that cysteine and
histidine residues form chelating complexes with certain metals. In the most popular form,
proteins are N- or C-terminally fused to a polyhistidine tag consisting of mostly 6 to 10 consec-
utive histidine residues. These form a complex with immobilised nickel- or cobalt ions through
their imidazole sidechain. Free imidazole at high concentrations displaces His-tagged proteins
by competing for metal coordination sites and can be used to elute the protein after it has been
stringently washed.
Cleared lysate was directly applied to a manually packed Ni-NTA column of appropriate size
(the matrix binds at least 10mg protein perml of resin) through a superloop connected to either
a FPLC (Pharmacia) or ÄKTA (GE Healthcare) chromatography system. To facilitate binding of
His-tagged protein to the Ni-NTA matrix, this was performed at a flow-rate of only 0.3ml/min.
After protein application, the column was washed with 10-20 column volumes of lysis buffer until
the absorption at 280 nm reached baseline level. His-tagged protein was finally eluted through
a 30ml gradient between 20mM (100% lysis buffer) and 190mM imidazole (25% lysis buffer,
75% IMAC elution buffer). Elution fractions containing major amounts of protein were pooled
and concentrated for further experiments.
Anion Exchange Chromatography (AEC) Ion exchange chromatography allows to separate
proteins according to their charge. Binding to the matrix depends on the pH and ion strength
of the buffer and the isoelectric point of the proteins to be separated. To allow for binding to a
positively charged anion exchange matrix, the buffer pH should be at least one pH unit above the
isoelectric point of the protein of interest. Separation of bound proteins is achieved by increasing
the buffer ion strength gradually or stepwise.
Optionally, proteins purified by IMAC were applied to a Mono Q HR 10/10 column (Pharmacia)
that had been preequilibrated with AEC buffer A. After washing the column with an additional
20ml AEC buffer A, bound proteins were eluted by an 80ml gradient to a salt concentration
of 1M using AEC buffer B. Elution fractions containing the protein of interest were pooled and
concentrated for further use.
Size Exclusion Chromatography (Gelfiltration) For preparative gelfiltration, a concentrated
protein sample was injected into a loop of two times the sample volume. The sample was
then applied onto a prequilibrated gelfiltration column and eluted isocratically. HiLoad 16/60
columns (Pharmacia/GE Healthcare) packed with two different Superdex matrices were used.
While Superdex 75 material separates proteins of a molecular weight between 3 and 70 kDa,
columns packed with a Superdex 200 matrix reliably separate proteins in a range between 10 and
600 kDa.
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2.3.5. Protein Concentration by Ultrafiltration
All protein solutions were concentrated in Amicon® Ultra filtration units (Millipore) with an
appropriate molecular weight cut-off (at least 20% below the molecular weight of the protein to
be concentrated) by centrifugation at 4000× g.
2.3.6. Purification of Strep-Tagged Proteins from Plants
To prepare transiently or stably expressed proteins carrying a Strep-tag from plant material,
leaves of Arabidopsis or Nicotiana plants (2 g fresh weight) were grinded in liquid nitrogen using
mortar an pestle. Homogenised material was then resuspended in 2-3ml Ex-Strep buffer and
briefly vortexed. Cell debris was pelleted through centrifugation at 4℃ and 20.000× g for 30
minutes. The supernatant was filtered through a sterile filter with a pore size of 0.22 µm before
adding 120 µl of 50% Strep-Tactin High Capacity matrix (IBA Life Sciences) to 2ml. After
incubation at 4℃ for 40min, this was poured onto a gravity-flow column (Bio-Rad) and the
matrix was washed with at least 20 column volumes W-Strep buffer in several steps before the
proteins were eluted by the application of either Elu-Strep buffer or by boiling the matrix with
2× SDS sample buffer.
2.4. Protein Analytical Methods
2.4.1. Denaturing SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE [Laemmli, 1970] is used to separate proteins according to their molecular weight.
Protein samples have to be prepared in presence of the anionic detergent sodium dodecyl sulfate
(SDS) and a reducing agent (e.g. DTT) and boiled for 5min at 95℃ to break disulfide bridges
and denature the protein. Anionic SDS then binds to the linearised protein in a 1.4:1 g ratio
resulting in a negative charge that is correlated with the protein weight. Charged proteins are
then applied onto gels containing varying amounts of polyacrylamide and separated in an electric
field. The migration behaviour depends on the polyacrylamide concentration: gels with high
concentrations allow small proteins to migrate faster compared to large proteins. This sieving
effect is used to adjust the molecular weight range of proteins that are separated in a gel.
Recipies for gels used in this thesis are presented in Table 2.16.
Table 2.16 | Recipies for SDS-PAGE gel solutions.
kDa range 50-200 30-95 20-80 12-60 10-43
10ml Resolving gel 5ml Stacking gel
Water (ml) 5.8 5.3 4.8 4.3 3.55 3.7
40% acrylamide mix (ml) 1.5 2 2.5 3 3.75 0.63
1.5 M Tris, pH 8.8 (ml) 2.5 2.5 2.5 2.5 2.5 -
1 M Tris, pH 6.8 (ml) - - - - - 0.63
10% SDS (µl) 100 100 100 100 100 50
10% APS (µl) 100 100 100 100 100 50
TEMED (µl) 10 7.5 5 5 5 5
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Self-cast gels were prepared by pouring resolving gel solutions given in table 2.16 between glass
plates separated by a 0.75mm spacer and were overlayed with 2-propanol. After polymerisation
of the resolving gel, the 2-propanol layer was discarded and a stacking gel solution was poured
between the glass plates on top of the resolving gel. After adding combs, the stacking gel was
allowed to polymerise at room temperature. These gels were used in Mini-PROTEAN systems
(Bio-Rad) with Tris-glycine running buffer, applying voltages between 100V and 140V until
proteins were separated.
Alternatively, pre-cast 4-12% gradient gels (Invitrogen/Life Technologies) were used in MES
running buffer, applying voltages between 150V and 200V.
Gels were documented using the ChemiDoc™ imaging system (Bio-Rad).
2.4.2. Protein Staining on Gels
After separating SDS-PAGE, proteins were stained using the triphenylmethane dye Coomassie
Brilliant Blue (CBB). Originally used as a textile dye, CBB binds unspecifically to positively
charged amino groups of protein side-chains and has become one of the most widely used
chemicals for protein detection since de St Groth et al. [1963] first used it.
Usually, a staining solution additionally contains an acidic component and either methanol or
ethanol to fix the proteins in the gel. During this thesis, two variants of staining/destaining
solutions were used. A staining solution based on Fairbanks et al. [1971] and composed of CBB,
ethanol and acetic acid was used to detect protein bands down to 100 ng protein. The gel was
stained for approximately 60min before it was destained in an ethanol/acetic acid solution while
heating up in a microwave. An alternative staining protocol described by Kang et al. [2003]
allows detection of proteins down to 10 ng protein per band. After separation, the gel is washed
twice with water for 5 to 10 minutes before a staining solution composed of CBB, aluminium
sulfate, ortho-phosphoric acid and ethanol is poured over. After staining for at least one hour,
the gel was destained over night in a mixture of ethanol and ortho-phosphoric acid.
2.4.3. Immunoblot Analysis (Western Blotting)
Alternatively to unspecific dye-staining, proteins can be visualised specifically after resolving
SDS-PAGE through western blotting developed by Towbin et al. [1979]. For that, proteins were
transferred from the gel to a Hybond™-ECL nitrocellulose membrane (GE Healthcare) using 1×
transfer buffer and a blotting apparatus (TE 22 Mini Tank Transfer Unit (GE Healthcare) or
Mini Trans-Blot® Module (Bio-Rad)) according to the manufacturer’s manual. Transfer was
carried out in the cold room for 90min and 90V. Membranes were then washed on an orbital
shaker for 5min in TBS-T before blocked for 1 h at room temperature in TBS-T containing
5% (w/v) non-fat dry milk (Roth) or 5% (w/v) BSA. The blocking solution was discarded and
the membranes were rinsed with TBS-T. Blocked membranes were then incubated on an orbital
shaker in TBS-T supplemented with non-fat dry milk or BSA at 2.5% (w/v) and the primary
antibody at an appropriate concentration either 1 h at room temperature or at 4℃ over night.
The primary antibody solution was afterwards removed, the membrane rinsed twice with TBS-T
before washing it three times for 15 minutes in TBS-T while shaking at room temperature. After
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washing, the membrane was incubated in TBS-T containing non-fat dry milk or BSA at 2% (w/v)
and the secondary antibody at an appropriate concentration for 1 h at room temperature. This
solution was subsequently removed and the membrane was rinsed and washed as described above.
Depending on the secondary antibody, proteins were detected either by chemiluminescence or
chromogenically.
Antibody Detection by Chemiluminescence For this detection method, secondary antibodies
conjugated with horseradish peroxidase (HRP) were used. HRP accepts various commercially
available substrates and, in the presence of peroxide, produces a transient product that decays to
a lower energy state while emitting light. This light can be captured on an X-ray film or by CCD
detectors. As HRP substrates we used the SuperSignal® West Pico or Femto kits (Pierce) ac-
cording to the manufacturer’s instructions and visualised produced light on photographic BioMax
light film (Kodak) in a dark room.
Antibody Detection by Chromogenic Substrates Instead of HRP, secondary antibodies car-
ried an alkaline phosphatase (AP) conjugate for this detection method. The AP hydrolyses
the substrate BCIP (5-bromo-4-chloro-3’-indolylphosphate p-toluidine salt) that subsequently
tautomerises and finally produces an indigo dye through dimerisation of the tautomers in an
alkaline environment. The dimerisation reaction is coupled to the reduction of a second com-
ponent, nitro-blue tetrazolium chloride (NBT), to the purple NBT-formazan that enhances the
chromogenic signal.
For chromogenic detection, membranes were preequilibrated for 10 minutes in AP reaction
buffer while shaking at room temperature. 10ml of AP reaction buffer were then supplemented
with 66 µl of a NBT-stock (0.5 g NBT in 10ml dimethylformamide) and 33 µl of a BCIP-stock
(0.5 g BCIP in 10ml dimethylformamide). The membrane was incubated in this solution at room
temperature and gentle shaking until the desired staining intensity was reached. The reaction
was stopped by washing the membrane rigorously in water.
Ponceau Staining Membrane-bound proteins can additionally be stained unspecifically and
reversible by negatively charged Ponceau S dye before blocking with non-fat dry milk. For that,
membranes were briefly incubated in a Ponceau S working solution until bands appeared. The dye
solution was then removed and membranes were washed in TBS-T until they were completely
destained.
2.4.4. Protein Quantification
Bradford Assay This protein quantification method developed by Bradford [1976] uses the al-
ready introduced dye Coomassie Brilliant Blue (CBB). In an acidic environment, CBB maximally
absorbs light of a wavelength around 465 nm and appears brownish. Upon formation of pro-
tein/dye complexes, the deprotonated, anionic sulfonate form of CBB is stabilised and produces
a blue colour. This colour change can be followed photometrically at a wavelength of 595 nm
where the anionic CBB form has its absorption maximum. Although CBB binds more efficiently
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to basic amino acids, an absorption increase at 595 nm is almost proportional to the protein
concentration of a given solution.
To determine protein amounts, usually 2 µl sample were diluted in 798 µl water and mixed with
200 µl Bradford solution (Roth). The absorbance at 595 nm was measured photometrically after
10 minutes of incubation in the dark and at room temperature. Dilutions series of BSA were
used as standards to quantify the amount of protein.
Spectroscopic Measurement at 280 nm The protein concentration in a homogeneous and
pure protein solution can be directly measured photometrically as aromatic amino acids (es-
pecially tryptophan and tyrosine), and less important disulfide bonds, absorb light of 280 nm
wavelength. The Lambert-Beer law introduced in section 2.2.10 allows to calculate the concen-
tration of a pure protein solution using following formula:
ρ =
A280 ×MW
ε280 × d
where ρ is the protein’s concentration (in mg/ml), A280 is the absorption of light at a wave-
length of 280 nm,MW is the molecular weight of the protein (in Da), ε280 is the molar absorption
coefficient (in M-1 cm-1) at the same wavelength and d is the cell pathlength (in cm).
The molar absorption coefficient ε280 can be estimated as described by Pace et al. [1995] if
the amino acid composition of the protein is known. According to Grimsley and Pace [2004],
the protein concentration in an unpurified mixture can be estimated by assuming that a protein
concentration of 1mg/ml gives an A280 value of 1.3 as this is the average value for 116 proteins
of various molecular weights and amino acid compositions [Pace et al., 1995].
2.4.5. Circular Dichroism (CD)
Circular dichroism is a spectroscopic technique that allows to study folding and unfolding of
proteins in solution. In a CD experiment, circularly polarised light is passed through a protein
solution. As reviewed by Kelly et al. [2005], any chiral (optically active) chromophore produces
a CD signal as they differently absorb left- and right handed components of circularly polarised
light. The difference between these components is expressed in terms of ellipticity (θ). In
proteins, peptide bonds, disulfide bridges and aromatic side chains yield CD signals if circularly
polarised light of a given wavelength is used. Yet most importantly, the arrangement of peptide
bonds in secondary structure elements produces CD spectra in the far UV range (180-240 nm)
that are characteristic for α-helices, β-sheets and unstructured regions. As extensively reviewed
by [Greenfield, 2006b,a], this information can be used to (1) estimate the secondary structure
composition of a protein, (2) determine whether a purified protein or a mutant variant is folded,
(3) study how binding of a ligand affects protein stability and even to (4) estimate binding
constants of protein-protein and protein-ligand interactions.
In this thesis, CD spectroscopy was used to study the folding state of recombinantly expressed
protein variants. Purified protein was gelfiltrated in 10mM NaH2PO4, 50mM Na2SO4, pH 7.5
and set to a concentration of 0.2mg/ml before injecting it into a 0.01 cm cell. CD spectra at
10℃ were collected in the range of 190-240 nm using a scanning speed of 100 nm per minute and
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10 accumulations per scan. To follow protein unfolding and determine its melting temperature
(Tm), a freshly prepared protein solution was heated from 10 to 80℃ at a constant rate of
1℃ per minute while following the CD signal at a wavelength of 222 nm. The ellipticity at
this particular wavelength is dominated by a negative CD signal characteristic for α-helices.
Thermal unfolding of α-helices goes along with this signal becoming more positive. All CD
experiments were performed on a J-715 spectropolarimeter (JASCO) and analysed using the
Spectra Manager™ software (JASCO).
2.4.6. Differential Scanning Fluorimetry (Thermofluor)
The Thermofluor method was developed by Pantoliano et al. [2001] and allows to screen sub-
stances that increase the thermostability of a protein. Generally, the protein is heated in the
presence of fluorescent dye that preferentially binds to hydrophobic patches on the protein sur-
face. Minimising the number of hydrophobic amino acid side-chains that are exposed to an
aqueous environment is an essential driving force of proper protein folding and therefore most
hydrophobic patches are buried within a folded protein’s core. However, if the protein is thermally
unfolded, these patches become accessible for the fluorescent dye that emits light of a certain
wavelength upon binding to hydrophobic regions. The amount of light emitted by the dye is thus
directly correlated with the folding state of the protein.
Following protein unfolding in the presence of (putative) ligands, different buffer systems and
further additives allows to characterise an environment in which the protein is most thermostable.
As described by Ericsson et al. [2006], Vedadi et al. [2006] and others, thermal stability as derived
from Thermofluor experiments has been shown to be correlated with the tendency of a protein to
form crystals. This correlation is one of the reasons why the thermophile bacterium Thermotoga
maritima has been chosen as a model organism in structural genomics [Lesley et al., 2002].
I designed a screen containing 96 different buffers, salts and additives (see Appendix Table
A.1). Each protein was purified and used in a standard buffer (mostly 10mM NaH2PO4, pH 7.5)
at a concentration of 1mg/ml. In white 96 well PCR plates (Low Multiplate 96, Bio-Rad), 5 µl
protein solution were mixed with 5 µl 10× SYPRO® Orange dye solution (Sigma-Aldrich) and
40 µl of 96 different components from the screen. This plate was carefully sealed with Microseal
’B’ Adhesive Seals (Bio-Rad), centrifuged for 1 minute at 500× g to mix the components and
placed into a CFX96™ real-time PCR machine (Bio-Rad). This machine heats up all samples
from 4 to 95℃ at a constant rate of 12℃ per minute while reading the emission of fluorescence
at 516 nm every 5 seconds (excitation: 492 nm). This yields melting curves for most condition
(some additives may quench the fluorescence signal or denature the protein even at 4℃ ) of
which the first derivative allows to determine the melting temperature Tm. The curves were
analysed using the CFX Manager™ software (Bio-Rad).
2.4.7. Dynamic Light Scattering (DLS)
Dynamic light scattering allows to determine the size distribution of small particles (like proteins)
in solution. Following complex physics, proteins scatter laser light and the intensity of scattered
light fluctuates as the protein molecules move through Brownian motion. As large proteins or
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protein assemblies move slower compared to small proteins, the degree of fluctuation in light
intensity can be directly used to estimate the hydrodynamic radii of proteins and their assemblies
in solution. Prior to protein crystallisation, DLS is widely used to determine whether a protein
solution is monodisperse (consists of objects that have the same size, shape or mass) or poly-
disperse (inconsistent distribution of size, shape and mass) as expressed in a mean polydispersity
ratio, %Pd. Zulauf and D’Arcy [1992], Ferré-D’Amaré and Burley [1994], and others could show
that a monodisperse protein solution tends to yield crystals with a higher probability compared
to polydisperse samples. A large-scale analysis of several hundred crystallisation trials carried
out by the Northeast Structural Genomics Consortium [Price et al., 2009] shows that monodis-
perse samples (normalised polydispersity (%Pd) below 10) yield crystals more frequently than
"predominantely monodisperse" or polydisperse samples (%Pd between 10 and 30 or %Pd >
30, respectively). Polydispersity arises from multiple stoichiometric states and/or protein aggre-
gates. In case of polydisperse protein samples, substances that increase monodispersity should
by identified by DLS before setting up crystallisation trials.
For DLS experiments, the protein concentration in a purified sample was adjusted to 0.1 -
0.5mg/ml (smaller proteins need to be at a higher concentration). This solution was centrifuged
for 20min at 20.000× g at 4℃ to remove larger particles. 100 µl of the supernatant were pipet-
ted into disposable UVettes® (Eppendorf) and the polydispersity was measured in a DynaPro
NanoStar™ instrument (Wyatt Technology) using laser light at a wavelength of 830 nm. The
normalised polydispersity (%Pd) and molecular weight of a sample (assuming globular proteins)
were averaged across five consecutive measurements of each 10 acquisitions. All experiments
were performed using a DynaPro NanoStar™ instrument (Wyatt Technology).
2.4.8. Lipase Assay
Recombinantly expressed EDS1 or its lipase-like domain EDS11-384 were purified by immobilised
nickel-affinity chromatography and gelfiltration according to section 2.3.4. Purified EDS1 and
EDS11-384 were incubated in 50mM Tris-HCl buffer, pH 8.5 at a concentration of 50 µM and
in presence of 0.5% (w/v) Triton X-100 and 1mM of different p-nitrophenyl (pNP) esters for 2
minutes at 30℃. Triton X-100 was used at a concentration where it forms micelles harbouring
the p-nitrophenyl substrates that promote "interfacial activation" as explained in more detail
in section 3.4.2. The reaction was followed by detecting the photometrically active product
p-nitrohenolate at a wavelength of 412 nm (see Fig. 2.2). Bovine serum albumine (BSA) and a
lipase from Mucor miehei (MML) at concentrations of 50 µM were used as negative and positive
controls, respectively.
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Figure 2.2 | P-nitrophenyl ester based hydrolase assay. Hydrolases catalyse the reaction of p-
nitrophenyl esters with varying chain length (R) to p-nitrophenol through hydrolysis of the ester bond.
At a basic pH, p-nitrophenol deprotonates to the p-nitrophenolate that produces a yellow colour with an
absorbance maximum at approximately 412 nm.
2.5. Structural Methods
2.5.1. Protein Crystallisation
88% of all protein structures deposited in the Protein Data Bank (PDB [Berman, 2000]) have
been solved by X-ray diffraction [5] . Prerequisite, and in many cases the high-hanging fruit, is
that the protein needs to form crystals in which the proteins molecules are arranged in ordered
pattern in all three dimensions. As pointed out by Doye et al. [2004], most proteins in a cellular
environment "do not want to crystallise, because a protein that is prone to crystallisation, or
in fact any form of aggregation, is potentially deleterious to the cell.". Although structure
elucidation from small crystals grown in vivo may "open new routes in structural biology" in
combination with the recently established technique of serial femtosecond X-ray crystallography
(SFX) [Koopmann et al., 2012] this remains an exception and most crystals used for X-ray
diffraction data collection are still being produced in vitro.
Protein crystallisation takes place in two steps – the formation of a crystal nucleus followed
by crystal growth. Both steps require the controlled oversaturation of a pure and homogeneous
protein solution. Summarised by McPherson [2004] many methods to achieve oversaturation
are available: (1) altering the protein itself (e.g. by pH changes that affect the ionisation state
of surface residues), (2) altering the chemical activity of the water (e.g. by addition of salts),
(3) altering the degree of attraction of protein molecules for another (e.g. by pH changes or
the addition of bridging ions), (4) altering the nature of interactions between the protein and
the solvent (e.g. by polymers and ions), (5) altering the temperature or (6) direct removal of
water (evaporation). As it is virtually impossible to predict a suitable combination of satura-
tion effects that promotes the formation of crystal nuclei, the sparse matrix sampling method
developed by Jancarik and Kim [1991] has become the most widespread method to search for
crystallisation conditions. These screens are composed of crystallant solutions (including salts,
volatile and non-volatile organic solvents and long-chained polymers) that are empirically derived
based on known or published crystallisation conditions of various proteins. Although many dif-
ferent techniques exist in which protein and crystallant are mixed (and gradually oversaturated),
the vapour diffusion method has been used in this thesis as it requires only small amounts of
protein sample and allows robotic pipetting of crystallisation trials. As depicted in Figure 2.3,
the protein solution is mixed with a crystallant solution (often in 2:1, 1:1 or 1:2) ratios and
[5]http://www.rcsb.org/pdb/static.do?p=general_information/pdb_statistics/index.html (request
date: January, 2013)
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placed on top of a reservoir containing only the crystallant. As the crystallant concentration
within the protein drop is lower than that in the reservoir, water will diffuse in the vapour phase
leading to an increasing concentration of both protein and crystallant in the drop. The processes
yielding macroscopic protein crystals can be visualised by the phase diagram shown in Figure 2.4.
Chemical (i.e. the composition of the protein drop) and physical parameters (e.g. crystallisation
temperature, rate of equilibrium or methodology to approach the equilibrium) can be combined
with biochemical factors (e.g. posttranslational, chemical or genetic modification of the protein
or controlled proteolysis of the sample) if a protein fails to crystallise.
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Figure 2.3 | Vapour diffusion technique. In
both sitting- and hanging drop vapour diffusion,
the protein solution is mixed in an arbitrarily
ratio with the crystallant from the reservoir.
Each condition is sealed and incubated at differ-
ent temperatures to achieve diffusion of water
through the gas phase out of the drop. This
leads to the gradual saturation of the protein in
solution and potentially to crystal growth.
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Figure 2.4 | The phase diagram of protein
crystallisation. As described in the text protein
crystallisation relies on supersaturation of the
protein in solution. Through the combination
of different parameters (see text) and a defined
supersaturation of the protein, crystal nuclei ap-
pear in the labile zone of the phase diagram.
As the crystals grow, the solution depletes in
protein and the metastable zone is reached in
which the crystals continue to grow while pro-
tein is still supersaturated. Figure adapted from
[Chayen, 2004] .
For robotic sparse matrix sampling, protein solutions at varying concentrations (5-15 mg/ml)
were mixed with crystallants from commercial screens that are listed in Table 2.4 using either a
Matrix® Hydra® II eDrop (Thermo Scientific) or a mosquito® Crystal (TTP LabTech) robot
and 96 well Intelli® (Art Robbins) or iQ (TTP LabTech) plates, respectively. This allowed
to reproducibly pipet nanoliter volumes (Hydra® II: ≥ 500 nl per pipetting step; mosquito®:
≥ 100 nl per pipetting step) of protein and crystallant. Plates were kept at 4℃ or 20℃ for
several months and inspected regularly under the microscope.
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Initial hits were optimised by varying crystallant pH, crystallant concentration, growth tem-
perature, drop sizes and through the addition of small molecule substances, primarily those of
Additive and Detergent Screens 1-3 (Hampton Research).
Crystal Seeding As depicted in the phase diagram (Fig. 2.4), the conditions for the formation
of protein crystal nuclei differ from those needed for crystal growth. To circumvent the necessity
of spontaneous crystal nucleus formation, crystal seeds can be added to the protein drop in
many ways. While even non-proteinous seeds potentially support nucleus formation and have
been successfully used more or less systematically (synthetic silicates [Ino et al., 2011] but also
hairs from a 5-year-old horse [Thakur et al., 2007] were deemed helpful), more common seeding
techniques require that a protein was once crystallised. These crystals are then transferred into
a new (equilibrated) protein drop either directly (macroseeding) or as submicroscopic seeds that
have been obtained by crushing the initial crystal (microseeding) or by dislodging seeds from
the initial crystal with an animal hair (e.g. cat whisker) that is then streaked through the new
protein drop (for details on "streak seeding" see [Stura and Wilson, 1991]).
Microseeding and streak seeding were successfully used in this thesis. For microseeding ex-
periments, a single crystal was transferred into a drop of reservoir or a stabilising solution (i.e.
a solution in which the crystallant concentration is 1.05-1.2× higher compared to the reservoir
solution) using a nylon loop. This crystal was then crunched using a acupuncture needle and this
seed stock was diluted with reservoir or stabilising solutions between 100- and 5000-fold (Fig.
2.5). New drops were set up as follows: 0.5 drop volume (DV) protein solution + 0.35-0.45DV
reservoir solution + 0.15-0.05DV seed solution. Seeds were either added directly or 1 to 48
hours after protein and crystallant solutions had been mixed.
For streak seeding single crystals were briefly touched with human eyelashes, cat whiskers,
hairs from a horse’s tail or a young hedgehog and streaked three to four times through different
(preequilibrated) crystallisation drops (Fig. 2.5).
no seeds 1:10 dilution 1:1000 dilution
first streak second streak third streak
A
B
scale bar: ~200 µm
scale bar: ~130 µm
+microseed solution
Figure 2.5 | Protein crystal seeding. (A)
Microseed solutions were used in different
dilutions to alter the outcome of crystalli-
sation trials. (B) Streak seeds were analo-
gously diluted by streaking the same seed-
ing tool (e.g. a cat whisker) through mul-
tiple drops.
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2.5.2. Cryoprotection
Macromolecular cryocrystallography as reviewed by Garman and Schneider [1997] became popular
during the 1990s after recognising that protein crystals suffer significantly less from radiation
damage if diffraction data are collected at low temperatures. As already described by Hope
[1988], crystal need to be in a cryoprotecting solution before freezing them in liquid nitrogen
or directly in a nitrogen stream to avoid "internal ice formation on cooling below the freezing
point. While Hope transferred his protein crystals into a mixture of Paratone-N and mineral
oil, cryoprotection can be achieved through the addition of alcohols (e.g. glycerol, methanol,
2-propanol, 2,3-butanediol), sugars (e.g. sucrose, xylitol, dextrose, trehalose), salts or glycols
(e.g. polyethylenglycols of varying chain length or 2-methyl-2,4-pentanediol (MPD))[6]. Protein
crystals may even directly grow in a cryoprotecting solution or, if one is less lucky, transfer
into the cryoprotecting solution can be achieved through (1) direct transfer and soaking for
arbitrary amount of time (depending on temperature, crystal size and nature of crystal solvent
channels and the diffusion coefficient of the cryoprotectant) or (2) a stepwise increase of the
cryoprotectant concentration to minimise the effect of an osmotic shock.
2.5.3. Heavy Atom Soaking
Heavy atom solutions were prepared by solving each compound listed in Table 2.17 directly in
a solution suitable for cryoprotection of the protein at a stock concentration of approximately
30mM. They were used after cryoprotection at a final concentration of 10mM. Native crystals
were soaked in the presence of heavy atoms for 1, 5 or 10m.
2.5.4. Crystal Mounting
Following cryoprotection, crystals were picked up in CryoLoops™ with diameters between 0.05
and 0.4mm (Hampton Research) installed in SPINE standard CryoCaps™ (Molecular Dimensions)
and mounted on a goniometer head.
2.5.5. Diffraction Data Collection
Detailed descriptions of the techniques that underlie X-ray protein crystallography fill whole books
[Blow, 2010; Rupp, 2009; Rhodes, 2006]. I used them to introduce some basic concepts in the
following paragraphs.
Generation of X-rays X-ray structure solution from crystals uses that the atoms within a
crystal diffract a beam of hard X-rays (usually with wavelengths below 2Å) into specific directions.
The X-ray beam can be generated by an X-ray tube in which electrons are produced by heating
up a cathode, commonly a tungsten filament. These electrons are then accelerated towards
a metal (often copper or molybdenum) anode using an electric field of around 40 kV. These
high energy electrons then displace electrons from energetically low-lying orbitals of the metal
anode atoms upon collision. This, in turn, results in higher orbital electrons dropping down to
[6]Berejnov et al. [2006] lists these cryoprotectants and a critical concentration at which they should be used.
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Table 2.17 | Heavy atom derivatives used for crystal soaking.
Platinum derivatives MW (Da) Useful?
[Agniswamy et al., 2008]
1. Potassium tetrachloroplatinate(II) 415.11 ++
2. Potassium tetranitroplatinate(II) 457.3 ++
3. Potassium tetracyanoplatinate(II) 431.41 (+)
4. Potassium hexaiodoplatinate 1034.7 +
5. Diamminedichloroplatinum 300.06
6. Dichloro(ethylenediamine)platinum 326.1
7. Potassium tetrachloropalladate(II) 326.42
8. Potassium hexachloroplatinate(IV) 486.01
Gold derivatives
9. Potassium tetrachloroaurate(III) 377.88 ++
10. Gold(I)iodide 328.87
11. Potassium dicyanoaurate(I) 288.1 ++
Mercury derivatives
12. Mersalyl salt 483.37 ++
13. Mercury(II)acetate 318.7 ++
14. Mercury(II)chloride 371.5 +
15. Ethylmercury(II)chloride 265.11 +
16. 2-(Ethylmercurimercapto)benzoic acid 404.81
17. 4-Hydroxymercuribenzoic acid 360.7
18. p-Aminophenylmercuric acetate 351.8
19. Mercury dibromofluorescein 804.75
20. Phenylmercuryacetate 336.74
Lanthanoids
21. Gadolinium(III)sulfate octahydrate 746.81
22. Ytterbium(III)nitrate pentrahydrate 449.13
23. Lanthanum(III)acetate hydrate 316.04
24. Samarium(III)chloride hexahydrate 364.8
Lead derivatives
25. Trimethyllead acetate 310.35
26. Triethyllead acetate 352.43
Others
27. Potassiumhexachloroosmate(IV) 481.12 +
28. Potassium osmate(VI) dihydrate 368.45
29. Uranylnitrate hexahydrate 502.13
30. Potassium hexachloroiridate(IV) 483.12
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fill the vacancy while loosing energy that they emit as X-ray photons with a wavelength that
is characteristic for the anode metal type (characteristic X-rays). This mechanism is used by
laboratory X-ray machines which are commonly referred to as home sources.
Alternatively, X-rays can be produced at a cyclic particle accelerator (synchrotron). Therein,
electrons are constantly accelerated in a storage ring through bending magnets. As a by-product
of magnetic bending, the electrons emit radiation that can be used to create a beam of monochro-
matic X-rays. Synchrotron radiation is characterised by a highly brilliant beam that is often
tunable in wavelength through monochromatisation.
For diffraction data collection during this thesis, two home-source generators (that of a
SuperNova™ (Agilent) or a MicroMax-007 HF generator (Rigaku)) were used. Diffraction data
were additionally collected at the following synchrotron beamlines:
• X06SA (PXI), X06DA (PXIII); Swiss Light Source (Paul Scherrer Institute), Villingen
• BL14.1 and BL14.2; BESSY, Berlin
X-ray Diffraction by Protein Crystals A protein crystal is made of molecules that are built up
in a regular way so that equivalent molecules interact identically with their neighbours. As the
molecules of protein crystals are irregularly shaped, they contain rather large solvent channels
making them soft and fragile compared to inorganic crystals. The solvent content usually varies
between 30 and 60% [Matthews, 1968].
The molecules within the crystal reside on a crystal lattice and are related by symmetry opera-
tions. The smallest repeating unit that can generate the crystal with only translation operations
is called the unit cell. Within each unit cell, several molecules can be related by other symmetry
operations (rotations and reflections) and these form the asymmetric unit (see Fig. 2.6).
asymmetric unit
unit cell crystal
Figure 2.6 | Building blocks of pro-
tein crystals. The protein crystal is
formed by translation operations of
the unit cell in all three dimensions.
Within each unit cell, molecules of an
asymmetric unit can be additionally
described by rotations and reflections.
Adapted from http://www.rcsb.org/
pdb/101/static101.do?p=education_
discussion/Looking-at-Structures/
bioassembly_tutorial.html (request
date: January, 2013)
The electrons of periodically arranged molecules within a crystal scatter the photons of an
X-ray beam in random directions. The X-ray photons within the beam travel as waves that
are characterised by a wavelength, an amplitude and a phase. While the scattered waves have
the same wavelength as the incident beam (which depends on the photon source; see above),
the amplitude and phase depend on the distribution of scattering objects within the crystal.
After hitting the crystal, the randomly scattered waves will interfere with each other. While this
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mostly leads to destructive interference in which the waves cancel each other out, there is also
constructive interference occurring in which the waves’ amplitudes reinforce each other (Fig. 2.7
A). The conditions required for constructive interference can be expressed through the Bragg’s
law [Bragg and Bragg, 1913].
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A B Figure 2.7 | Graphical representation of
Bragg’s law. (A) Examples of construc-
tive and destructive interference of two
waves. (B) If the ray R2 travels an addi-
tional distance that is an integral multiple
of λ then constructive interference with
ray R1 occurs. See text for details.
If the grey dots in Figure 2.7 B represent crystal lattice points that lie on sets of planes sepa-
rated by a distance d and the incident beam with a wavelength of λ impinges upon the planes at
an angle θ and is reflected at the very same angle, then constructive interference occurs if the
ray R2[7] travels an additional distance of 2 BC as the scattered waves are then in phase: the
single amplitudes A1 and A2 add to a reinforced amplitude Ar.
As sin θ = BC/AB and BC = AB sin θ = d sin θ, the Bragg’s law is usually expressed as:
2d sin θ = nλ
where n is an integer. So whenever the difference in path length (2d sin θ) for waves reflected
from successive planes is equal to an integral number of wavelengths λ, they emerge in phase
with each other and interfere constructively.
The maximum possible resolution obtained in an X-ray diffraction experiment is then defined as:
dmin = λ/2 sin θmax
Thus, reflections with large diffraction angles (or Bragg angles) θ contain most high-resolution
information.
As the crystal, mounted on a goniometer head, is rotated within the beam, different layers
of atoms satisfy Bragg’s law and produce constructive interference. This results in diffraction
peaks with an intensity related to the number and type of atoms in the diffracting layer.
From Diffraction to Structure The ultimate goal of an X-ray diffraction experiment is to
obtain an electron density map of the asymmetric unit’s contents. This map is then used to
[7]Pointed out by Rupp [2009], there are not two incoming X-rays involved (as schematically depicted in Figure
2.7) but it is the electromagnetic field vector of the same photon that excites all atoms within its coherence
length.
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automatically or manually build an atomic model of the contents. To calculate an electron den-
sity map in real space from a diffraction data set in reciprocal space, it requires a mathematical
operation called Fourier transform. The recorded diffraction data set consists of numerous single
reflections that represent the sum of the contributions of all scattering objects in the crystal’s unit
cell. The sum for each single reflection hkl is called the structure factor Fhkl where hkl describes
the position of an individual reflection. The structure factor is directly used in a Fourier transform
to calculate the electron density map and is expressed for each of the N atoms in the unit cell as:
Fhkl =
∑
N
ni fie
2pi(hxi+kyi+lzi )e−Bi sin
2θ/λ2
where ni is the occupancy factor for the ith atom, fi is the atomic scattering factor, 2pi(hxi+kyi+lzi)
is the phase factor and the last term is a description of thermal and crystal disorder known as
the Debye-Waller factor (or B-factor).
The total occupancy factor ni of atoms within the peptide chain is 1. However, amino acid side
chains can adopt different conformations with partial occupancies below 1. The same can be
true for any ligand or solvent molecule that is not homogeneously distributed among the crystal.
The atomic scattering factor fi is the amplitude of a wave scattered by an atom relative
to the amplitude of the wave scattered by an isolated electron and increases with the sum of
scattering atoms inside the crystal unit cell and with their charge density. It further decreases
with increasing Bragg angles at a fixed wavelength. The B-factor depends on the displacement of
a crystal atom from its average position in the lattice[8] and high B-factors reduce the maximum
possible resolution. The intensity of a diffracted beam is directly related to the amplitude of the
structure factor, information on the structure factor phase, however, is lost and thus the phase
factor 2pi(hxi+kyi+lzi) can not be directly estimated. This is known as the "phase problem".
2.5.6. De novo Phasing Based on Heavy Atoms
The Patterson function introduced by Patterson [1935] allows to determine the relative positions
of atoms in a crystal unit cell without the knowledge of phases and is described as:
P (u, v , w) = 1/V
∑
h
∑
k
∑
l
|Fhkl |2e−2pii(hu+kv+lw)
where u,v,w are the coordinates of a point in the resulting Patterson map and |Fhkl| is the
structure factor amplitude that is directly measured in a diffraction experiment (as it is related
to the intensity of a reflection: |Fhkl | ∝
√
Ihkl). As described above, the structure factor am-
plitude contains contributions of each scattering object in the unit cell. The determination of
relative positions between scatterers thus becomes complicated and virtually impossible for too
many scattering objects. While the Patterson function can be of direct use when solving the
structures of small inorganic compounds, it is not directly applicable to proteins that regularly
contain several thousand atoms within a single unit cell.
Nevertheless, the Patterson function is commonly used by protein crystallographers. The most
popular phasing approach is that of a molecular replacement (this and other phasing techniques
[8]And is therefore often referred to as atomic displacement parameter (ADP)
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are reviewed by Taylor [2010]). It requires the structure of a protein that is related to the
protein in the crystal. This structure (the search model) is used to calculate its Patterson
map. A Patterson map is also calculated from the structure factor amplitudes of the recorded
reflections and these maps are then rotated and translated until the search model is correctly
orientated relative to the new unit cell.
Yet, if no search model is known (usually a sequence identity of more than 25% with an
rmsd below 2Å is needed), phases have to be determined experimentally. Again, the Patterson
function is used, yet not to calculate the relative distances of protein atoms in the unit cell
but rather the distances of heavy atoms that reside on fixed positions within the crystal unit
cell. Given this limited number of scattering object, the Patterson function can be used for
phasing. The introduction of heavy atoms is required as all scattering objects in the unit cell
contribute to the intensity of a reflection and thus to the structure factor amplitude that we
need to calculate a Patterson map. As described above, this amplitude is directly correlated with
the atomic scattering factor fi, that in turn depends on the charge density and therefore the
number of electrons around atom i. Heavy atoms contain a large number of electrons (platinum
for instance contains 13 times more electrons than carbon), and therefore contribute measurably
to the structure factor amplitude.
Their precise contribution to the structure factor amplitude |Fhkl| can be measured differently:
in an isomorphous replacement experiment, data of two separate crystals are measured one of
which is derivatised with a heavy atom. The structure factor amplitudes for the native and the
derivatised crystals are then measured and the isomorphous difference between them can be used
to estimate the heavy atom structure amplitude that is then used to generate a Patterson map.
As the name suggests, this technique requires isomorphous crystals. Crick and Magdoff [1956]
could show that already a 0.5% change in the unit-cell dimensions leads to an average 15%
change of measured intensities rendering the determination of the heavy-atom structure factor
amplitude impossible.
Alternatively, phases can be determined using a phenomenon called anomalous scattering that
occurs because atoms scatter X-rays as a function of the incoming photons’ wavelength. During
normal scattering, an X-ray wave impinges on the atom and causes the electrons to oscillate with
the same frequency as the incoming beam. The oscillating electrons, in turn, emit X-rays having
the wavelength as the incident beam but a changed amplitude (as described above). If the energy
of the X-ray beam, however, is close to the transition state that can bring the atom to an excited
state (the absorption edge), anomalous scattering occurs in addition to normal scattering. This
comes because a fraction of the X-ray beam is absorbed and re-emitted with a different phase,
altering the structure factor by adding an anomalous and a dispersive component. These phase
differences can be used to determine the position of anomalous scatterers within the asymmetric
unit.
In a multi-wavelength anomalous dispersion (MAD) experiment, only one protein crystal is
derivatised with a heavy atom. The absorption edges of commonly used heavy atoms are given
in table 2.18. While these are close to wavelengths used in X-ray diffraction experiments (1 Å),
carbon and other common elements of proteins have different edges and do not significantly
contribute to anomalous scattering.
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Table 2.18 | Absorption edges of different atoms (see http://skuld.bmsc.washington.edu/scatter/
AS_periodic.html for more heavy atoms; request date: December, 2012).
Atom K-edge L I-edge L II-edge L III-edge
Carbon 43.7 Å
Sulphur 5.02 Å
Platinum 0.158Å 0.893Å 0.934Å 1.072Å
Gold 0.154Å 0.864Å 0.903Å 1.040Å
Mercury 0.149Å 0.836Å 0.873Å 1.009Å
Diffraction data of a derivatised crystal are collected at multiple wavelengths which leads
to different contributions of the heavy atom to normal and anomalous scattering. Usually,
wavelengths are chosen at the absorption peak (maximum anomalous scattering), at the point
of inflection on the absorption curve (minimal dispersive scattering) and at a remote wavelength
that is far away from the absorption edge.
2.5.7. Data Processing, Model Building and Refinement
Intensities measured in X-ray diffraction experiments were integrated and scaled using XDS [Kab-
sch, 2010] and Scala [Evans, 2006]. Scaled intensities were combined with phases that were
experimentally determined as described above. The resulting structure factors were used for
automated model building by the RESOLVE program [Terwilliger, 2003]. The final model served
as a starting points for iterative cycles of manual model building in Coot [Emsley et al., 2010]
followed by structure refinement using the PHENIX software suite [Adams et al., 2011]. The
quality of the refined protein model is usually expressed by two R-factors, Rfree and Rwork. The
Rwork is defined as:
Rwork =
∑
||Fobs | − |Fcalc ||∑
|Fobs |
where |Fobs| and |Fcalc| are the observed and calculated structure factor amplitudes. The result-
ing Rwork value thus is a measure how well a simulated diffraction pattern that is calculated from
the atomic model matches the diffraction pattern recorded in the actual experiment. While a
perfect fit would produce an Rwork of 0, a calculated diffraction pattern using randomly arranged
atoms will produce an Rwork of approximately 0.63. During the process of structure refinement,
this value can be made artificially small through using too many refinement parameters (so-called
overfitting). Brünger [1992] recognised this and proposed to use another R-factor, Rfree in addi-
tion. Before the structure refinement starts, a certain percentage (usually about 1000 reflections
are enough) are removed from the data that are used for refinement. The Rfree-value is then
calculated analogous to the Rwork but expresses how well the diffraction pattern calculated from
the refined model matches the diffraction data that were not used during refinement. Both
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R-factors, Rwork and Rfree are dependent on the maximum resolution of the collected data and
typically lie between 0.2 and 0.3.
2.5.8. Molecular Dynamics
Protein motions are essential for the function of most proteins. Molecular dynamics simulations
allow to compute the movements of atoms and molecules in solution and have helped to un-
derstand small and large scale protein motions during enzyme catalysis, orchestrated motions
within huge protein complexes and also mechanisms of protein folding [Karplus and Kuriyan,
2005]. Soon after Rahman and Stillinger [1974] had simulated the motions within liquid wa-
ter, the first molecular dynamics simulation of a 58 amino acid protein was reported in 1977
by McCammon et al. [1977]. Although improved force fields that describe the energy of the
protein as a function of its atomic coordinates and a rapid increase in computational power
nowadays allow the simulation of larger proteins and even protein assemblies, large scale motions
are comparatively slow [Zwier and Chong, 2010] and remain challenging to predict.
Preparation and simulation of proteins were performed according to a tutorial[9] with slight
modifications. In brief, proteins were prepared from crystal structures (deletion of crystalline
water molecules, alternative side-chain conformations) and handed over to the GROMACS (ver-
sion 4.5.1) program [Van der Spoel et al., 2005]. After putting the protein in a cubic water box
(SPC/E model) and adding ions to neutralise the system’s charge, an energy minimisation was
performed in which the structure is relaxed. Subsequently, the system was equilibrated for each a
100 ps until a stable temperature and density were reached. The actual simulation was performed
over 50 ns on the CHEOPS high-performance computing cluster (Regionales Rechenzentrum der
Universität zu Köln)[10]
2.6. Yeast Methods
The yeast two-hybrid method allows to detect interactions between proteins. Established by
Fields and Song [1989], nowadays several variants of this system coexist. The general principle,
however, is always the same: for the easiest case of two proteins that shall be analysed for
interactions, these protein are fused to each one domain of a transcription factor. The commonly
used GAL4 transcription activator endogeneously exists in yeast cells and consists of a DNA
binding domain (BD) and an activation domain (AD). While the domains are non-functional
on their own, they are brought into close proximity if the fused proteins do physically interact
with each other. This is sufficient to reconstitute the activity of the GAL4 activator and leads
to transcription of a downstream reporter gene. We used the yeast ADE2 and HIS3 genes
as reporters. These genes encode for proteins that are essential for the biosynthesis of the
nucleobase adenine and the amino acid histidine, respectively. If those cells are plated on media
that do lack adenine and/or histidine (both are essential for their survival), they can only grow
if a functional GAL4 activator is reconstituted through the interaction of the proteins fused to
the GAL4 activation and binding domain. This system is illustrated in Fig. 2.8.
[9]http://www.bevanlab.biochem.vt.edu/Pages/Personal/justin/gmx-tutorials/index.html(request
date: April, 2010)
[10]http://rrzk.uni-koeln.de/cheops.html (request date: December, 2012)
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Figure 2.8 | The yeast two-hybrid system. (A) The GAL4 transcription activator is used naturally by
yeast cells to control transcription of any gene. (B) The activation (AD) and binding domain (BD) of
the GAL4 activator can be separately fused to two proteins (bait and prey) to test them for interaction.
If the proteins physically interact, AD and BD domain are brought into close proximity and render the
GAL4 activator functional. This can be used to selectively transcribe a reporter gene. Yet, if the bait
and prey proteins do not interact, the activator remains non-functional and transcription of the reporter
gene does not take place (C)/(D).
2.6.1. Transformation of Yeast Cells
Ito et al. [1983] found that yeast cells treated with alkali cations and polyethylene glycol of
distinct chain length are able to pick up plasmid DNA from their environment. Based on this
finding, Gietz and Schiestl [1991] proposed an optimised protocol for the transformation in
which yeast cells are made competent by lithium acetate and polyethylene glycol and plasmids
are transformed by heat-shocking in the presence of single-stranded carrier DNA.
For up to 40 parallel transformations, a 100ml culture of yeast cells was grown over night
at 30℃ in a shaker until the cells reached an OD600 of approximately 0.6. If cells grew to a
higher optical density, the over-night culture was diluted to an OD600 of 0.2 in the morning
and incubated shaking until they reached the desired density. Cells were then pelleted by 5
minutes of centrifugation at 1000× g. The pellet was once resuspended in 20 to 30ml sterile
water and pelleted again by centrifugation as described. After resuspending the pellet in 1-2ml
of sterile 100mM Lithium acetate in TE-buffer, the cells were incubated for 10 minutes at
30℃. For a single transformation, 240 µl 50% (w/v) PEG3350, 36 µl 1M lithium acetate, 50 µl
single-stranded DNA (previously boiled for 15min at 94℃ and afterwards kept on ice) and 24 µl
10× TE-buffer were mixed with 50 µl of the competent cells and 0.4 µg of each plasmid to be
transformed. After brief vortexing, this mixture was incubated for 30 minutes at 30℃ before
heat-shocked for 20 minutes in a 42℃ waterbath. Transformed cells were subsequently spun
down by centrifugation at 20.000× g for 30 seconds. The supernatant was discarded, the cells
resuspended in 100 µl non-selective SD medium and spread out on (selective) SD-agar plates.
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2.6.2. Selection of Co-Transformants
Gateway® cassettes were cloned into pGADT7 and pGBKT7 plasmids (see Clontech Matchmaker®
Yeast Two-Hybrid System User Manual for details) to allow the creation of "Entry Clones" (see
section 2.2.6). These plasmids carry the LEU2 and TRP1 gene, respectively, encoding for pro-
teins that are essential for the biosynthesis of the essential amino acids leucine and tryptophan.
Successful transformation of each plasmid into yeast cells can thus be checked by their ability to
grow on SD-agar that lacks one or both of these amino acids.
2.6.3. Analysis of Protein-Protein Interactions
As described above, reporter genes encoding for proteins essential for bioynthesis of adenine
and histidine (ADE2 and HIS3, respectively) were used to analyse the interaction between bait
and prey proteins. Four single colonies of successfully co-transformed cells were streaked on
SD-agar plates lacking leucine and tryptophan (-LW; control) and histidine (-LWH) and adenine
(-LWHA). These plates were incubated at 30℃ and cell growth was documented after 2 and 5
days. As the GAL2-ADE2 reporter is more stringently regulated than GAL1-HIS3, cell growth
on -LWH but not on -LWHA plates indicates residual interaction of the proteins.
2.6.4. Total Protein Extraction and Immunoblot Analysis
An apparent loss-of-interaction can be caused by the instability of one of the protein interaction
partners in yeast cells. It is therefore critical to analyse protein accumulation by immunoblot
detection of the protein in total protein extracts.
5ml liquid YPD medium were inoculated with cells from SD (-LW) plates and incubated over
night at 30℃ in a rotary shaker. On the next morning, the OD600 of each culture was measured
and equivalent amounts of cells were harvested by centrifugation at 20.000× g for 10 minutes.
Cell lysis was performed in three cycles of freezing in liquid nitrogen and thawing at room
temperature. Each sample was mixed with 100 µl 2× SDS sample buffer, boiled for 15 minutes
at 96℃ and the debris was spun down through centrifugation at 20.000× g (5min). 10 µl of
each sample were separated by SDS-PAGE and the proteins were detected by immunoblotting
as described in section 2.4.3.
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"Every experiment proves something. If it doesn’t prove what you wanted it to prove,
it proves something else."
— Anonymous
Preamble
All protein sequences of EDS1, SAG101 and PAD4 were derived from the model plant Arabidopsis
thaliana and represent the full-length variants EDS1 (i.e. amino acids 1-623)[11], SAG101 (1-
537)[12] and PAD4 (1-541)[13] unless otherwise stated. According to the Arabidopsis Information
Resource (TAIR) nomenclature, protein products of genes are written in capital letters without
italics (e.g. EDS1), wildtype gene alleles in italic capital letters (e.g. EDS1) and mutant gene in
lower case italic letters (eds1) whereas different alleles of the same gene are distinguished with
a number following a hyphen (e.g. eds1-2).
As this thesis has been developed in a fruitful cooperation with the Max Planck Institute for
Plant Breeding Research (MPIPZ, Köln), single experiments were not done by myself and are
marked as such. Especially most in planta experiments were gratefully handed over to Johannes
Stuttmann and Jaqueline Bautor. This is graphically illustrated in Figure 3.34 at the end of the
results section.
3.1. Sequence Analysis: EDS1, SAG101 and PAD4 Exist in all
Higher Plants and Share Lipase Homology
EDS1-related research has mainly focused the model plant Arabidopsis. The rapidly increasing
number of published higher plant[14] genomes[15], however, allows to analyse if and by how far
the EDS1 protein family is conserved among other plants.
Protein sequences were retrieved from plant databases[16] using Arabidopsis EDS1, SAG101
and PAD4 as query sequences in a tBLASTn search[17]. Putative orthologues were aligned and
curated manually in several iterations. Sequences with an identity of more than 95% were
considered redundant and removed randomly using the ExPASy "Decrease redundancy" tool[18].
The final set was clustered within a phylogenetic tree using the Phylogeny.fr website [Dereeper
et al., 2008].
As shown in Appendix Figure A.1, EDS1, SAG101 and PAD4 fell into three clusters within
this tree and allowed to distinguish between them even if the sequences had not been properly
[11]Ecotype Landsberg erecta and TAIR locus name AT3G48090
[12]Ecotype Columbia and TAIR locus name AT5G14930
[13]Ecotype Columbia and TAIR locus name AT3G52430
[14]Such that have vascular tissues necessary for the transport of fluids and nutrients
[15]Seven were available in 2008 and this number jumped to 36 by the end of 2012 (http://en.wikipedia.org/
wiki/List_of_sequenced_plant_genomes; request date: January, 2013)
[16]phytozome.net, bioinformatics.psb.ugent.be/plaza, maizesequence.org, NCBI and solgenomics.net
[17]The tBLASTn search uses a protein sequence as input which is being compared to the six-frame translations of
a nucleotide database. This is especially useful in coding regions of homologous proteins in unannotated sequences
[18]http://web.expasy.org/decrease_redundancy/ (request date: December, 2012)
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annotated. It was thus possible to analyse features of the proteins individually. Similar results
were obtained when the sequences were aligned using T-Coffee [Notredame et al., 2000] and
used for tree-building by the SeaView program [Gouy et al., 2010].
Interestingly, orthologues of EDS1 and PAD4 were present among genomes of mono- and
dicotyledonous plants whereas SAG101 orthologues existed only in dicotyledonous species (Fig
3.1 A).
Genomes that contained orthologous sequences of EDS, PAD4 (and SAG101 in case of di-
cotyledonous species) were selected to analyse and compare sequence features of the EDS1
protein family in more detail. The organisation in two domains of which one is lipase-like and
the other is unrelated to known proteins and therefore termed EP domain (as presented in Fig.
1.6) was found in all analysed sequences.
3.1.1. EDS1 and PAD4 Contain Conserved Triad Residues
In all orthologues of EDS1 and PAD4, three positions within the lipase-like domain are invariably
conserved that correspond to a serine-aspartate-histidine (S-D-H) catalytic triad (Fig. 3.1 B).
A catalytic triad generally consists of a nucleuphilic, an acidic and a basic side chain that
orchestrate the reactions of proteases, esterases, lipases and other enzymes [Dodson and Wlo-
dawer, 1998]. Using the crystal structure of bovine chymotrypsin-A, Blow et al. [1969] proposed
that these residues function as a "charge relay system" in which the proton of the catalytic serine
is transferred along hydrogen bonds to histidine and finally aspartate rendering the deprotonated
serine nucleophilic. The deprotonated serine is then able to perform a nuclophilic attack on the
carbonyl C-atom of a substrate ester bond to start one of manifold reactions. Although it has
been shown experimentally that the aspartate residue actually does not change its protonation
state during the reaction [Bachovchin, 1985; Kossiakoff and Spencer, 1981], the acidic residue
assists proton transfer from the serine to the histidine side-chain probably through stabilising the
protonated histidine and fixing the configuration around the active site [Ishida and Kato, 2004].
A triad of serine, asparate and histidine is most commonly found and referred to as the "classical
triad" – the concept, however, can also be realised with different residues and in rare cases a
dyad is sufficient for catalysis [Rydel et al., 2003; Dessen et al., 1999; Ekici et al., 2008].
Lipases and esterases that use a nucleophilic serine are often characterised by another sequence
feature: the serine is embedded in a GxSxG-motif that structurally results in an exceptionally
sharp turn in which the nucleophile can be easily approached by the substrate [Brenner, 1988;
Nardini and Dijkstra, 1999]. This motif is as well strictly conserved among all EDS1 and PAD4
orthologues (Fig. 3.1 B).
In contrast, Arabidopsis SAG101 does not contain a single conserved residue of a S-D-H triad
and although individual positions are conserved among SAG101 orthologues from other species,
they never constitute a complete triad (Fig. 3.1 B). Paradoxically, SAG101 [He, 2002] and,
more convincingly, PAD4 [Louis et al., 2012] have been proposed to be active hydrolases and
EDS1 is commonly annotated as such in widely used databases[19]. Still, their catalytic activity
is debated [Wiermer et al., 2005] and while many recent studies help to understand where the
EDS1 protein family genetically acts [Heidrich et al., 2011; Bhattacharjee et al., 2011; Louis
[19]http://www.uniprot.org/; http://www.arabidopsis.org/ and others (request date: January, 2013)
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Figure 3.1 | Sequence features of the EDS1 protein family. Orthologues of Arabidopsis EDS1, PAD4
and SAG101 were retrieved from databases and clustered in a phylogenetic tree as described in the
text. (A) shows a cladogram of a sequence subset that unambiguously fell into three clusters. Within
each cluster, the sequences were aligned using T-Coffee [Notredame et al., 2000]. The conservation
of positions corresponding to the catalytic S-D-H of α/β hydrolases – including a lipase-typical GxSxG
motif around the triad’s serine – is shown in (B).
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et al., 2012; Zhu et al., 2011], the biochemical functions of EDS1, SAG101 and PAD4 remain
elusive. Structural information can provide such insights and the following sections shall illustrate
the progress towards my goal of structure elucidation.
3.2. The Production and Characterisation of Recombinant Proteins
Although technical progress in recent years has drastically reduced the amounts of protein needed
for in vitro experiments, preparation on the scale of milligrammes remains a prerequisite, espe-
cially in protein crystallography for which proteins additionally have to be exceptionally pure.
Even though Lohkamp and Dobritzsch [2008] were able to crystallise a protein (yet not the one
that they actually looked for) from a 50 protein mixture and no predominant species, this re-
mains an exception to the rule. In general, one should follow the advice of Alexander McPherson
according to whom protein crystallisation relies on three important factors: "purity, purity and
homogeneity" [McPherson, 2004].
For protein production, plants themselves have attracted attention as expression hosts with
yields of up to 4mg/g fresh biomass [Marillonnet et al., 2005; Werner et al., 2011]. Yet, this
number is inferred from the green fluorescent protein (GFP) expression and differs significantly for
other proteins. Additionally, purification from green plant compartments remains challenging and
I therefore decided to produce EDS1-related proteins in a bacterial expression system (E. coli)
that is flexible, easy to cultivate and allows for extremely high production levels of heterologous
proteins (60mg of green fluorescent protein per gramme dry weight were achieved in bioreactors
[Aucoin et al., 2006]).
3.2.1. Protein Expression
Variants of EDS1, SAG101 and PAD4 were cloned into expression vectors by Steffen Rietz and
J. Stuttmann (both MPIPZ, Köln) carrying different – mostly polyhistidine – or no additional
affinity tags. I transformed these into an E. coli strain optimised for expression according to
section 2.2.12. In addition to full-length proteins from different plant species, N- and C-terminal
variants comprising the lipase-like and EP domain, respectively, were proposed on the basis of
limited proteolysis experiments (Steffen Rietz) or structural information that I obtained during
this thesis. I was able to express major soluble amounts of all proteins that are listed in Table
3.1.
Despite major effort, soluble PAD4 could not be produced recombinantly. Expression of dif-
ferent orthologues, co-expression with EDS1 as a binding partner (and reported stabiliser of
PAD4 [Feys et al., 2005, 2001; Rietz et al., 2011]) and of PAD4-fusions with affinity-tags that
potentially act as solubility enhancers [LaVallie et al., 1993; Kapust and Waugh, 1999] did not
yield noteworthy amounts of soluble protein. One of many expression tests performed according
to section 2.3.1 is presented in Fig. 3.2. All protein variants of EDS1, SAG101 and PAD4 that
were either not expressed or remained insoluble are listed in Table 3.2.
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Table 3.1 | Variants that were expressible as soluble protein on the scale of milligrammes. Yield is given
as the approximate amount of soluble protein in mg per litre E. coli culture
Variant MW (kDa) Used for Yield (mg/l)
EDS1-His 72.5 Crystallisation, interaction
studies, functional studies
8-12
EDS1L262P-His [Rietz et al., 2011] 72.5 Crystallisation 8-12
EDS1 w/o tag 71.5 Crystallisation, interaction
studies
8-12
EDS1-TEV-His 73.5 Crystallisation 8-12
Trx-His-EDS1 87 Crystallisation, interaction
studies
3-4
EDS11-362-His (lipase-like domain) 41.5 Crystallisation 12-15
EDS11-384-His (lipase-like domain) 44.5 Crystallisation, interaction
studies, functional studies
12-15
EDS11-384 w/o tag (lipase-like domain) 43.5 Interaction studies 12-15
EDS11-616-His 72 Crystallisation 7-10
EDS1-His from Arabis alpina 72 Crystallisation 3-4
His-SAG101 63 Crystallisation, interaction
studies
6-9
SAG101 w/o tag 62 Interaction studies 6-9
SAG101291-537-His (EP domain) 31 Interaction studies >25
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Figure 3.2 | Co-expressions of PAD4
variants. Arabidopsis PAD4 was ex-
pressed as a codon-optimised gene either
untagged or fused to solubility-enhancing
affinity tags (MBP: maltose binding pro-
tein; Trx: thioredoxin) in the presence
of EDS1 using pRSF-Duet and pCDF-
Duet expression vectors. Proteins were ex-
pressed over night at 12℃. Soluble (sol)
and insoluble (ins) fractions were sepa-
rated and analysed by SDS-PAGE. Mi-
nor amounts of soluble MBP-PAD4 aggre-
gated during purification, probably due to
improper folding. Asterisks mark the ex-
pected band positions of EDS1 (∗E) and
PAD4 (∗P).
3.2.2. Protein Purification
Milligramme amounts of His-tagged EDS1 and SAG101 variants were prepared in two steps: each
protein was purified separately through (1) immobilised metal-affinity chromatography (IMAC)
and (2) gelfiltration as described in section 2.3.4. An exemplary IMAC purification of EDS1-His
and gelfiltration results of frequently used proteins are presented in Fig. 3.3 A and B.
In gelfiltrations following IMAC purification, the majority of each protein eluted in monomeric
form. However, especially full-length EDS1 and SAG101 repeatedly formed higher order molec-
ular states that eluted in the unresolved void volume of the column and might be protein ag-
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Table 3.2 | Protein variants that I was not able to express and purify due to low level expression or
insolubility of the protein.
EDS1 variants
EDS11-234-His
EDS11-351-His
EDS11-475-His
EDS11-604-His
EDS1259-604-His
EDS1384-604-His
EDS1368-623-His
EDS1384-623-His
His-EDS1 (including Gateway®-linker)
StEDS1 (low soluble ammounts)
PAD4 variants
PAD41-310-His
PAD4 (co-expressed with EDS1-His)
GST-PAD4 (codon-optimised; including Gateway®-linker)
His-PAD4 (codon-optimised; including Gateway®-linker)
Trx-His-PAD4 (codon-optimised; including Gateway®-linker)
MBP-PAD4 (codon-optimised)
Trx-His-PAD4 (codon-optimised; including Gateway®-linker; co-expressed with EDS1)
MBP-PAD4 (codon-optimised; co-expressed with EDS1)
AaPAD4-His
AaPAD4-His (co-expressed with AaEDS1)
StPAD4-His
SAG101 variants
SAG1011-292-His
gregates. Lipase-like N-terminal EDS11-384 additionally formed a minor state that is, judged by
molecular weight size standards, a dimer (Fig. 3.3 B).
All proteins purified in this way were >95% pure as analysed by SDS-PAGE (Fig. 3.4). For
single crystallisation experiments, I additionally purified the proteins by anion exchange chro-
matography as described in section 2.3.4 directly preceding gelfiltration.
3.2.3. Protein Characterisation
As described in section 2.4.7, polydispersity of a sample (i.e. the amount of objects in solution
that differ in size, shape or mass) can be detrimental to protein crystallisation. Polydispersity of
selected EDS1 samples prepared for crystallisation was thus analysed directly after gelfiltration
by means of dynamic light scattering. As Table 3.3 summarises, the samples did not exceed
30%Pd and they were thus used for crystallisation without further manipulation. The estimation
of molecular weight supported a predominantly monomeric EDS1 lipase-like domain (theoretical
mass of 44.5 kDa) in solution, while the estimated weight of full-length EDS1 was in between
that of a monomer (72.5 kDa) and a dimer (145 kDa).
Especially for truncated variants of heterologously expressed proteins, proper three-dimensional
folding has to be confirmed before they can be used in further experiments. Consequently, I
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A
B
Figure 3.3 | Purification of isolated EDS1 and SAG101 variants. (A) Exemplaric chromatogram of
a Ni-NTA purification of EDS1-His. Indicated fractions were pooled and used for further experiments.
(B) Each of the presented proteins was applied to a preparative HiLoad 16/60 Superdex 75 column
(GE Healthcare) directly after IMAC purification and eluted isocratically. The column’s void volume – in
which large molecular species are not separated – is indicated. Peaks corresponding to the monomeric
form of each protein are marked with an asterisk whereas putative dimers of N-terminal EDS11-384 are
indicated with two asterisks.
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Figure 3.4 | SDS-PAGE analysis of recombinantly produced proteins. The total soluble fraction of E.
coli cell lysates and samples from either both or the final purification step were separated by SDS-PAGE.
Bands migrating at the expected size of each protein are indicated by an asterisk. IMAC – immobilised
metal-affinity chromatography, SEC – size exclusion chromatography.
Table 3.3 | Polydispersity of protein samples used for crystallisation. Protein samples were analysed
directly after gelfiltration and values for the normalised polydispersity (%Pd) and an estimate of the
molecular weight were averaged from five consecutive measurements taking 10 acquisitions per measure-
ment.
EDS1 EDS11-384
Polydispersity (%Pd) 15.0 8.9
Molecular weight (kDa) 101.8 37.6
performed circular dichroism (CD) spectroscopy in the far UV range as described in section
2.4.5. Recorded CD spectra of EDS11-384 and SAG101291-537 are shown in Fig. 3.5 A.
These fragments were additionally denatured through a temperature gradient between 10 and
80 ℃. Unfolding of secondary structure elements was followed by monitoring the CD signal at
a wavelength of 222 nm where especially α-helices contribute to a negative ellipticity value (Fig.
3.5 B and C). The results presented in Figure 3.5 suggested that both domains were intrinsically
folded.
Thermofluor assays (section 2.4.6) allow the determination of a protein’s melting temperature
in the presence of different buffers, salts and additives. As thermostability of a protein is cor-
related with its ability to form crystals [Ericsson et al., 2006], I performed Thermofluor assays
prior to crystallisation setups.
In general, full-length EDS1, N-terminal EDS1 and SAG101 are most thermostable at pH
values between 7.5 and 8.5 and less thermostable in the presence of increasing salt concentrations
(Fig. 3.6 A and B). However, especially results obtained for full-length proteins have to be treated
with caution as their melting curves occasionally showed two melting events, presumably resulting
from separated unfolding of lipase-like and EP domain (see Appendix Fig. A.2).
The substances that reproducibly stabilised any of the tested proteins are listed in Table 3.4 for
EDS1, SAG101 and EDS11-384. The most effective, trimethylamine N-oxide, is a small organic
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A B
C
Figure 3.5 | CD spectroscopy of N-terminal EDS1 and C-terminal SAG101. (A) The CD spectra
of EDS11-384 and SAG101291-537 were taken at 10℃ and in 10mM NaH2PO4, pH 7.5. (B) As a
reference, idealised CD spectra of different secondary structure elements are shown in the same range
of wavelengths between 185 and 260 nm. (C) The same samples were subsequently heated from 10℃
to 80℃, following the ellipticity at a wavelength of 222 nm. Both curves were fitted to the Boltzmann
equation that allows to derive a melting point, Tm.
osmolyte that naturally occurs in marine organisms where it protects proteins against elevated
urea levels and deep sea pressure [Krywka et al., 2008] and has been proposed to be used in
protein crystallography by Bolen [2004] and others. I used it at concentrations between 0.5 and
5% (w/v) in crystallisation screenings and optimisations after recognising the positive effect on
protein thermal stability. Similar stabilising effects that promote crystal growth have also been
described for glycerol Sousa [1995] and it was thus used at a final concentration of 20% (v/v)
in crystallisation trials. Bicine buffer at pH 8.0 was regularly chosen as gelfiltration buffer during
purifications for the same reason.
Figure 3.7 summarises the melting points for EDS1, SAG101 and their domain variants
as determined in either circular dichroism or Thermofluor assays. Compared with the corre-
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Figure 3.6 | Trends observed in Thermofluor experiments. Thermal stability of EDS1, the N-terminal
EDS1 domain EDS11-384 and SAG101 in dependence of different buffer pH values (A) and salt concen-
tration (B). Tm – protein melting temperature.
Table 3.4 | List of substances that reproducibly increased the thermostability in Thermofluor assays com-
pared to a control (water).
Condition Increase of Tm (in ℃)
EDS1
5% (w/v) Trimethylamine N-oxide 3
50mM Bicine, pH 8.0 1
20% (v/v) Glycerol 1
EDS11-384
5% (w/v) Trimethylamine N-oxide 2
50mMBicine, pH 8.0 1
20% (v/v) Glycerol 1
SAG101
5% (w/v) Trimethylamine N-oxide 1
sponding full-length proteins, N-terminal EDS11-384 is more thermostable whereas C-terminal
SAG101291-537 with a Tm of 32℃ already unfolds at remarkably low temperatures.
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Figure 3.7 |Melting points of EDS1, SAG101 and
two of their domains. The melting temperatures
were either determined by Thermofluor (EDS1 and
SAG101), circular dichroism (SAG101291-537) or both
(EDS11-384).
3.2.4. Recombinant EDS1 Interacts With and Stabilises SAG101
As known from plants and yeast two-hybrid studies [Feys et al., 2005], EDS1 interacts with the
sequence-related protein SAG101. To prepare a recombinant complex of EDS1 and SAG101,
I expressed both proteins separately and co-purified an excess of untagged EDS1 with an N-
terminally His-tagged SAG101 as described in section 2.3.4 and [Wagner et al., 2011] (Fig. 3.8
A and B). 40mM imidazole, 50mM NaCl, 0.5mM EDTA, pH 7.4 was used as buffer during
gelfiltration and in crystallisation trials. The homogeneous complex could be identified as a
heterodimer by analytical gelfiltration and subsequent SDS-PAGE as shown in Figures 3.8 B and
C. Approximately 8-12mg of pure EDS1/SAG101 heterodimer were purified from two litres of E.
coli cell culture (1 l per protein were unified). According to dynamic light scattering experiments
directly following gelfiltration, the complex solution was more polydisperse (22.3%Pd) compared
to EDS1 and its lipase-like domain (see Table 3.3) while the molecular weight estimated from
these experiments (146 kDa) further supported a heterodimer of actually 134.8 kDa in solution.
Notably, isolated SAG101 tended to precipitate in various buffer systems making in vitro
experiments difficult and crystallisation virtually impossible. However, this tendency could be
dramatically reduced in the presence of recombinant EDS1 as shown in Fig. 3.8 D.
3.3. Crystal Structure of a Functional EDS1/SAG101 Heterodimer
3.3.1. Appearance of EDS1/SAG101 Crystals
The mutual stabilisation of EDS1 and SAG101 (Fig. 3.8 D) may be the reason why of all proteins
used in crystallisation trials (refer to Table 3.1) only the EDS1/SAG101 complex, regardless of
a rather high polydispersity, yielded crystals suitable for X-ray structure determination. The first
intergrown crystals appeared in sitting drop sparse-matrix screenings with 10% (w/v) PEG4000
and 5% (v/v) 2-propanol in 100mM HEPES, pH 7.5 as a crystallant (Classic Screen 3, Jena
Bioscience) but did not show any X-ray diffraction on a homesource (SuperNova™, Agilent) or
a synchrotron X-ray beam (BESSY, Berlin). After optimisation of the crystallisation conditions,
diffracting crystals grew in 5% (w/v) PEG4000, 5% (v/v) 2-propanol and 100mM HEPES, pH
7.5 (Fig. 3.9 A and B). Through the use of crystal seeds, large single crystals grew reproducibly
and diffracted to resolutions below 3Å (Fig. 3.9 C and D).
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Figure 3.8 | Recombinant EDS1 and SAG101 form a stable heterodimer. (A) 50ml of an E. coli
lysate including His-tagged SAG101 and an excess of untagged EDS1 were applied onto a Ni-NTA column
of appropriate size. After washing with at least 10 column volumes IMAC lysis buffer, the proteins were
eluted using an imidazole gradient to a final concentration of 250mM. Indicated fractions were pooled,
concentrated and applied to a preparative HiLoad 16/60 Superdex 200 column. (B) The proteins
were isocracally eluted at a flow-rate of 0.5ml/min. Indicated fractions containing the EDS1/SAG101
complex were pooled and used for further experiments. The retention volumes of ferritin (440 kDa),
lactate dehydrogenase (140 kDa) and bovine serum albumine (66 kDa) are indicated as molecular weight
markers. (C) SDS-PAGE analysis of the total soluble fraction after lysing unified pellets of EDS1 and
SAG101 and a purified sample after size-exclusion chromatography (SEC). (D) Recombinantly produced
and purified EDS1 and SAG101 were left over night at different temperatures either as single protein
(two top panels) or mixed in an equimolar ratio (lower panel). On the following day, the protein solutions
were centrifuged at 20000× g and 4℃ for 15 minutes to pellet precipitated protein. Equal amounts of
the supernatant were then analysed on SDS-PAGE as shown.
Without using microcrystalline seeds, those crystals were hardly reproducible. Analysis of 288
equally pipetted crystallisation trials set up by a robot (mosquito® Crystal, TTP LabTech)
revealed that crystals appeared in only about 5% of all drops emphasising a statement from
Chruszcz et al. [2008]: "We predict that, although the proliferation of the best experimental
protocols and the development of new methodologies will decrease crystallographers’ dependence
on fortunate circumstances, luck will still play a significant role in the foreseeable future". Mi-
croseeding and streak-seeding (see section 2.5.1) helped to overcome this problem and this was
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Figure 3.9 | EDS1/SAG101 pro-
tein crystals. (A) Intergrown crys-
tals appeared in an optimised condi-
tion containing 5% (w/v) PEG4000,
5% (v/v) 2-propanol and 100mM
HEPES, pH 7.5. and diffracted to
approximately 3.5 Å at a synchrotron
beam (B). (C) Through the use of
microseed dilutions, large single crys-
tals could be obtained that show in-
creased diffraction of up to 2.2 Å
(D).
particularly important when I had to systematically test cryoconditions and heavy atom soaking
using (and often destroying) native crystals.
3.3.2. A Gold Salt Allowed Experimental Phase Determination
Solving a protein structure de novo requires the experimental determination of crystallographic
phases. One way to solve the so-called "phase problem" (see section 2.5.6) relies on the in-
troduction of heavy atoms into the protein in its crystalline state (heavy-atom soaking). In a
first experiment, native EDS1/SAG101 protein crystals were incubated in the presence of 30
different compounds at a final concentration of 10mM (see section 2.5.3 for details). Such
compounds that did not immediately lead to macroscopic crystal cracking were chosen for a
second experiment in which native crystals were cryoprotected through stepwise transfers into
a stabilising solution (100mM HEPES, 12% (w/v) PEG 4000, 5% (v/v) 2-propanol, pH 7.5)
containing increasing concentrations of glucose (up to 35% (w/v) in steps of 5% incubating for
2min in between them). Heavy atom compounds solved in the final cryoprotectant (containing
35% glucose) were added at final concentrations of 10mM and crystals were incubated in their
presence for 1, 5 and 10 minutes before frozen in liquid nitrogen and used for diffraction data
collection at a tunable synchrotron X-ray beamline (BESSY, Berlin). Native protein crystals
were cryoprotected using the same protocol without additional heavy-atom soaking.
Following a fluorescence scan, I used the CHOOCH program [Evans and Pettifer, 2001] to
determine a peak, inflection and a remote wavelength suitable for a multiwavelength anoma-
lous dispersion (MAD) experiment (see section 2.5.6) and collected data were analysed for the
presence of an anomalous diffraction signal using XDS [Kabsch, 2010]. A crystal soaked for 10
minutes in the presence of potassium dicyanoaurate was found to be suitable for anomalous data
collection. Statistics of the MAD experiment and a data set collected from a native crystal are
given in Table 3.5.
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The Auto-rickshaw pipeline [Panjikar et al., 2005][20] was used to determine experimental
phases. Auto-rickshaw uses several tools from the CCP4 software suite [CCP4, 1994] to prepare
and scale the data sets and uses the SHELXC and SHELXD programs [Sheldrick, 2010] to solve
the heavy-atom substructure. A total of 8 heavy atom binding sites (Fig. 3.10) were identified,
refined and used for phase calculation by the CP3 program (CCP4). The programs DM (CCP4)
and RESOLVE [Terwilliger, 2003] were then used for density modification calculations and an
initial protein model was automatically build by Buccaneer (CCP4).
Table 3.5 | Data collection statistics for peak (pk), inflection (inf) and high energy remote (her) datasets
used to determine experimental phases and a native dataset that was used for structure refinement. Values
in parentheses are for highest-resolution shell.
pk inf her native
X-ray source BESSY
MX14.1
BESSY
MX14.1
BESSY
MX14.1
BESSY
MX14.1
X-ray detector MAR225 MAR225 MAR225 MAR225
Wavelength (Å) 1.0399 1.0404 1.0313 0.9184
Spacegroup P212121 P212121 P212121 P212121
a,b,c (Å) 111.5, 112.5,
125.3
111.5, 112.5,
125.3
111.5, 112.5,
125.3
112.6, 113.6,
125.4
Oscillation angle (°) 0.5 0.5 0.5 0.5
Matthews coefficient (Å3 Da-1) 2.32
Solvent content (%) 47
Molecules in ASU 1 1 1 1
Resolution, overall (Å) 35.00-2.80 35.00-2.80 35.00-2.80 35.00-2.21
Resolution, highest shell (Å) 2.87-2.80 2.87-2.80 2.87-2.80 2.25-2.21
Overall B-factor (Å2) 43.71
Number of observations 276685
(13483)
269898
(13806)
280878
(14693)
613386
(19038)
Unique reflections 74252 (5129) 74668 (5398) 74531 (5183) 78935 (3608)
Completeness (%) 99.4 (93.1) 99.7 (97.5) 99.4 (94.0) 97.3(79.1)
Multiplicity 3.7 (2.6) 3.6 (2.6) 3.8 (2.8) 7.8 (5.3)
Mean I/σ(I) 14.3 (2.0) 17.6 (2.7) 20.8 (3.1) 21.6 (2.0)
Rmeas (see section A.3) 6.8 (54.8) 5.5 (40.9) 4.9 (38.9) 5.4 (97.2)
SAG101
EDS1
HA positions
Figure 3.10 | Location of anomalous signal. An anoma-
lous map calculated by PHENIX [Adams et al., 2011] from the
peak (pk) dataset using the final protein model as an addi-
tional input reveals the location of anomalous signal within the
EDS1/SAG101 structure. Anomalous electron density shown
in black was contoured at 7 standard deviation (σ) greater than
the mean anomalous electron density of the unit cell and indi-
cates the positions of heavy atoms (HA).
[20]Accessible through http://www.embl-hamburg.de/Auto-Rickshaw/ (request date: December, 2009)
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The experimental phases determined by Auto-rickshaw were then combined with structure
factor amplitudes collected from a native crystal that diffracted to a resolution of 2.21 Å and
used for automated model building by RESOLVE. The final model was refined with the PHENIX
software suite [Adams et al., 2011] and iterative manual model building between refinements was
carried out in Coot [Emsley et al., 2010]. The process of model building is depicted in Figure
3.11. The coordinates and structure factors have been deposited in the Protein Data Bank under
the code 4HVE.
After Auto-rickshaw (3.3 Å) After RESOLVE (2.21 Å) Final model (2.21 Å)
SAG101
EDS1
Figure 3.11 | The process of automated and manual model building. The EDS1/SAG101 complex
model is depicted after automated model building through Auto-rickshaw using a resolution maximum
of 3.3 Å, following automated model building by the RESOLVE program and after manual rebuilding
that lead to the final model. The upper panel depicts parts of the model that were built while the lower
panel shows the according electron density at each stage. Electron density was contoured at 1 standard
deviation (σ) greater than the mean electron density of the unit cell. Automated tools often start by
building the protein’s backbone (polyglycines) and extend this to polyalanines or the correct side-chain
group as the electron density improves.
3.3.3. Both Domains of EDS1 and SAG101 Participate in Heterodimer
Formation
The final model contains all but 4 terminal EDS1 residues and all SAG101 residues with a
segment missing between Proline 35 and Aspartate 52. As expected from sequence analysis, a
central structural feature of EDS1 and SAG101 is their organisation in two distinct domains. As
shown in Figure 3.12, both participate in the formation of a head-to-head dimer in which EDS1
and SAG101 interact through a large interface that will be further analysed in section 3.6.
63
3. Results
C
C
N
N
E
P
 d
o
m
a
in
1
291
537
SAG101 
lip
a
s
e
-l
ik
e
 d
o
m
a
in
EDS1
S123
D187
H317
1
384
623
E
P
 d
o
m
a
in
lip
a
s
e
-lik
e
 d
o
m
a
in
Figure 3.12 | Crystal structure of the
EDS1/SAG101 heterodimer. EDS1 and
SAG101 are each organised in two dis-
tinct domains. Both domains partici-
pate in complex formation and both N-
terminal and C-terminal domains interact
with each other burying a large surface
area. While the lipase-like domains con-
tain a core of mainly parallel β-strands
(yellow) connected by α-helices, the C-
terminal EP domains are exclusively heli-
cal. The positions of the conserved S-D-
H triad within lipase-like EDS1 are shown
schematically.
3.4. The Lipid Link
3.4.1. The EDS1 Lipase-Like Domain Is Closely Related to Hydrolases
As sequence analysis emphasised the relation of EDS1 (and less convincingly SAG101) to lipases,
I wondered how closely this is at the structural level. The Dali server [Holm and Rosenström,
2010] allows to compare[21] a query protein structure to all structures deposited within the
Protein Data Bank [Berman, 2000][22]. The five closest related structures to N-terminal EDS1
and SAG101 are listed in Table 3.6 and have a common lipase class 3 (triacylglycerol lipase)
fold.
I chose a small and well-characterised triacylglycerol lipase from the fungus Mucor miehei
(MML; PDB codes 3TGL and 4TGL) for a detailed structural comparison to the EDS1 and
SAG101 lipase-like domains. For an individual description of secondary structure elements, I
proposed a nomenclature that deviates from the canonical α/β hydrolase fold [Ollis et al., 1992].
As shown in topology diagrams (Fig. 3.13), N-terminal EDS1 contains all but the first central
β-strand of the MML with the most C-terminally β10 being inverted and structural related to
the MML N-terminus. This differently organised domain-terminus additionally involves α-helices
αK,L,M and is necessary for the connection to the C-terminal EP domain. The two-domain
organisation also results in an extended loop-out between β-strands b1 and b2 within EDS1 and
SAG101 that contacts the EP domain and probably stabilises the orientation of both domains
towards each other. Other eye-catching differences that will be discussed in further detail are:
(1) the N-terminal α-helix αA’ within SAG101 that occupies the position of EDS1 and MML
[21]The Dali-server calculates intramolecular distance matrices for each of the protein and aligns them pairwise
resulting in a similarity score. The Z-score reported in Table 3.6 is a normalised similarity score and increases with
higher similarity between two proteins. Z-scores below 2 indicate no structural relationship, while highly related
proteins eventually produce Z-scores of above 16 (as stated in http://ekhidna.biocenter.helsinki.fi/how/
week2/day8/stralignment.pdf; request date: March, 2013)
[22]Approximately 80.000 protein structures by the end of 2012
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Table 3.6 | The five closest structural homologues of the N-terminal EDS1 or SAG101 domain as iden-
tified by the DALI-server. For each entry, the PDB entry code (PDB), the DALI Z-score (Z), the
average distance between aligned atoms (rmsd), the sequence identity (id) and related entries in the
Pfam database are given.
EDS11-384 PDB Z rmsd id (%) Pfam
SAG1011-290 22.9 2.9 Å among 243
aligned residues
19
Feruloyl esterase A 1uza 20.2 2.3 Å among 205
aligned residues
16 Lipase 3
Malassezia globosa LIP1 (SMG1) 3uue 19.5 2.7 Å among 215
aligned residues
16 Lipase 3
Thermomyces lanuginosa lipase (TLL) 1gt6 19.2 2.3 Å among 202
aligned residues
21 Lipase 3
Mucor miehei lipase (MML) 4tgl 18.9 2.6 Å among 208
aligned residues
21 Lipase 3
Gibberella zeae lipase (GZEL) 3ngm 18.4 3.3 Å among 210
aligned residues
17 Lipase 3
SAG1011-290
Feruloyl esterase A 1uza 19.2 2.6 Å among 209
aligned residues
14 Lipase 3
Malassezia globosa LIP1 (SMG1) 3uue 18.5 2.9 Å among 211
aligned residues
8 Lipase 3
Mucor miehei lipase (MML) 3tgl 18.2 2.8 Å among 206
aligned residues
16 Lipase 3
Rhizopus niveus lipase (RNL) 1lgy 18 2.8 Å among 203
aligned residues
16 Lipase 3
Thermomyces lanuginosa lipase (TLL) 1dt5 17.6 2.8 Å among 201
aligned residues
12 Lipase 3
β10 and contributes decisively to the EDS1/SAG101 interaction interface,
(2) the α-helix a1 that plays a crucial role in the regulation of MML and is degenerated to a
310-helix in EDS1 and SAG101 and, most prominent,
(3) an insertion into the canonical α/β hydrolase fold between EDS1 αE and β8 that comprises
73 amino acids between residues I192 and Y267 folding into three α-helices, αF,G,H. This will
be referred to as EDS1 "N-terminal insertion" throughout the rest of the text.
Notably, SAG101 misses this EDS1-like insertion between the aspartate and histidine triad
positions. Moreover, the protein backbone surrounding the SAG101 aspartate-position is differ-
ently organised in SAG101 and EDS1 (Fig. 3.13 and 3.14). While this strengthens the notion
that the SAG101 triad is generally unconserved, a detailed look at the EDS1 triad (S123, D187,
H317) reveals that this is not only conserved sequentially but also structurally (Fig. 3.1 B and
3.14).
3.4.2. EDS1 Contains an Insertion Into the Canonical α/β Hydrolase Fold That
is Conformationally Stabilised Through SAG101
The N-terminal EDS1 insertion introduced above is interesting in two ways: firstly, it covers the
conserved triad residues and, secondly, it directly interacts with SAG101.
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Figure 3.13 | Topology diagrams of
the N-terminal EDS1 and SAG101
domains compared to an active li-
pase. In the topologies of an active
lipase from Mucor miehei (MML) and
the lipase-like domains of EDS1 and
SAG101 elements exhibiting the canon-
ical fold of α/β hydrolases are in black
while elements that are structurally con-
served among EDS1 and SAG101 are
in grey. Secondary structure elements
that are differently organised in EDS1
and SAG101 are in red and contain the
N-terminal EDS1 insertion (αF,G,H).
A SAG101 region that could not been
placed due to missing electron density
is indicated as black dashes. The di-
agrams were created using TopDraw
[Bond, 2003]
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S123
S144
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MML
EDS1
SAG101
Figure 3.14 | Detailed view on the
EDS1 triad. The S-D-H triad positions
of EDS1 (blue), SAG101 (green) and
Mucor miehei lipase (grey) were super-
imposed using least-square fitting and
the residue numbers are given for all
triad positions.
Intriguingly, the structure of the Mucor miehei lipase that I already used for structural com-
parison was initially crystallised as well in a state in which the triad was solvent-shielded [Brady
et al., 1990]. Way before that, Sarda and Desnuelle [1958] had observed that lipases are ac-
tivated in the presence of an oil-water interface, a mechanism termed interfacial activation[23].
Brady et al. [1990] consequently speculated that a protein loop that they refer to as the "lid"
covers the active site but can be "removed or displaced, possibly through interfacial activation".
[23]The authors find lipase activity and interface dimension to be as related as enzymatic activity and substrate
concentration: "l’activité de la lipase dépend des dimensions de l’interface de l’émulsion comme l’activité d’un
enzyme ordinaire dépend de la concentration de la solution du substrat."
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They could confirm this by co-crystallising the same lipase with a small-molecule inhibitor that
stabilises the enzyme’s open conformation [Derewenda et al., 1992]. The transition between
open and closed state involves particularly hydrophobic side chains from α-helix a1 (Fig. 3.13
and 3.15 A) that is able to bind a hydrophobic interface (for instance lipid or detergent micelles
or a crystal contact), thereupon undergoes a conformational change and thus renders the active
site accessible.
This regulatory MML helix a1 is degenerated to a 310-helix in SAG101 and EDS1 that does not
completely restrict solvent accessibility of the triad pocket (Fig. 3.15 B and C). Within EDS1,
however, the hydrophobic side-chains F47 and F52 stabilise the position of helix αF (being part
of the N-terminal insertion) that folds on top of the triad (Fig. 3.16 A).
Judging by crystallographic B-factors that are correlated with the structural flexibility of a
protein region, α-helices αF and αG are rather rigid and only a small loop between them possesses
flexibility (Fig. 3.16 B). In this state, which is not stabilised through crystal contacts, the triad
would be hardly accessible for a small molecule. Yet, it is important to notice that helix αH
and the preceding αG (both are part of the N-terminal EDS1 insertion) are in direct contact to
SAG101 (Fig. 3.15 C). I therefore asked whether the N-terminal EDS1 insertion could – as a
whole or partly – undergo conformational changes upon SAG101 dissociation.
SAG1011-290
a1 
EDS1
A B
MML a1 
(open/closed)
EDS11-350
SAG101
a1 
αH
αG
αF
C
Figure 3.15 | The N-terminal domains of EDS1 and SAG101 adopt an α/β hydrolase fold. The
active lipase from Mucor miehei (grey) was superimposed with either EDS11-384 (blue) or SAG1011-290
(green) and the proteins are individually presented. (A) Within the MML, α-helix a1 that regulates
activity, as described in the text, is in green (open conformation) or red (closed conformation). (B)
The 310 helix a1 of SAG101 is in black, bound EDS1 is shown as surface representation. (C) Within
lipase-like EDS1, 310 helix a1 and the N-terminal insertion comprising helices αF,G,H are in black. The
surface of bound SAG101 is shown. The MML active site and analogous positions within EDS1 and
SAG101 are indicated as a yellow sphere.
Consequently, I computationally calculated the motions of either isolated EDS1 or EDS1 in
complex with SAG101 in a water box as described in section 2.5.8 for a time frame of 50 ns.
As shown in Figure 3.16 C, simulated motions surrounding the triad generally resemble what
could have been inferred from crystallographic B-factors: while there is structural flexibility
between α-helices αF and αG, the insertion adopts an overall stable conformation. Yet, if the
motions of isolated EDS1 were simulated, the third helix within the N-terminal insertion (αH)
became flexible as shown in Figure 3.17. This helix is characterised by hydrophobic side-chains
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and will be important for the detailed discussion of EDS1/SAG101 interaction in section 3.6.
Hence, a conformational change upon SAG101 dissociation in an aqueous environment was to
be expected but could be accompanied by concerted molecular motions that take to long to be
computationally modelled. I thus did not want to generally exclude the possibility that the EDS1
triad could be accessed by a small molecule.
Structural motions calculated by the NMSim tool in "large scale motions" mode [Krüger et al.,
2012][24] emphasised the flexibility of EDS1 helix αH upon SAG101 dissociation but did not point
to associated motions of other structural elements (see Appendix Fig. A.3).
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Figure 3.16 | The EDS1 triad might be inaccessible. (A) N-terminal EDS1 (blue) was superimposed
with the Mucor miehei lipase (MML) in open (green) and closed (red) conformation. The lipase
inhibitor DEP (diethylphosphonate) that stabilises the open conformation of MML is drawn to indicate
where a ligand or substrate could bind. Within EDS1, the triad residues and such that effectively block
solvent access to them are drawn as sticks. (B) is a schematic representation of (A) in which the
EDS1 elements are coloured based on their crystallographic B-factors. High B-factor values (reddish)
indicate high structural flexibility. (C) shows the flexibility of the same region as determined in a 50 ns
molecular dynamics simulation of EDS1/SAG101.
Sequence analysis revealed that Arabidopsis PAD4 does not contain the EDS1-like N-terminal
insertion and this, in combination with a conserved S-D-H triad among all PAD4 orthologues
(Fig. 3.1 B), renders this protein probably the most obvious candidate for hydrolytic activity. It
shall, however, be pointed out that actually most PAD4 orthologues do contain an N-terminal
insertion that could as well block access to the triad (Fig. 3.18).
[24]http://cpclab.uni-duesseldorf.de/nmsim/ (request date: September, 2012)
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SAG101
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Figure 3.17 | Structural flexibility of the EDS1 insertion upon SAG101 dissociation. Atomic motions
of EDS1/SAG101 (A) and EDS1 alone (B) in a waterbox were simulated over 50 ns. The N-terminal
EDS1 insertion encompassing α-helices αF,G,H is coloured according to structural flexibility. The
position where a small molecule ligand or a substrate could bind is indicated by a yellow sphere.
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3.4.3. EDS1 Does not Depend on Hydrolytic Activity in Central Immune
Pathways
To test whether the triads of EDS1 and PAD4 were conserved throughout evolution due to
a function in Arabidopis immune signalling, J. Stuttmann (MPIPZ, Köln) stably transformed
an eds1-2/pad4-1 double null mutant in accession Columbia (Col-0) with an EDS1 variant
that misses all three triad residues (S123A+D187A+H317A) and a PAD4 variant in which the
potentially catalytic serine S118 was exchanged to alanine and expressed both variants under
their own promoters.
These plants were infected with an incompatible isolate (Emwa2) of the oomycete Hyaloper-
onospora arabidopsis. Incompatible Hyaloperonospora isolates trigger a TIR-NB-LRR-mediated
hypersensitive response on wildtype Arabidopsis plants. As introduced, the hypersensitive re-
sponse is a defencive cell death mechanism that effectively stops pathogen invasion. This cell
death can be visualised by the diazo dye Trypan Blue that stains fungal structures (hyphae,
oospores etc.) and dead but not vital plant cells. As controls, J. Stuttmann (MPIPZ, Köln)
additionally infected plants that were transformed accordingly with wildtype variants of EDS1
and PAD4 and plants that did not express EDS1, PAD4 or both proteins. While these single and
double null mutant plants failed to induce defencive cell death at the site of Hyaloperonospora
infection, the triad mutant variants of EDS1 and PAD4 restored a hypersensitive response to
wildtype levels indicating that catalytic activity is dispensable in this context (Fig. 3.19 A).
Partial complementation of line #45_3 can be explained with a comparably low level of mutant
protein (Fig. 3.19 C).
The same plants were further infected with the compatible Hyaloperonospora isolate Noco2.
Compatible Hyaloperonospora isolates do not trigger localised cell death but are still restricted
in growth by residual plant defence mechanisms – the basal resistance. We found that the triad
mutants of EDS1 and PAD4 were fully functional in this context whereas plants missing EDS1,
PAD4 or both proteins were significantly compromised in their ability to restrict the oomycete’s
growth (Fig. 3.19 B). For both experiments, J. Stuttmann (MPIPZ, Köln) selected plant lines
that accumulated the EDS1 variant to wildtype amounts (Fig. 3.19 C).
3.4.4. Small Molecule Binding to the Triad Seems Improbable
As the EDS1 triad could be further conserved due to a function in binding instead of hydrolysing
small molecules, I proposed structure-guided exchanges that further perturbed a putative binding
pocket (Fig. 3.20 A). J. Stuttmann transformed these variants stably in eds1-2 null mutant
plants and infected these with the incompatible Hyaloperonospora isolate Cala2 that does not
survive on wildtype Col-0 plants. While the oomycete was able to sporulate on eds1-2 plants,
all transformed EDS1 variants, including those with a completely artificial environment around
the conserved triad, were fully functional in restricting pathogen growth (Fig. 3.20 B).
3.4.5. Recombinant EDS1 Does Not Hydrolyse Artificial Substrates
Given that EDS1 has been identified as a component of further signalling cascades including
an immunity-unrelated response to photo-oxidative stress [Straus et al., 2010; Rustérucci et al.,
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Figure 3.19 | EDS1 and PAD4 are not acting as hydrolases in central immune pathways. (A) Con-
trol plants and homozygous eds1-2 pad4-1 null mutant plants were transformed with PAD4, EDS1
or mutant variants carrying exchanges in residues of the catalytic triad under their own promoters
(pEDS1/pPAD4). These were infected with the incompatible Hyaloperonospora isolate Emwa2. In-
fected leaves were stained with Trypan Blue 4 days after infection and analysed under a microscope.
hr – hypersensitive response, fh – free hyphae. Scale bar= 200 µm. (B) The same lines as in (A) were
infected with the compatible Hyaloperonospora isolate Noco2 and fungal growth was scored by spore
counting. Data from four independent experiments, each containing ≥ 3 biological replicates, were
normalised to Col= 100% sporulation. Letters indicate statistically different classes. (C) Steady-state
and pathogen-induced EDS1 protein accumulation in lines used in (A) and (B). Total protein extracts
were prepared from three week-old plants that were either left uninfected or exposed for 48h to Pseu-
domonas syringae pv. tomato (Pto) DC3000 and subjected to SDS-PAGE followed by immunoblot
analysis using α-EDS1. Ponceau staining of the membrane is shown as a loading control.
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Figure 3.20 | The EDS1 triad does not bind a small molecule in TIR-NB-LRR-mediated resistance.
(A) shows a comparison of the putative ligand binding site in the EDS1-SAG101 structure (blue) and a
model of the modified protein containing S123A, D187A, H317A, F47W and V189M mutations (red).
Estimated space available for a ligand is indicated in yellow, residues potentially contacting a ligand
and the αF helix covering the substrate binding site in the crystal structure are shown. (B) eds1-2 null
mutant plants with EDS1 variants expressed as C-terminal fusions to YFP under control of the EDS1
promoter (pEDS1) and control plants were infected with the incompatible Hyaloperonospora isolate
Cala2 and macroscopic disease symptom formation was scored 7 days after infection. Scale bar= 2.5
mm. Expression of YFP-EDS1 fusion proteins and complementation in individual lines is shown in
Appendix Figure A.4.
2001; Ochsenbein et al., 2006], I analysed EDS1 hydrolytic activity in vitro by measuring the
hydrolysation of artificial substrates. Recombinantly produced EDS1 and its lipase-like domain
EDS11-384 were incubated separately in the presence of p-nitrophenyl esters of varying chain
lengths while following the production of the photometrically active product p-nitrophenolate.
While pNP-esters with shorter chains (pNP-acetate, -propionate, -butyrate) are preferentially
hydrolysed by esterases, long-chain esters (pNP-octanoate, -myristate, -palmitate) are more
typical lipase substrates. In two completely independent experiments, neither EDS1 nor its
lipase-like domain hydrolysed any of the six substrates under the given conditions while the lipase
of Mucor miehei, which I already used for structural comparison, does so (Fig. 3.21).
3.4.6. Lipase-Like EDS1 Is Not Sufficient for Proper Immune Signalling
These results show that EDS1 does neither bind nor hydrolyse a small molecule in central Ara-
bidopsis immune pathways. Recombinant EDS1 was further not able to hydrolyse artificial
esterase and lipase substrates.
To examine the importance of lipase-like EDS1 in Arabidopsis resistance, J. Stuttmann (MPIPZ,
Köln) transformed eds1-2 null mutant plants with full-length EDS1 and the previously charac-
terised variant EDS11-384 under a constitutive 35S promoter and infected these with an incom-
patible isolate of Hyaloperonospora, Cala2. While plants expressing full-length EDS1 were able
to restrict Hyaloperonospora growth through the establishment of a hypersensitive response at
the infection site, plants that did either miss EDS1 or expressed only its lipase-like domain were
severely compromised in TIR-NB-LRR-mediated signalling (Fig. 3.22 A). It was ensured that
several plant lines were tested and that these expressed the lipase-like domain to sufficient levels
(Fig. 3.22 B). In localisation studies with YFP-fused EDS11-384, J. Stuttmann (MPIPZ, Köln)
was additionally able to show that the inability to trigger an immune response was not due to
mislocalisation of the protein domain (see Appendix Fig. A.5).
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result of impaired immune signalling. (B) Protein accumulation and complementation of individual T1
transformants shown in (A).
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3.5. The C-terminal Domains of EDS1 and SAG101 Are Only
Distantly Related to Known Proteins
The inability of the lipase-like EDS1 domain to complement for the loss of full-length EDS1
in plant immunity emphasised the importance of the C-terminal EP-domain. Sequence analysis
had shown that this domain is present in all EDS1, PAD4 and SAG101 orthologues and has no
other relatives on sequence level. To search for structural homologues, I compared EDS1385-623
and SAG101291-537 with all available protein structures in the PDB using the Dali algorithm as
described in section 3.4.1 and Table 3.7 list the 5 closest homologues to both domains.
Table 3.7 | The five closest structural homologues of the C-terminal EDS1 or SAG101 domain as iden-
tified by the DALI-server. For each entry, the PDB entry code (PDB), the DALI Z-score (Z), the
average distance between aligned atoms (rmsd), the sequence identity (id) and related entries in the
Pfam database are given.
EDS1385-623 PDB Z rmsd id (%) Pfam
SAG101291-537 17.5 2.7 Å among 185
aligned residues
31
Negative regulator of
ofd1 (Nro1)
3qtm 5.5 4.2 Å among 145
aligned residues
8 n/a
Glutathione
S-transferase
1yq1 5 3Å among 92 aligned
residues
8 Glutathione
S-transferase domain
Nisin cyclase 2g02 4.8 4.3 Å among 99 aligned
residues
4 Lanthionine synthetase
C-like protein
Translocase of outer
membrane 70 kDa
subunit (Tom70)
2gw1 4.7 3.6 Å among 133
aligned residues
11 Tetratricopeptide
repeat
26S proteasome
regulatory subunit
Rpn6
3txm 4.7 3.5 Å among 126
aligned residues
11 PCI domain
SAG101291-537
Glutathione
S-transferase
1ml6 7.6 3.3 Å among 102
aligned residues
8 Glutathione
S-transferase domain
(N- and C-terminal)
Syntaxin 6 1lvf 7 3.4 Å among 89 aligned
residues
6 Syntaxin 6 domain
Mouse protein 25 alpha
(MO25alpha)
2wtk 6.8 2.6 Å among 82 aligned
residues
8 Mo25-like
Symmetrical sisters-1
(SYS-1)
3c2g 6.7 3.6 Å among 88 aligned
residues
4 n/a
Target of Myb1
(Tom1)
1wrd 6.4 3.3 Å among 82 aligned
residues
9 GAT domain
While the N-terminal domains of EDS1 and SAG101 are closely related to lipases (resulting
in Dali Z-scores above 20), the list of homologues to the C-terminal domains consists of far less
related proteins (Z-scores below 10)[25] that stem from all sorts of cellular functions and protein
folds. Still, one common scheme was occurring: many of the homologous proteins were only
[25]As described before, Z-scores below 2 indicate no structural relationship, while highly related proteins produce
Z-scores of 16 and above (source: http://ekhidna.biocenter.helsinki.fi/how/week2/day8/stralignment.
pdf; request date: March, 2013)
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functional in multi-protein complexes like the proteasome, the mitochondrial translocase complex
or the TREX complex that acts in nuclear export of mRNA [Wu and Sha, 2006; Ellisdon et al.,
2012; Pathare et al., 2012].
The EDS1 and SAG101 EP domain organisation and their structural relation to one of the
more closely related homologues (Tom70 from the translocase complex) is depicted in Figure
3.23.
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Figure 3.23 | EP domain organisation. (A) Topology diagrams of the EDS1 and SAG101 EP domains
in which α-helices were named alphabetically by their order in the sequence following a nomenclature
introduced in Figure 3.13. (B) highlights the structural relation between the EDS1 EP domain and
one of its closest structural homologues, the transporter of outer membrane (TOM) protein Tom70.
Helix tandems that belong to an tetratricopeptide repeat motif in Tom70 and their structural relatives
in EDS1385-623 and SAG101291-537 are coloured accordingly in (A) and (B).
3.6. Interactions Within the EDS1 Protein Family
Protein-protein interactions of EDS1-related proteins have emerged as probably their central
functional feature: not only does EDS1 interact with PAD4 and SAG101 but has also been
reported to be in a physical complex with immune receptors [Bhattacharjee et al., 2011; Bonardi
and Dangl, 2012; Heidrich et al., 2011] as introduced in section 1.3.5. Detailed molecular
information on the formation of EDS1-containing complexes, however, is lacking. While I had
already shown that full-length EDS1 and SAG101 do interact as recombinant proteins, I next
asked which of the domains was able to bind the corresponding full-length partner. I expressed
full-length variants of EDS1 and SAG101 as well as the EDS1 lipase-like domain (EDS11-384)
and the SAG101 EP domain (SAG101291-537) separately. E. coli cell suspensions containing
different combinations of each one untagged and one His-tagged protein were then mixed, lysed
and purified as described in sections 2.3.3 and 2.3.4. In these co-purification experiments,
His-tagged SAG101 and an untagged variant of lipase-like EDS11-384 were able to interact as
depicted in Figure 3.24. In contrast, the EP domain of SAG101 was not able to form a stable
complex with full-length EDS1.
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-
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-
-
- Figure 3.24 | Co-purifications of EDS1,
SAG101 and two of their domains. For
co-purifications, soluble cell lysates of His-
tagged and an excess of untagged pro-
tein were mixed and applied to Ni-NTA
matrix. After binding at 4℃, the ma-
trix was rigorously washed with at least 10
column volumes IMAC lysis buffer. His-
tagged proteins were eluted by applica-
tion of IMAC elution buffer and the elution
fractions were separated by SDS-PAGE.
To further analyse the interactions within the EDS1 family, I made use of the yeast two-
hybrid system introduced in section 2.6. Although it had been shown that EDS1 interacts with
itself, SAG101 and PAD4 in such assays [Feys et al., 2001, 2005; Rietz et al., 2011], I had
to re-establish the respective controls using Gateway-cloned genes in a GAL4-based yeast two-
hybrid system (see sections 2.2.6 and 2.6 for further information). I was able to show the
previously described interactions between combinations of full-length proteins (EDS1+EDS1,
EDS1+SAG101 and EDS1+PAD4) and could additionally verify the interaction of N-terminal
EDS1 with SAG101 3.25. As a result, I was able to further dissect the interactions between
combinations of proteins.
SAG101
BD
EDS1
empty
EDS1
PAD4
PAD4
SAG101
AD
EDS11-384
EDS11-362
EDS11-362
SAG101
EDS11-384 empty
SAG101
empty
BD
empty
EDS1
EDS1
empty
EDS1
EDS1
empty
AD
-LW -LWH -LWHA
-LW -LWH -LWHA
EDS11-384 PAD4
Figure 3.25 | Interactions within the EDS1 protein family in yeast two-hybrid assays. EDS1 or N-
terminal domain variants (EDS11-362 and EDS11-384) were fused to the GAL4 activation domain (AD).
In yeast two-hybrid assays, I analysed their interaction to EDS1, PAD4 and SAG101 fused to the GAL4
binding domain (BD). Successfully co-transformed cells that contain the AD- and BD-fusion proteins
are able to grow on media lacking leucine and tryptophan (-LW). Cells only grow on -LWH and -LWHA
plates (lacking histidine or additionally adenine) when the fused proteins do physically interact. As the
GAL2-ADE2 reporter is more stringently regulated than GAL1-HIS3, cell growth on -LWH but not on
-LWHA plates indicates a residual interaction.
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3.6.1. Sequential Mutations in SAG101 Are Necessary to Suppress Interaction
to EDS1
Manual selection of critical residues at the interface between EDS11-384 and SAG101 was as-
sisted through the tools HotPoint[26] [Tuncbag et al., 2010], HSPred[27] [Lise et al., 2009] and
KFC2[28] [Zhu and Mitchell, 2011; Darnell et al., 2007] that predict so-called hot spots of pro-
tein interaction. Clackson and Wells [1995] had shown for a hormone-receptor that within a
protein-protein interaction interface only a small and complementary set of hot spots residues
contributes significantly to binding affinity. This was confirmed for larger sets of protein-protein
interactions by Bogan and Thorn [1998] and others.
The hot spot of interaction between N-terminal EDS1 and SAG101, as predicted by the tools
mentioned above, is made of a SAG101 hydrophobic pocket that accommodates EDS1 helix αH
(Fig. 3.26 A and B). Within SAG101 and EDS11-384, single side chains at this interface were
mutated to either alanine or the more polar serine. The effect of these exchanges on complex
formation was evaluated in yeast two-hybrid assays using a GAL4 activation domain (AD) fusion
of EDS11-384 and a binding domain (BD) fusion of SAG101. A comprehensive list of all tested
variants is given in Appendix Table A.2.
Possibly due to an interaction that is weaker compared to the full-length protein complex, the
interaction of EDS11-384 to SAG101 could only be shown on selective media lacking histidine (-
LWH) but not additionally adenine (-LWHA) (Fig. 3.25). I therefore documented growth of yeast
cells after two and five days incubation at 30℃ to qualitatively compare effects on interaction.
Cells that were impaired in growth indicated weakened interaction between the tested variants
and single mutations were sequentially combined to achieve an additive effect. As depicted in
Fig. 3.26 C, only combinatorial exchanges within SAG101 were sufficient to significantly reduce
the interaction to wildtype EDS11-384 whereas even single mutations in EDS11-384 lead to a
significant loss-of-interaction to SAG101 (Fig. 3.26 D. and Appendix Table A.3).
Yet, when the resulting variants SAG101 L12A+L21A+I141A (LLI) and EDS1 L258A+L262A
(LL) were probed against the respective binding partner in full length, interaction was at least
partially restored, arguing for a contribution of the C-terminal interface to complex formation.
The C-terminal interface between EDS1 and SAG101 EP domains is a mixture of hydrophobic
interactions, hydrogen bonding and salt bridges that are predominantly formed between two he-
lices, EDS1 αP and SAG101 αN (Fig. 3.27 A and B). Several mutations within C-terminal
SAG101 were tested in yeast two-hybrid experiments and an exchange of Y306 to alanine
within the SAG101LLI variant reduced binding to full-length EDS1 (Fig. 3.27 C). The vari-
ant SAG101LLIY is severely compromised in its interaction to EDS1, yet a residual interaction
is indicated by growth of the yeast cells on -LWH medium.
Contrary to SAG101, the combination of single exchanges within the N-terminal EDS1 in-
teraction interface ( resulting in a EDS1 I254A+L258A+F261A+L262A (LLIF) variant) turned
out to be sufficient to achieve a similar effect (Fig. 3.27 D) and further mutations within the
C-terminal interface did not reduce residual interaction that is indicated by the growth of cells
[26]http://prism.ccbb.ku.edu.tr/hotpoint/ (request date: April, 2011)
[27]http://bioinf.cs.ucl.ac.uk/hspred (request date: April, 2011)
[28]http://kfc.mitchell-lab.org/ (request date: April, 2011)
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Figure 3.26 | Interactions between N-terminal EDS1 and SAG101 in yeast two-hybrid assays. (A)
shows the anchoring point of the N-terminal interaction interface that consists of hydrophobic EDS1
helix αH that is accommodated by a schematically represented hydrophobic pocket within SAG101.
EDS1 αH belongs to the N-terminal EDS1 insertion that is coloured black. Structural details of this
interaction site is shown in (B) in which side chains that were exchanged according to the text are
represented as sticks. (C) The effect of single and combinatorial exchanges within the hydrophobic
pocket of SAG101 as analysed after 2 and 5 days of yeast cell growth on selective -LWH plates.
Protein accumulation of AD- and BD-fusion proteins as recognised by α-HA and α-c-Myc antibodies,
respectively, is shown below. (D) Accumulated protein amounts of EDS11-384 variants and their effect
on SAG101 binding is shown according to (C).
on -LWH plates. The more comprehensive list of analysed variants is given in Appendix Tables
A.4 and A.2.
To validate these effects in planta, J. Stuttmann (MPIPZ, Köln) infected tobacco (Nicotiana
benthamiana) plants using the tobacco mosaic virus (TMV)-based magnICON system (Icon
Genetics) that allows transient expression of the introduced genes. In co-purification experiments
with StrepII-tagged SAG101 and untagged EDS1 variants that are schematically explained in
Figure 3.28 A, he could verify that SAG101LLIY is indeed compromised in EDS1 interaction
but also in protein stability (Fig. 3.28 B). In contrast, the stability of EDS1 variant LLIF is not
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Figure 3.27 | Interactions between full-length EDS1 and SAG101 in yeast two-hybrid assays. (A)
shows the interaction interface between the EDS1 and SAG101 EP domains. Two parallel helices,
EDS1 αP and SAG101 αN, are highlighted that form most of the interactions. These consist of
hydrophobic interactions, salt bridges and a network of hydrogens bonds as depicted in more detail in
(B). (C) Yeast two-hybrid interactions between activation domain (AD) fusions of full-length EDS1 and
binding domain (BD) fusions of different SAG101 variants (LL= L12A+L21A, LLI= LL+I141A, LLIY=
LLI+Y306A). Pairs of plasmids were co-transformed into yeast cells, grown on plates selecting for co-
transformation (-LW) and four single colonies were streaked onto plates selecting for weak (-LWH) and
strong (-LWHA) protein interaction. Cell growth was monitored after 2 days at 30℃. Accumulation of
the protein fusions in yeast cells was assayed by total protein extraction, SDS-PAGE and subsequent
immunoblot analysis using α-HA and α-c-Myc antibodies that recognise GAL4 activation- or binding
domain, respectively. (D) Yeast two-hybrid interactions between activation domain (AD) fusions of
different EDS1 variants (LL= L258A+L262A, LLI= LL+I254A, LLIF= LLI+F261A) and a binding
domain (BD) fusion of full-length SAG101 that were analysed as described for (C).
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affected and the exchanges result in a drastic reduction of interaction to SAG101 in plants (Fig.
3.28 C).
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Figure 3.28 | Interactions between full-length EDS1 and SAG101 in tobacco. (A) Schematic rep-
resentation of co-purification experiments from tobacco. According to section 2.3.6, total protein
extracts of 2 g plant material were purified through the addition to Strep-Tactin matrix. Following
rigorous washing, StrepII-tagged and co-purified proteins were eluted and separated by SDS-PAGE. (B)
Co-purification of untagged EDS1 in wildtype form and variants of SAG101 fused to StrepII. Samples
separated by SDS-PAGE were analysed by immunoblotting using Strep-Tactin conjugated with alkaline
phosphatase (AP) or antibodies against EDS1 (α-EDS1). (C) Co-purification of untagged EDS1 vari-
ants (var.) and a StrepII-fusion of wildtype SAG101.
3.6.2. An EDS1 Variant Implies Similarities Between EDS1/SAG101 and
EDS1/PAD4 Complex Formation
We analysed the same EDS1LLIF variant in yeast and tobacco for interaction to the well-
characterised EDS1 binding partner PAD4 and surprisingly found that this interaction is similarly
affected by the introduced mutations (Fig. 3.29 A and B). It was therefore tempting to speculate
that SAG101 and PAD4 bind EDS1 in a similar manner. This finding and the notion that SAG101
and PAD4 are sequentially more closely related to each other than to EDS1 (Fig. 3.29 C)
motivated us to build a homology model based on structural information I had obtained through
EDS1/SAG101 complex crystals.
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Figure 3.29 | Basis for a PAD4 homology model. (A) Yeast two-hybrid interactions between activation
domain (AD) fusions of EDS1 variants (see text) and a binding domain (BD) fusion of full-length PAD4.
Interaction was assayed as described for Figure 3.27 C. (B) Co-purification of untagged EDS1 variants
shown in (A) and a StrepII-fusion of wildtype PAD4 that were transiently expressed in Nicotiana ben-
thamiana. Input and elution fractions were separated by SDS-PAGE and analysed by immunoblotting us-
ing Strep-Tactin conjugated with horseradish peroxidase (HRP) or antibodies against EDS1 (α-EDS1).
See Figure 3.28 for experimental details. (C) Sequence identities (id) and similarities (sim) between
proteins of the EDS1 family as calculated by SIAS (http://imed.med.ucm.es/Tools/sias.html;
request date: August, 2012).
Raphaël Guerois (CEA, Gif-sur-Yvette) used the EDS1/SAG101 crystal structure as a tem-
plate and build a homology model of PAD4 in place of SAG101 using the Rosetta modeling
suite [Kaufmann et al., 2010]. Not surprisingly, the resulting complex model looks almost like
the crystallised EDS1/SAG101 complex (Fig. 3.30 A). To validate this model, we analysed the
putative interaction interface of EDS1 and PAD4 in yeast and tobacco. Interestingly, the pre-
dicted N-terminal interface between both proteins reveals that PAD4 could (similar to SAG101)
possess a hydrophobic pocket for the accommodation of EDS1 helix αH (Fig. 3.30 B).
I chose critical residues within this pocket and J. Stuttmann (MPIPZ, Köln) mutated them
into alanines. As EDS11-384 and PAD4 did not form a detectable protein complex in yeast
two-hybrid assays (see Fig. 3.25), I directly analysed these variants using full-length EDS1 and
PAD4. I found that three simultaneous exchanges within the hydrophobic pocket of PAD4
(PAD4M16A+L21A+F143A) are sufficient to significantly reduce the interaction to EDS1 (Fig.
3.30 C). This was verified by co-purification of transiently expressed EDS1 and PAD4 variants
from tobacco plants (Fig. 3.30 D).
This does not only validate the general correctness of our model but additionally implies that
EDS1 indeed binds SAG101 and PAD4 in a similar manner. All variants that were analysed in
yeast two-hybrid assays are listed in Appendix Table A.5.
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Figure 3.30 | Validation of the PAD4 homology model. (A) Structural overview of the EDS1/PAD4
heterodimer homology model. (B) Close-up view on the putative interaction site within the N-terminal
interface of EDS1 and PAD4. The PAD4 hydrophobic pocket is schematically indicated. (C) Verifica-
tion of the EDS1/PAD4 model by yeast two-hybrid assays. We designed variants of PAD4 that carry
mutations within the hydrophobic pocket shown in (B) and tested these in yeast two-hybrid assays as
described before. (D) Co-purification of untagged EDS1 and StrepII-fusions of PAD4 variants (var.)
shown in (C) and transiently expressed in Nicotiana benthamiana as described for Figure 3.27.
3.7. EDS1 Interaction With Itself
I further tested whether the EDS1LLIF variant was still able to interact with itself in yeast and
found that this was the case. This was to be expected as the monomers within homooligomers
are generally symmetry-related to each other [Goodsell and Olson, 2000], a criterion that would
not be fulfilled if EDS1 interacted with itself in a SAG101-like manner. As additional information
on EDS1 homooligomerisation is contradictory – Feys et al. [2001] found in yeast two-hybrid
assays that the EDS1 EP domain is sufficient for self-interaction while Zhu et al. [2011] were
only able to see an interaction between EDS1 and the EDS1 lipase-like domain in planta – I
can only speculate on how EDS1 homomers are formed. Although Feys et al. [2005] showed by
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analytical size-exclusion chromatography of plant extracts that EDS1 monomers exist alongside
homodimers, EDS1 is generally assumed to be homodimeric.
In contrast, full-length EDS1 produced in E. coli seemed to be predominantly monomeric as
shown by size-exclusion chromatography (Fig. 3.31 A, B, C). I was further not able to produce a
stable recombinant EDS1 homomer by chemical crosslinking with BS3 that irreversibly connects
the primary amines of lysine residues or the N-termini of polypeptide chains (Fig. 3.31 D).
Untagged EDS1 could further not be efficiently co-purified with a Trx-His-EDS1 fusion or a His-
tagged variant of N-terminal EDS11-384 (Fig. 3.31 E). Surprisingly, EDS11-384 formed a minor
dimeric fraction according to gelfiltration experiments depicted in Fig. 3.3 B.
While a prokaryotic protein expression system (e.g. E. coli) comes along with many benefits,
including ease of cultivation and genetic manipulation, there is a major drawback: posttrans-
lational modifications found naturally on many eukaryotic proteins are generally not applied to
the recombinant protein. I wondered whether EDS1 carried such modifications that could be
necessary for homodimerisation and tried to answer this question by purifying StrepII-tagged
EDS1 from Arabidopsis thaliana as described in section 2.3.6. The purified protein solution was
separated by SDS-PAGE (Fig. 3.32) and the band of EDS1 protein was cut from the gel and
handed to Tobias Lamkemeyer (CECAD) for mass spectrometry analysis. Apart from a putative
acetylation site on the EDS1 N-terminus that was already observed by Gobbato [2007], I did not
find convincing hints pointing towards further modifications of EDS1 in planta.
3.7.1. Protein Crystals of EDS1 Might Reveal its Molecular State
In addition to the crystallisation and structure solution of the EDS1/SAG101 complex, I was
able to produce protein crystals of His-tagged EDS1 without an additional binding partner. The
protein was purified by IMAC as described in section 3.3 and was afterwards gelfiltrated on a
HiLoad 16/60 Superdex 75 column (GE Healthcare) in 10mM Bicine, 50mM NaCl, 0.5mM
EDTA, pH 8. The peak fractions were pooled and concentrated while exchanging the protein
buffer to 10mM Bicine, 5mM TCEP, pH 8. EDS1 at concentrations of 5, 10 and 15mg/ml
was used in sparse-matrix screening, mixing protein and crystallant in a 1:1 ratio. Initial crystals
grew in the presence of 100mM Tris (pH 8), 250mM sodium tartrate and 10% (w/v) PEG8000
as a crystallant (JBScreen Kinase screen, Jena Bioscience) and only at 4℃ but not at 20℃(Fig.
3.33 A). Crystals grown in the presence of only 8% (w/v) PEG8000 were considerably larger and
used for collection of diffraction data (Fig. 3.33 B). They were cryoprotected by soaking them
for 30 to 60 seconds in 100mM Tris (pH 8), 250mM sodium tartrate, 25% (w/v) PEG8000
and 7.5% (v/v) PEG400 and frozen in liquid nitrogen. While the crystals hardly showed X-ray
diffraction on a home source, diffraction data to a maximum resolution of approximately 9 Å (Fig.
3.33 C) were collected at a synchrotron beam (Swiss Light Source, Villingen). Notably, these
crystals degraded over time (Fig. 3.33 D), possibly due to the oligomerisation (aggregation?)
of recombinant EDS1 over time that I described in Figure 3.31 C and that could deplete the
crystal in protein.
Preliminary analysis according to Matthews [1968] suggested that there were multiple EDS1
molecules (at least two) within each asymmetric unit. However, data to this resolution are only
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Figure 3.31 | EDS1 self-interaction analysis. (A) IMAC-purified EDS1 was analysed on a 10/300 GL
Superdex 200 column (GE Healthcare) after letting it stand at 4℃ for 4 days. The elution profile
and subsequent SDS-PAGE analysis of indicated fractions revealed that EDS1 exists predominantly
as a monomer but apparently also as a higher order molecular complex. The retention volumes of
ferritin (880 kDa, 440 kDa), lactate dehydrogenase (140 kDa) and bovine serum albumine (66 kDa) are
indicated as molecular weight markers. (B) A similar distribution was found on a preparative HiLoad
16/60 Superdex 200 column (GE Healthcare). (C) This oligomerisation of EDS1 happens over time:
while freshly gelfiltrated EDS1 exists almost exclusively as a monomer, a small fraction forms higher
order molecular complexes after 1 or 4 days at 4℃. (D) Chemical crosslinking with bissulfosuccinimidyl
suberate (BS3) was performed for 2 h on ice using EDS1-His at a concentration of 1mg/ml and different
excesses of BS3 that potentially forms SDS-resistant amide bonds between proteins and allows analysis
through SDS-PAGE. (E) For co-purifications, soluble E. coli lysates of His-tagged Trx-His-EDS1 and
EDS11-384-His were mixed with an excess of untagged EDS1 and applied onto a Ni-NTA matrix. After
binding at 4℃, the matrix was rigorously washed with at least 10 column volumes IMAC lysis buffer and
proteins were eluted by the application of IMAC elution buffer. Eluates were analysed by SDS-PAGE.
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EDS1 and PAD4 fused to an StrepII affinity tag were co-
expressed under a constitutive 35S promoter in Arabidopsis and
purified from leaves as described in section 2.3.6. Both proteins
were constitutively under a 35S promoter and the plants were
either left unchallenged or were infected with the bacterium
Pseudomonas syringae pv. tomato (Pst) DC3000. As a con-
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Figure 3.33 | Crystals of EDS1. (A) Crystals from the initial screen that grew within 6 days at 4℃
in 100mM Tris pH 8.0, 250mM sodium tartrate and 10% (w/v) PEG8000. (B) Optimised crystals
that appeared in the presence of only 8% (w/v) PEG8000 leaving all other parameters unchanged. (C)
A single diffraction image of one of the optimised crystals taken at a synchrotron beam (Swiss Light
Source, Villingen). The maximum resolution of 9 Å is indicated. (D) Degraded crystals, approximately
two weeks after first appearance.
hard to interpret and the crystals were predicted to be either twinned or characterised by a rather
high crystallographic symmetry (a cubic spacegroup, probably P432).
As optimisation of diffraction by means of crystal annealing [Stevenson et al., 2001], dehydra-
tion through transfer in dehydrating solutions [Heras and Martin, 2005], soaking in glutaraldehyde
[Heras and Martin, 2005; Wine et al., 2007] and micro- and streak-seeding [Bergfors, 2003] was
unsuccessful, these crystals remain an outlook that might open the way to the structure of a
further functional EDS1 state. Or, to put it in the words of Newman [2005], "There are a num-
ber of manipulations that are available to the experimentalist with poorly diffracting crystals.
However, there are no systematic studies that have mapped particular problems to particular
solutions and certainly no guarantees are issued with any of these methods."
Final Remark
The experimental contributions within each section are graphically summarised in Figure 3.34.
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the PAD4 homolgy model.
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"The least initial deviation from the truth is multiplied later a thousandfold."
— Aristotle
As sessile organisms, plants must flexibly adapt to environmental stresses. To defend themselves
against invading pathogens, they have evolved a multi-layered immune system that is brilliantly
described by Jones and Dangl [2006]. While the first inducible layer recognises pathogens outside
the plant cell through pathogen-associated molecular patterns (PAMPs) and triggers an immune
response that is often sufficient to keep the plant healthy, successful pathogens have evolved
effector molecules that suppress these defence mechanisms. Effector molecules are, in turn,
recognised by intracellular plant immune receptors (the so-called R proteins) that activate a
strong defencive response that is usually associated with localised cell death at the infection site
and thus has to be tightly controlled.
R proteins of the TIR-NB-LRR type need the nucleo-cytoplasmatic plant protein EDS1 for
successful signalling [Aarts et al., 1998; Parker et al., 1996]. EDS1 interacts with the sequence-
related proteins PAD4 and SAG101 and they collectively form the EDS1 protein family that is
defined by an N-terminal lipase-like domain and a C-terminal EP (EDS1-PAD4 defined) domain
that has no obvious homologues at sequence level [Feys et al., 2005]. The plant-specific EDS1
family has been shown to integrate biotic and abiotic stress signals as introduced in section
1.3.3. The molecular mechanism by which EDS1-requiring complexes transduce these signals
are, however, poorly understood. In this thesis, I sought to elucidate the structure of EDS1 and
its sequence-related binding partners PAD4 and SAG101 to provide a basis for their mechanistic
description.
4.1. Defining Open Questions
By the beginning of my experimental work, virtually nothing was known about the molecular
details that underlie EDS1 family protein functions. While it had been clear that N-terminal
EDS1, PAD4 and, to a lesser extend, SAG101 were related to eukaryotic lipases at sequence
level [Jirage et al., 1999; Falk et al., 1999; Feys et al., 2005] (Fig. 1.6), hydrolytic activity had
only been reported for SAG101 in an immunity-unrelated context [He, 2002]. The structural
degree of lipase-relation was thus unclear. Further, it was unknown whether the C-terminal EP
domain of all three proteins was not only sequentially but also structurally unique and to which
extend both domains participated in the well-characterised interactions within the EDS1 protein
family [Feys et al., 2005; Rietz et al., 2011].
Representing central components of plant pathogen resistance, the EDS1 protein family raised
the interest of scientists worldwide, some of whom tried to create homology models of EDS1
and PAD4 utilising their relation to lipases to answer these questions [Singh and Shah, 2012].
The Limitations of Structure Prediction Thanks to the growing knowledge of protein struc-
tures and sophisticated prediction methods, freely accessible web-tools have become popular
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to predict the three-dimensional structures of proteins. Figure 4.1 shall illustrate that such
predictions are not trivial, especially for multi-domain proteins.
Both the Phyre2 [Kelley and Sternberg, 2009] and the I-TASSER [Zhang, 2008] web-tools
are being used to predict several ten thousand structures per year[29]. Before solving the crystal
structure of EDS1, I used these tools and will briefly compare the results to the experimentally
determined structure. For prediction, I chose the primary sequences of either full-length EDS1
or that of EDS11-384 (encompassing the lipase-like domain) and EDS1385-623 (EP domain) sep-
arately. The predicted models were superimposed on EDS1 extracted from the EDS1/SAG101
complex structure (Fig. 4.1).
Especially when the sequence of full-length EDS1 was used as query, the predicted struc-
tures differed significantly from crystallised EDS1 (upper panel of Fig. 4.1). Although separate
predictions of the lipase-like and EP domain produced more reliable results (lower panel), the
orientation of the domains towards each other and the position of functional features – for in-
stance α-helix αH that is essential for SAG101 binding – would not have been answered by these
models.
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Figure 4.1 | EDS1 structure predictions. Primary sequences of EDS1 in full length or EDS11-384 and
EDS1385-623 (representing the lipase-like and EP domain, respectively) were used as sequence inputs
for structure prediction by the Phyre2 [Kelley and Sternberg, 2009] and the I-TASSER [Zhang, 2008]
web-tools. The resulting models were superimposed on the experimentally determined EDS1 structure
(extracted from the EDS1/SAG101 complex) shown on the upper left. The position of EDS1 helix αH
is highlighted within the crystal structure to illustrate that even the most precise model (domain-wise
prediction by I-TASSER) reveals significant differences to crystallised EDS1.
Structures that possess yet unknown folding aspects thus remain challenging to predict. When
novel structures are solved experimentally and deposited in the freely accessible Protein Data
[29]see http://www.sbg.bio.ic.ac.uk/phyre2 (request date: February, 2013) and http://zhanglab.ccmb.med.
umich.edu/I-TASSER/ (request date: February, 2013)
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Bank (PDB) [Berman, 2000] they, in turn, help to improve the accuracy of structure prediction
tools that rely on the availability of structural information. As will be discussed later, we used the
novel EDS1/SAG101 structure to predict a homology model of EDS1 in complex with PAD4.
In the following pages, I will present functional implications of the obtained structures, begin-
ning with a widely discussed aspect of EDS1 function, that of lipase homology.
4.2. Possible Roles of the Lipase-Like Domains
As expected from sequence analysis (section 3.1), I could show that N-terminal EDS1 and
SAG101 are indeed closely related to lipases at the structural level (Table 3.6). Lipases belong
to the α/β hydrolase fold family that was defined after Ollis et al. [1992] had recognised that
enzymes of the same phylogenetic origin but diverse cellular functions share a closely related
topology: a central arrangement of β-sheets that is surrounded by α-helices (Fig. 3.15). To-
gether, they provide a skeleton for the correct position of critical catalytic residues – often a
triad that I described in section 3.1.1.
While Ollis et al. [1992] introduced the canonical fold on the basis of five different enzymes,
the family rapidly expanded [Nardini and Dijkstra, 1999; Carr and Ollis, 2009] and the ESTHER
(ESTerases and α/β Hydrolase Enzymes and Relatives) database contains more than 30000
manually curated proteins as of today [Lenfant et al., 2013]. Although most family members
act as enzymes, numerous inactive α/β "hydrolases" have been characterised in recent years
[Lenfant et al., 2013].
I will introduce and discuss three models that could explain how the lipase-like domains of
EDS1, SAG101 and PAD4 contribute to their biological function. Basically, I discriminate be-
tween the following modes of action: (1) hydrolytic activity in the synthesis or degradation of
a small signalling molecule, (2) binding of a small molecule that is not hydrolysed but rather
triggers a conformational change that is essential for downstream signalling and (3) a role that
is independent of a small molecule and instead involves interactions between proteins.
4.2.1. The Lipase-Like Domains and Small Molecules: Implications From Plant
Hormone-Binding α/β Hydrolases
The first two conceivable modes involve small molecules and are depicted in Figure 4.2 A and B.
In the following paragraphs, I will present two proteins that act in either the hydrolytic synthesis
or in non-hydrolytic binding of a plant hormone (Fig. 4.2 C and D) and highlight analogies and
dissimilarities between them and the lipase-like domains of EDS1, SAG101 and PAD4.
The SABP2 Model The 29 kDa protein SALICYLIC ACID BINDING PROTEIN2 (SABP2)
was found in tobacco plants [Du and Klessig, 1997] and identified as an α/β hydrolase on sequence
basis. Initially proposed as a receptor for salicylic acid, Kumar and Klessig [2003] could show that
SABP2 hydrolyses artificial para-nitrophenyl (pNP) substrates using a serine-aspartate-histidine
(S-D-H) triad (Fig. 4.3 A).
Using a crystal structure, Forouhar et al. [2005] finally revealed that SABP2 catalyses the
reaction of methyl salicylate to salicylic acid, a plant hormone that I introduced as a central
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Figure 4.2 | Possible roles of the
EDS1 lipase-like domain. (A) Hy-
drolysis of a small molecule is one
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the lipase-like domain of EDS1 (and
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component of plant systemic acquired resistance (section 1.3.2). Methyl salicylate, in contrast,
is biologically inactive and probably represents a transport form that needs SABP2-assisted
conversion to salicylic acid [Park et al., 2007]. Interestingly, SABP2 was crystallised bound to
a salicylic acid molecule (Fig. 4.3 A) that is completely shielded from the solvent by a "cap
domain" – the enzyme is therefore assumed to be inhibited by its reaction product [Forouhar
et al., 2005] (Fig. 4.4 A). While the authors could only speculate about an open-closed transition
that allows for substrate binding and product release, the SA-bound and apo form of SABP2 look
almost identical when crystallised and in solution (as revealed by nuclear magnetic resonance)
[Forouhar et al., 2005].
GID1
detailed view
GA
S
D
V
αb
A
SABP2
cap domain
SA
H S
D
detailed view
B
N-terminal extension
Figure 4.4 | Accessibility of the SABP2 and GID1 triads. Molecular tunnels leading from the surround-
ing solvent to the triad positions (indicated by a yellow sphere in the more schematic representation)
were calculated using the CAVER tool [Petrek et al., 2006; Chovancova et al., 2012] within PyMOL
[Schrödinger, LLC, 2010] and are coloured orange. The triad positions are further shown in more detail.
(A) The cap domain of SABP2 that shields a salicylic acid (SA) molecule from the solvent, is in black.
(B) The N-terminal extension of GID1 that folds on top of a gibberelic acid (GA) molecule, and subse-
quently binds to a transcription factor as described in the text, is in black.
The GID1 Model Contrastingly, major conformational changes upon small molecule binding
are essential for the function of another plant hormone-binding protein, GIBBERELIC ACID
INSENSITIVE DWARF1 (GID1). GID1 participates in multiple plant growth responses including
flowering, expansion of leaves and stem elongation [Sun, 2010].
Similar to SABP2, GID1 has been crystallised in the presence of a bound, solvent-shielded
hormone, gibberelic acid [Shimada et al., 2008]. Yet in contrast to SABP2, GID1 does not
contain a S-D-H triad and is thus unable to hydrolyse gibberelic acid. Instead of the SABP2-
like cap domain, GID1 contains an N-terminal extension to the canonical α/β hydrolase fold and
Murase et al. [2008] could beautifully illustrate how this protein works: gibberelic acid binds to the
non-conserved GID1 triad and triggers a conformational change within the N-terminal extension
that stably folds onto the gibberelic acid binding pocket. This closed conformation (Fig. 4.4
B) allows binding of a transcriptional regulator that is subsequently marked for proteasomal
degradation through the attachment of ubiquitin [Murase et al., 2008].
Intriguingly, the triad’s histidine within GID1 is replaced by a valine side chain that participates
in gibberelic acid binding (Fig. 4.3 B). Shimada et al. [2008] could show that GID1 variants
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in which either this particular valine-position or the triad’s conserved serine were exchanged to
alanine could not efficiently bind gibberelic acid.
Analogies Between SABP2, GID1 and Lipase-Like EDS1 N-terminal EDS1 possesses a
conserved catalytic triad (Fig. 3.1 B and 4.3 C) and could thus act in the hydrolysis of a small
signalling molecule. In the SAG101-bound state, however, this triad is efficiently shielded from
the solvent through an insertion into the canonical α/β hydrolase fold (see Fig. 4.5 A and
compare it to the closed state of an active lipase from Mucor miehei shown in Fig. 4.5 C).
Molecular dynamics simulations, as described in section 3.4.2, did not suggest that this in-
sertion switches into a more open conformation spontaneously or upon SAG101 dissociation.
These simulations, however, covered only a 50 ns which might be too short to allow for large
scale molecular motions that regularly take microseconds to seconds [Henzler-Wildman and Kern,
2007].
To cover rather large motions, I used the NMSim webserver [Krüger et al., 2012]. In a three-
step approach, NMSim decomposes the protein into rigid clusters and flexible regions and in a
second step, the rigid blocks are rotated and translated towards each other whereas the links
between them are kept flexible. In a third step, the conformations of backbone and side chain
atoms are re-adjusted and the computed structures are iteratively corrected regarding steric
clashes and the violation of physico-chemical constraints [Ahmed et al., 2011]. As shown in
Appendix Figure A.3, large scale conformational changes that would expose the triad are not to
be expected according to NMSim.
There were further no convincing experimental hints pointing towards an EDS1 enzymatic
activity. Neither recombinant EDS1 in full length nor its lipase-like domain, EDS11-384, did
hydrolyse pNP-esters analogous to SABP2 (Fig. 3.21). Similar assays are commonly used to
identify and characterise hydrolytically active enzymes (see [Reiter et al., 2000] and others).
We could additionally demonstrate that central immune functions of EDS1 do not depend
on hydrolytic activity. The simultaneous exchange of all S-D-H triad residues within a EDS1
S123A/D187A/H317A mutant had no effect on the protein’s function in Arabidopsis TIR-NB-
LRR-mediated and basal resistance against the pathogenic oomycete Hyaloperonospora (Fig.
3.19).
Although the functionality of EDS1 S123A/D187A/H317A in immune signalling reasoned
against a GID1-like function in binding (instead of hydrolysing) a small molecule, we further
perturbed the triad’s environment as described in section 3.4.4. In pathogen assays, even a
quintuple EDS1 mutant variant was able to successfully fend of a Hyaloperonospora infection,
ultimately arguing against small molecule binding to the EDS1 triad pocket as part of this immune
response (Fig. 3.20).
Analogies Between SABP2, GID1 and Lipase-Like SAG101 Arabidopsis SAG101 does not
contain residues of a S-D-H triad (Fig. 4.3 D) and thus can not be enzymatically active although
otherwise reported by He [2002], who mass spectroscopically measured the release of oleic acid
from triolein using SAG101 that was recombinantly produced in E. coli.
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Figure 4.5 | Accessibility of the EDS1 and SAG101 triads. Molecular tunnels leading from the sur-
rounding solvent to the triad positions (indicated by a yellow sphere in the more schematic representation)
were calculated using the CAVER tool [Petrek et al., 2006; Chovancova et al., 2012] within PyMOL
[Schrödinger, LLC, 2010] and are coloured orange. The triad positions are further shown in more detail.
(A) The EDS1 N-terminal insertion as well as the 310 helix a1 – a remnant of the regulatory Mucor
miehei lipase helix a1 – are shown in black. (B) The SAG101 310 helix a1 is coloured black. (C)/(D)
The closed and open conformation of the MML are shown in which α-helix a1 is highlighted in red and
green, respectively. Within (D), the lipase inhibitor DEP (diethylphosphonate), that stabilises the open
conformation of MML, is shown as black sticks.
Not having an EDS1-like insertion that covers the former triad pocket (see Fig. 4.5 B and
compare it to the open state of an active lipase fromMucor miehei shown in Fig. 4.5 D) SAG101
could, however, participate in ligand binding analogous to GID1.
Appealingly, I could not model SAG101 residues 35 to 53 within the crystal structure due to
missing electron density that is a result of structural flexibility within this region. Lying close to
the former triad pocket, binding of a small molecule could conformationally stabilise this region
in order to form a protein binding platform comparable to the N-terminal GID1 extension.
This scenario becomes unlikely when SAG101 orthologue sequences are analysed: as shown
in Figure 4.3 D, the SAG101 diad (the aspartate-position is not conserved at all) is highly
variable in its composition. Specific recognition of a small molecule should, however, result in
the conservation of such residues if they were to participate in ligand binding. Accordingly, in
GID1 orthologues from various plant species, the histidine position is consistently replaced by
either a valine or an isoleucine side chain, both being aliphatic and chemically related (sequence
alignment not shown). They assist ligand binding by a hydrophobic interaction to giberellic acid
(Fig. 4.3 B).
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Further, the flexible region between AtSAG101 Proline 35 and Aspartate 53 seems to represent
an insertion that does not exist to the same extend in other SAG101 orthologues (see Appendix
Fig. A.6). A functional importance is thus highly unlikely.
Analogies Between SABP2, GID1 and Lipase-Like PAD4 While SAG101 seems to have
lost an α/β hydrolase-related ability to bind or convert a small molecule, PAD4 has actually been
proposed to be hydrolytically active in Arabidopsis resistance against insect feeding [Louis et al.,
2012]. The conservation of a S-D-H among PAD4 orthologues in mono- and dicotyledonous
plant species (Fig. 3.1 B) generally supports this claim.
Louis et al. [2012] exchanged single amino acids from the PAD4 S-D-H triad and plants
expressing these mutants were used to compare the feeding behaviour of the insects and their
infestation rate. The authors found that an exchange of the catalytic serine resulted in plants
that were less efficient in controlling insect infestation and in preventing insect feeding, arguing
for a critical function of this residue. The same – although to a lesser extend – was observed for
an exchange of the triad’s aspartate. Paradoxically, an exchange of the histidine position had no
effect on insect resistance. Although I described in section 3.1.1 that an incomplete triad can
per se catalyse one of many α/β hydrolase reactions, any exchange within a conserved S-D-H
triad should result in a measurable loss-of-function.
Still, following up on these results, we probed a PAD4 variant with an exchanged triad serine
(S118A) in TIR-NB-LRR-mediated and basal resistance of Arabidopsis against Hyaloperonospora
and found that this residue was dispensable (Fig. 3.19 A and B). PAD4 is thus not catalytically
active in these immune pathways.
From a structural point of view, it is discussable whether PAD4 could actually hydrolyse a
small molecule. As described in section 3.4.2, Arabidopsis PAD4 does not contain an EDS1-
like insertion into the canonical α/β hydrolase fold. A sequence alignment spanning this region
in various EDS1 and PAD4 orthologues (Fig. 3.18), however, reveals that non-existence of
an insertion is only typical for PAD4 variants from Brassicaceae species. As we saw at the
beginning of this discussion, predicted models of such uncommon insertions (using, for instance,
our Arabidopsis PAD4 homology model) are not necessarily reliable. The question whether an
insertion in non-Brassicaceae PAD4 orthologues shields the triad or not is, thus, left unanswered.
Could the Inactive Lipase-Like Domain Act as a Decoy? The enzymatically inactive lipase-
like domain of SAG101 (and potentially EDS1 and/or PAD4) could act in concert with TIR-NB-
LRR R proteins as a decoy in assisting pathogen effector recognition. As introduced in section
1.2.2, decoys are proteins that have no function in plant immunity but rather mimic the actual
effector target(s). Thereby, they protect immune components from being modified and, together
with R proteins, induce an effector-triggered immunity. In such a model, the N-terminal halves
of EDS1 family proteins could act as molecular traps for effectors that are targeting active α/β
hydrolases of the plant immune response.
Given that the EDS1 family participates in a broad range of plant signalling pathways and acts
downstream of virtually all characterised TIR-NB-LRR R proteins [Aarts et al., 1998; Parker
et al., 1996; Borhan et al., 2004; Glazebrook et al., 1997; Zhou, 1998], this scenario is highly
unlikely.
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4.2.2. The Lipase-Like Domains and Protein-Protein Interactions: Implications
From an Inactive α/β "Hydrolase"
As described in section 3.4.1, numerous elements of lipase-like EDS1 and SAG101 are structurally
differently organised compared to a structurally related lipase from the fungus Mucor miehei
(MML) (Fig. 3.13), the most prominent difference being the N-terminal EDS1 insertion. Such
insertions into the canonical α/β hydrolase fold are commonly found among lipases which use
them as lids to regulate the activity of the enzyme through interfacial activation as described in
section 3.4.2.
However, as shown above, also non-lipolytic enzymes like SABP2 can contain similar insertions
(in this case the cap-domain) that are involved in the protein’s regulation in a yet unknown
manner. The N-terminal extension of GID1 does not only regulate small molecule access to
the triad but additionally acts as a hub for protein-protein interactions upon binding of a non-
hydrolysed ligand (gibberellic acid).
In another α/β hydrolase, the acetylcholinesterase (AChE), an insertion does not at all shield
the active site from the solvent but forms a gorge towards a conserved S-E-H catalytic triad (Fig.
4.6 A and B). Faerman et al. [1996] proposed on the basis of molecular dynamics simulations
that small motions along this Ω-loop allow rapid access of the substrate and release of products
rendering the acetylcholinesterase one of the fastest existing enzymes.
The AChE is of interest for two reasons: first, a backdoor mechanism has been proposed as
an alternative route towards or away from the catalytic triad (Fig. 4.6 A). This mechanism has
been widely discussed since the first AChE crystal structure [Sussman et al., 1991] to explain
the astonishingly high turnover numbers that reach up to 10000 product molecules per second.
Only recently, Sanson et al. [2011] used another crystal structure, in which AChE is inhibited
by the snake-venom component aflatoxin, in combination with molecular dynamic simulations to
show that the flexible side chains of a tyrosine and a tryptophan residue contribute to an efficient
traffic of substrates and products.
While a related backdoor entrance does not necessarily exist in EDS1 and is actually not
supported by my molecular dynamics simulations (section 3.4.2), this anecdote shall illustrate
that even minor conformational changes (e.g. flexibility between EDS1 helices αF and αG as
depicted in Fig. 3.16 B and C) may suffice to allow access of small molecules to the EDS1 triad.
The NL-1 Model Secondly, introduction of the AChE is important for the discussion of an
AChE-related α/β hydrolase that does neither convert nor bind a small molecule and represents
the third conceivable mode of action for the lipase-like domains of EDS1, SAG101 and PAD4.
The mammalian protein NEUROLIGIN-1 (NL-1) exhibits a modified AChE Ω-loop that is referred
to as Cys-loop and permits accessibility of the triad site (Fig. 4.6 C). Within the NL-1 triad,
the serine position is further exchanged to a glycine residue (Fig. 4.6 D) and the combination
of these two features ensures that NL-1 is enzymatically inactive.
Instead, NL-1 has become optimised for binding another protein, neurexin, using an interaction
interface that resides away from the former active site [Araç et al., 2007]. The NL-1/neurexin
interaction is necessary for the formation of synapses in the mammalian brain.
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Figure 4.6 | Structural relation between NEUROLIGIN-1 and the acetylcholinesterase. Molecular
tunnels leading from the surrounding solvent to the triad positions (indicated by a yellow sphere in the
more schematic representation) were calculated using the CAVER tool [Petrek et al., 2006; Chovancova
et al., 2012] within PyMOL [Schrödinger, LLC, 2010] and are coloured orange. The triad positions are
further shown in more detail. (A) The acetylcholinesterase Ω-loop that guides substrates and products
to and away from the active site is shown in green. The snake-venom inhibitor aflatoxin that blocks the
enzyme’s main entrance is shown as black sticks. The "backdoor entrance" proposed by Sanson et al.
[2011] is indicated. (C) Structurally related to the Ω-loop, a so-called Cys-loop permits substrate entry
to the (incomplete) triad of NEUROLIGIN-1 (NL-1). (B) The conserved S-E-H triad of AChE is shown
and a bound acetylcholine molecule indicates where the substrate binds. (D) This substrate binding site
is blocked by the Cys-loop in NL-1 that does moreover not contain a triad serine.
Modifications to the Canonical α/β Hydrolase Fold Within the EDS1 and SAG101 Lipase-
Like Domains Comparably, N-terminal EDS1 and SAG101 have become optimised for mutual
binding. Two of the three α-helices that form the unique EDS1 N-terminal insertion are directly
interacting with SAG101. Among the surface-exposed residues within this insertion, such amino
acids that face SAG101 are highly conserved, emphasising their functional importance (Fig. 4.7
A).
SAG101 does, in turn, contain a hydrophobic pocket within its lipase-like domain that is formed
by parallel β-strands within the protein’s core and an α-helix, αA’, which does not exist in the
Mucor miehei lipase (Fig. 3.13). This hydrophobic arrangement is untypical of lipases and
accommodates helix αH from the N-terminal EDS1 insertion (Fig. 4.7 B).
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The hydrophobic SAG101 pocket might be the reason why the protein precipitates in solution
whenever EDS1 is not present (Fig. 3.8 D). Within the EDS1/SAG101 heterocomplex, the
hydrophobic patch is shielded by EDS1 helix αH but inevitably becomes surface-exposed with-
out EDS1 being present. This renders isolated SAG101 prone to protein aggregation through
unspecific hydrophobic interactions. Isolated EDS1, in contrast, does not necessarily precipitate
as the hydrophobic helix αH undergoes conformational changes upon SAG101 dissociation (Fig.
3.17 and A.3) that might result in a more stable conformation.
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Figure 4.7 | Adaptions of lipase-like EDS1 and SAG101. (A) EDS1 is shown as spheres and the
conservation score of amino acids among the N-terminal insertion is calculated based on 31 EDS1
orthologue sequences that clustered in a phylogenetic tree (see Appendix Fig. A.1) and was plotted on
the structural surface using ConSurf [Ashkenazy et al., 2010]. EDS1 residues that are not part of the
insertion are in black. SAG101 is shown in green and the α-helix αA’ that helps to form a hydrophobic
pocket, as described in the text, is highlighted. (B) Comparison of the hydrophobic SAG101 (green)
that accommodates EDS1 (blue) α-helix αH to the respective region in the Mucor miehei lipase (MML;
grey) that is dominated by charge arginine and glutamine side chains.
Lipase-Like PAD4 Is Optimised to Bind EDS1 in a SAG101-Like Manner Zhu et al. [2011]
and Rietz et al. [2011] proposed that SAG101 and PAD4 do not compete for EDS1 binding. Rietz
et al. [2011] postulated this on the basis of an EDS1 variant that is compromised in interaction to
PAD4 but not SAG101 arguing for differential modes of interaction. Zhu et al. [2011] conducted
co-immunoprecipitation experiments with proteins expressed transiently in tobacco plants and
found that the degree of complex formation between EDS1 and SAG101 or PAD4 was not
altered in the absence or presence of the other EDS1 binding partner.
In the contrary, I found that exchanges within EDS1 helix αH equally affected the interaction
to both SAG101 and PAD4 in yeast two-hybrid assays and co-purification experiments from
tobacco plants as shown in Figures 3.27 D, 3.28 C and 3.29.
Based on this finding, Raphaël Guerois (CEA, Gif-sur-Yvette) built a homology model of PAD4
in complex with EDS1. This model suggested that PAD4 likewise possesses a hydrophobic pocket
(Fig. 3.30 B) and I was able to show that exchanges within this pocket indeed significantly
reduced the interaction to EDS1 arguing for the correctness of the EDS1/PAD4 heterodimer
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model (Fig. 3.30 C and D). I thus propose that the lipase-like domains of SAG101 and PAD4
have likewise become evolutionary optimised for EDS1 binding and do so in a similar manner.
4.2.3. The Lipase-Like Domain Drives the Interactions Within the EDS1 Family
I showed that N-terminal EDS1 and SAG101 share features of the inactive α/β hydrolase NL-1:
(1) SAG101 has a non-functional triad, (2) EDS1 has evolved a non-canonical insertion that
restricts triad accessibility and (3) both proteins have co-evolved a key-lock-like protein-protein
binding mechanism with EDS1 α-helix αH being the key that is inserted into a hydrophobic pocket
of lipase-like SAG101 (and additionally PAD4). It might thus well be that N-terminal EDS1 and
SAG101, albeit lipase-related, do (analogously to NL-1) exclusively function in protein-protein
interactions within the EDS1 protein family (Fig. 4.8).
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EDS1 (immune) signal
NL-1+
neurexin
synapse formationNL-1
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Figure 4.8 | Adaptions of lipase-like EDS1 and SAG101. As described in the text, NL-1
(NEUROLIGIN-1) possesses an α/β hydrolase fold but does not bind a small molecule. Instead, it
interacts with another protein, neurexin, and the NL-1/neurexin complex is involved in the formation
of synapses of the mammalian brain. As EDS1 and SAG101 share features of NL-1 (see text) and
are optimised for mutual binding, an analogous role in protein-protein binding is conceivable for their
lipase-like domains.
In line with this model, I found that the N-terminal lipase-like domains of EDS1, SAG101
and PAD4 are indeed driving the interactions within EDS1/SAG101 and EDS1/PAD4 hetero-
complexes. Recombinantly produced lipase-like EDS11-384 was able to interact with full-length
SAG101 while the C-terminal EP domain of SAG101 (SAG101291-537) did not efficiently bind
EDS1 (Fig. 3.24).
This is supported by computational analyses using the PPEpred [Su et al., 2009][30] and PISA
[Krissinel and Henrick, 2007][31] tools that predicted the lipase-like domain to contribute about
two-third of the total EDS1/SAG101 complex binding affinity (Tab. 4.1).
Experimental support for the importance of the lipase-like domain for complex formation comes
from in planta experiments in which Zhu et al. [2011] could show by bimolecular fluorescence
complementation that SAG101 interacts with EDS11-350 but not EDS1351-623.
Yeast two-hybrid assays that I used to characterise loss-of-interaction variants further empha-
sised this. As presented in Figures 3.27, 3.29 and 3.30, four simultaneous amino acid exchanges
at the protein-protein interaction interfaces between EDS1 and either SAG101 or PAD4 were
[30]PPEpred calculates a potential of mean force (PMF) that is based on the statistical analysis of protein-protein
interactions within the Protein Data Bank (PDB) and thus is a knowledge-based potential.
[31]PISA calculates the solvation free energy gain upon formation of the interface considering interface size and
composition and the number of salt bridges, H-bonds and disulfide bridges.
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Table 4.1 | Computational predictions of EDS1/SAG101 affinities.
PISA
EDS1 + SAG101 EDS11-384 + SAG101 EDS1 + SAG101291-537
Affinity (kcal/mol) -21.4 -16.3 -5.1
PPEpred
EDS1 + SAG101 EDS11-384 + SAG101 EDS1 + SAG101291-537
Affinity (kcal/mol) -23.21 -15.59 -7.62
necessary and sufficient to drastically reduce the formation of EDS1 heterocomplexes. Notably,
and with a single exception being the SAG101Y306A exchange, all these exchanges reside within
the N-terminal interfaces between the proteins. Site-directed mutagenesis within the C-terminal
interface, in contrast, had almost no effect on the interactions (see Appendix Tables A.2 and
A.4).
The Conservation of EDS1 and PAD4 Triads A conserved EDS1 S-D-H triad throughout
higher plants, including mono- and dicotyledonous species that have diverged 140–150 million
years ago [Chaw et al., 2004], seems to be in disagreement with a functional model that does
not involve small molecule hydrolysis. This conservation, however, could be a mere consequence
of structural restraints as the triad is in direct contact with the N-terminal EDS1 insertion and
might be necessary for the structural stability of this region (Fig. 3.16 A).
The PAD4 triad might be conserved for the same reason, especially within orthologs from
non-Brassicaceae species that possess N-terminal insertions analogous to EDS1 (Fig. 3.18).
4.3. The EP Domain Contributes Additively to the Interactions
Within the EDS1 Family
Although the interface between the lipase-like domains drives the interactions within the EDS1
protein family, I piled experimental evidence that the C-terminal interface between the EP do-
mains additively contributes to efficient complex formation.
Exchanges that lead to a significant loss-of-interaction between recombinantly produced N-
terminal EDS11-384 to SAG101 had no effect when the very same mutations were introduced
into full-length EDS1 in an analogous experiment (see Appendix Fig. A.7).
The fact that an exchange within the C-terminal SAG101 interface (Y306A) was necessary
to ultimately reduce the interaction between full-length EDS1 and SAG101 in yeast two-hybrid
assays (Fig. 3.27 C) further supports a contribution of the EP domains to the EDS1/SAG101
heterodimer formation.
This contribution might explain why lipase-like EDS11-384 on its own is unable to complement
for the loss of full-length EDS1 in Arabidopsis TIR-NB-LRR-mediated defence. When both
proteins were expressed individually under a constitutive 35S promoter in a eds1-2 mutant back-
ground, plants producing EDS1 in full length were able to initiate a wildtype-like hypersensitive
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response upon infection with an incompatible Hyalopoeronospora isolate, Cala2. Contrastingly,
plants producing only EDS11-384 were not able to halt pathogen infection (Fig. 3.22 A).
4.4. The Functional Importance of Interactions Within the EDS1
Family
4.4.1. EDS1 Heterocomplexes With SAG101 and PAD4 Seem Sufficient for
TIR-NB-LRR Signalling
Analysis of available plant genomes, as described in section 3.1, revealed that EDS1 and PAD4
exist among all higher plant species while SAG101 is apparently restricted to dicotyledonous
plants (Fig 3.1 A). EDS1 and PAD4 thus seem to represent the more ancestral signalling node
while the appearance of SAG101 coincides with that of TIR-NB-LRR R proteins which are
virtually non-existent in monocotyledonous species [Tarr and Alexander, 2009].
Yet somewhat paradoxically, SAG101 does not seem to be of central importance for TIR-NB-
LRR-mediated resistance signalling: plants that lack SAG101 but still contain PAD4 are able to
initiate a defencive hypersensitive response against biotrophic pathogens to the wildtype extend
[Feys et al., 2005].
J. Stuttmann (MPIPZ, Köln) could solidify the results of Feys et al. [2005] by inoculating wild-
type Arabidopsis plants of accession Columbia as well as single (eds1, pad4, sag101), double
(pad4/sag101) and triple (eds1/pad4/sag101) mutant plants with an incompatible Hyaloper-
onospora isolate, Cala2. While wildtype plants and such lacking SAG101 were fully resistant
through a successful TIR-NB-LRR-mediated immune response, pad4 mutant plants showed an
increased susceptibility (Fig. 4.9). This susceptibility phenotype was dramatically enhanced in
a pad4/sag101 double null mutant due to the introduced redundancy of SAG101 and PAD4 in
this type of resistance.
Strikingly, the same degree of susceptibility was observed in eds1 null mutant plants or
plants that lacked EDS1, PAD4 and SAG101, arguing for a model in which EDS1/PAD4 and
EDS1/SAG101 complexes represent the functional components of TIR-NB-LRR-mediated im-
mune signalling (Fig. 4.9).
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The EDS1 homooligomer does not seem to fulfil an additional function in this context. While
experimental evidence points toward the ability of EDS1 to form such homooligomers (possibly
homodimers) in plant cells [Feys et al., 2005] and in yeast two-hybrid experiments [Feys et al.,
2005; Rietz et al., 2011], its biological role remains elusive. I will thus focus my discussion on
the EDS1/SAG101 and EDS1/PAD4 heterospecies for which I was able to obtain structural
information. Protein crystals of isolated EDS1 that I presented in section 3.7.1 will potentially
answer if and how EDS1 interacts with itself and what might be the functional consequences of
that interaction.
4.4.2. Analysis of an EDS1 Loss-of-Interaction Variant in
TIR-NB-LRR-Mediated Resistance
To analyse the functional importance of EDS1 family heterocomplexes in TIR-NB-LRR-triggered
immunity, I designed a structure-guided EDS1 loss-of-interaction variant. EDS1LLIF carries four
simultaneous alanine-exchanges of hydrophobic side chains that reside in EDS1 helix αH. As
shown in yeast two-hybrid assays and by co-purification experiments from tobacco plants (Fig.
3.27 D, 3.28 C and 3.29), this variant is severely compromised in its interaction to both SAG101
and PAD4.
J. Stuttmann infected wildtype Arabidopsis plants and such that expressed EDS1 loss-of-
interaction variants under the native EDS1 promoter with an incompatible isolate of Hyaloper-
onospora (Cala2). While wildtype EDS1 and EDS1 variants that retained interaction to SAG101
and PAD4 were able to induce a TIR-NB-LRR-mediated hypersensitive response, EDS1LLIF was
unable to trigger localised cell death (Fig. 4.10). This strongly supports the biological signifi-
cance of EDS1/SAG101 and EDS1/PAD4 heterocomplexes within this type of resistance.
Following the line of thought that these heterocomplexes represent the exclusive functional
EDS1 states in TIR-NB-LRR-triggered resistance, I expected non-interacting EDS1LLIF to pro-
duce a phenotype that equals an eds1 null mutant plant. A slightly less dramatic effect as seen
in Fig. 4.10 could, however, be explained by residual complex formation.
Although co-purification experiments using transiently expressed proteins from tobacco plants
(Fig. 3.28 B and 3.29 B) implied a full loss-of-interaction between EDS1LLIF and SAG101 or
PAD4, yeast two-hybrid experiments argued for residual interaction as cells still grew on selective
-LWH plates (Fig. 3.27 D and 3.29 A).
EDS1 variants in which the hydrophobic side-chains are not exchanged to neutral alanine side
chains but rather polar or charged residues should be tested and could potentate the loss-of-
interaction (and loss-of-function).
4.4.3. Functional Importance of Heterocomplexes Is Supported by Surface
Conservation
The functional importance of intrafamilial interactions is further supported by a high degree
of sequence conservation among residues that participate in EDS1 heterodimer formation. I
combined sequence and structure information obtained during this thesis and used the ConSurf
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Figure 4.10 | Analysis of EDS1 loss-of-interaction variants in TIR-NB-LRR-mediated resistance.
Wildtype Arabidopsis plants of accession Columbia (Col), eds1-2 null mutant plants and plants ex-
pressing different EDS1 variants under an EDS1 promoter (pEDS1) in a eds1-2 null mutant back-
ground were infected with the incompatible Hyaloperonospora isolate Cala2. EDS1LL and EDS1LLI
represent variants that were only partially compromised in their interaction to SAG101 and PAD4 while
EDS1LLIF showed a severe loss-of-interaction (Fig. 3.27 D, 3.28 C and 3.29). The establishment of a
hypersensitive response accompanied by localised cell death was visualised 6 d after infection by Trypan
Blue staining. EDS1 protein accumulation of each tested line is shown in the lower right corner. hr –
hypersensitive response, fh – free hyphae, c – conidiophores. Scale bar= 200 µm.
server [Ashkenazy et al., 2010] to plot the degree of residue conservation onto the surfaces of
EDS1, SAG101 and the PAD4 homology model.
As illustrated in Figure 4.11, residues at the heterodimer interfaces were significantly more
conserved compared to the rest of each protein’s surface. Such evolutionary conserved residues
at protein surfaces have been shown to indicate functional importance and can be used to
characterise and predict protein binding sites for other proteins [Ma et al., 2003], peptides
[Petsalaki et al., 2009], DNA [Luscombe and Thornton, 2002], lipids [Adamian et al., 2011] and
a wide range of small molecule ligands [Huang and Schroeder, 2006].
The high degree of surface conservation at the interface of EDS1 to either PAD4 or SAG101
further allows to ask how a ternary EDS1/SAG101/PAD4 complex, proposed by Zhu et al.
[2011], should form. Our experimentally verified EDS1/PAD4 homology model and presence of
a single, highly conserved surface patch on EDS1 argue for a shared interface that is used for
interaction to SAG101 and PAD4. A ternary complex would thus require the formation of an
EDS1 homooligomer in which distinct EDS1 molecules either bind SAG101 or PAD4. Although
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EDS1 homooligomerisation is inevitably different from heterodimerisation as the monomeric
building blocks of homooligomers are generally symmetry related to each other [Goodsell and
Olson, 2000], surface analysis does not reveal further patches of high sequence conservation
that could be used as interfaces between EDS1 homomers (Fig. 4.11).
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Figure 4.11 | Surface conservation at the interaction interfaces of EDS1, SAG101 and PAD4. The
protein surfaces of EDS1 (top left) and SAG101 (top right) and PAD4 (bottom) are represented as
spheres and are coloured according to the degree of residue conservation and polarity of interface
residues. The conservation score is calculated based on orthologue sequences that clustered in a
phylogenetic tree (see Appendix Fig. A.1) and was plotted on the structural surface using ConSurf
[Ashkenazy et al., 2010][32]. A dotted line indicates the boundary between N-terminal (N) lipase-like
and C-terminal (C) EP domain. Dotted circles represent patches of conserved residues that will be
further discussed in the text.
4.4.4. Is the EDS1/SAG101 Interaction Transient?
While the results presented above emphasise the importance of protein-protein interactions within
the EDS1 family, their biochemical function remains elusive. As EDS1 has been proposed to
exist in molecularly and spatially distinct complexes within the plant cell, transitions between
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different states were and are assumed to be of central functional importance [Rietz et al., 2011;
García et al., 2010].
The interface between EDS1 and SAG101, however, is highly untypical for a transient het-
erodimer. Both proteins interact through an interface of more than 4000Å2 (see Tab. 4.2) that
can be, according to a classification by Lo Conte et al. [1999], considered a "large interface"
compared to "standard interfaces" between proteins that bury only an area of 1600 (±400) Å2.
Not only is the interface particularly large but also hydrophobic: Lo Conte et al. [1999] found
that protein-protein interfaces on average do contain 56% polar residues and thus do not signifi-
cantly differ from surfaces of monomeric proteins (57% non-polar residues [Miller et al., 1987]).
In contrast, 66% of all residues within the EDS1/SAG101 interface are non-polar. Interfaces
of that size and polarity are rather typical for homodimeric interactions: Nooren and Thornton
[2003b] analysed homo- and heterodimeric proteins and found that obligate[33] homodimers have
an average interface of 3818Å2[34] that consists of 64% non-polar residues whereas the average
interfaces of transient homodimers and heterodimers in general are much smaller and more polar
(see Tab. 4.2).
Table 4.2 | Structural details of the EDS1/SAG101 complex interface compared to transient and non-
transient homo- and heterodimers.
Data taken from [Nooren and Thornton, 2003b]
Homodimers Heterodimers
Obligate Transient Non-transient Transient EDS1/SAG101
Area (Å2) 3818 1480 1788 2424 4163
Non-polar residues (%) 64 63 56 59 66
The predicted binding affinities of below -20 kcal/mol (Tab. 4.1) do further point towards a
strong interaction between the two proteins. Nishi et al. [2011], for instance, used the PISA
tool for a large scale analysis of protein-protein interactions that they classify as follows: weak
transient (binding affinity ∼ 0 kcal/mol), strong transient (0 ≥ binding affinity ≥ -20 kcal/mol)
and permanent (binding affinity < -20 kcal/mol).
A strong association between EDS1 and SAG101 is further supported by the fact that se-
quential mutations at the interface between them were necessary to reduce their interaction
(Fig. 3.27 C and D). It is thus unlikely that EDS1 and SAG101 dissociate spontaneously – once
formed, the complex will rather need an external trigger to fall apart.
In line with the importance of stable EDS1 heterocomplexes, the proteins do mutually stabilise
each other in vitro and in plants. As discussed before, recombinant SAG101 tends to precipitate
without the stabilising effect of EDS1 – probably due to the exposure of hydrophobic patches.
[33]The constituents (protomers, monomers) of an obligate complex are unstable on their own in vivo whereas
those of a non-obligate complex can exist on their own [Nooren and Thornton, 2003a]
[34]The therein cited interface area was doubled as it is differently calculated. While Lo Conte et al. [1999] define
the interface area as the sum of the solvent-accessible surface areas (ASA) of the isolated components less that of
the complex, Nooren and Thornton [2003a] define it as the sum of the surface areas of the two individual proteins
minus the surface area of the protein complex divided by two. I decided to choose the former definition.
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Accordingly, the protein levels of SAG101 (and PAD4) in plant cells were dramatically reduced
in eds1 null mutant plants [Feys et al., 2005].
4.4.5. SAG101 Might Redirect EDS1 to the Nucleus
The tight association of SAG101 to EDS1 might be necessary for proper localisation of EDS1
during an immune response. García et al. [2010] found that triggering of TIR-NB-LRR R proteins
through an infection with Pseudomonas syringae pv. tomato (Pto) DC3000 expressing the
AvrRps4 effector leads to an increase of nuclear EDS1 levels 3 hours after infection. As higher
nuclear EDS1 accumulation is not reflected by an increased EDS1 gene expression, this is likely
due to a post-transcriptional mechanism. Nuclear accumulation of EDS1 was further shown to
precede or coincide with the expression of EDS1-dependent defence genes arguing for a role of
nuclear EDS1 in transcriptional reprogramming [García et al., 2010]. Accordingly, EDS1 that
is artificially kept in the cytoplasm is substantially compromised in pathogen-induced expression
changes [García et al., 2010].
Interestingly, Zhu et al. [2011] found by co-expressing pairs of EDS1, SAG101 and PAD4,
fused to fluorescent proteins that EDS1 preferentially localises to the nucleus when SAG101 but
not PAD4 is co-expressed with EDS1. When the authors co-expressed all three proteins, some
portion of EDS1 remained cytosolic. PAD4 could, however, not alter the localisation of EDS1
if it was expressed 24 or 48 h after EDS1 and SAG101. SAG101 might thus have a function
in retaining EDS1 inside the nucleus. This could be achieved through the tight association
of exclusively nuclear SAG101 (Fig. 1.5) to EDS1 for that I have gathered structural and
experimental evidence.
The dispensability of SAG101 in TIR-NB-LRR-mediated resistance of Arabidopsis against
Hyaloperonospora infection (Fig. 4.9) appears to be inconsistent with such a function. Even
in the absence of SAG101, EDS1, however, remains nuclear-cytoplasmatic [Zhu et al., 2011]
and low levels of nuclear EDS1 could be sufficient for successful TIR-NB-LRR signalling in
this pathogen-host interaction. In another immune response or in a situation where the plant
has to integrate biotic and abiotic stress signals simultaneously, a tighter regulation of EDS1
accumulation through SAG101 might be necessary.
When García et al. [2010] artificially removed EDS1 from the nucleus through fusion of a
functional NES (nuclear export signal) sequence to EDS1, the respective mutant plants were
compromised in TIR-NB-LRR-mediated as well as basal resistance against incompatible and com-
patible pathogens (Hyaloperonospora and Pseudomonas syringae). Notably, the plants retained
a substantial degree of resistance and this could imply that even a minor portion of EDS1, which
is not efficiently removed from the nucleus, is sufficient for residual immune signalling using these
systems [García, 2009].
4.4.6. Loss-of-Interaction Variants Will Help to Discriminate EDS1 Family
Functions
Recent studies suggested that the EDS1 protein family members EDS1, PAD4 and SAG101 exist
in distinct molecular assemblies with individual functions in plant signalling pathways [Louis et al.,
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2012; Zhu et al., 2011; Rietz et al., 2011; Kim et al., 2012]. This is generally supported by a
phylogenetic analysis described in section 3.1. EDS1, PAD4 and SAG101 orthologue sequences
form three distinct clusters within a phylogenetic tree (Fig. A.1), arguing for differential functions
of SAG101- and PAD4-containing complexes despite the functional redundancy in Arabidopsis
TIR-NB-LRR-mediated defence [Feys et al., 2005].
This is in accord with the observation that SAG101 and PAD4 do fulfil non-redundant roles
in Arabdiopsis defence against the plant-pathogenic turnip crinkle virus: Zhu et al. [2011] could
show that plants lacking SAG101 are equally susceptible to viral infection compared with plants
that do either lack EDS1 or PAD4, indicating that PAD4 can not even partially compensate
for the loss of SAG101. The authors further described an individual role of PAD4 in salicylic
acid-dependent signalling using the same pathogen-host system, based on the finding that an
exogenous treatment of plants with a salicylic acid analog restored resistance in pad4 but neither
eds1 nor sag101 null mutant plants [Zhu et al., 2011].
As introduced before, PAD4 acts independent of EDS1 (and SAG101) in another type of
Arabidopsis resistance against the phloem-feeding insect green peach aphid [Pegadaraju et al.,
2007, 2005; Louis et al., 2012]. Hence, PAD4 and SAG101 are able to fulfil individual roles in
plant defence signalling and are not generally redundant.
Despite the stabilising effect of EDS1 on PAD4 and SAG101 within presumably tightly bound
heterodimers (see section 4.4.4), at least PAD4 seems able to exist and function without EDS1
since the its ability to confer resistance against green peach aphid was not altered in plants
lacking EDS1 [Pegadaraju et al., 2007].
The EDS1, PAD4 and SAG101 loss-of-interaction variants that I was able to characterise will
be useful to further dissect the functions of protein complexes and isolated components of the
EDS1 protein family in these and probably other signalling pathways.
The EDS1L262P variant that is compromised in interaction to PAD4 [Rietz et al., 2011] was,
for instance, used by Kim et al. [2012] to show that EDS1, PAD4 and also EDS1L262P (i.e.
EDS1 not being in complex with PAD4) do interact with the TIR-NB-LRR protein VICTR to
function in root growth arrest of Arabidopsis plants. This suggests that the EDS1 helix αH,
in which Leucine 262 resides, is involved in the interactions of EDS1 to SAG101 and PAD4
(as comprehensively shown in this thesis) but not necessarily participates in interactions to R
proteins of the TIR-NB-LRR type.
4.5. The SAG101 and PAD4 EP Domains Could Mediate
Protein-Protein Interactions Outside the EDS1 Family
With the lipase-like domains being optimised for interactions within the EDS1 family, the EP
domain could emerge as a docking platform for proteins outside the family. Strikingly, the EP
domains of EDS1 and SAG101 are, yet distantly, related to proteins that fulfil a function in large
protein assemblies (Table 3.7 and Fig. 3.23).
Structurally, these proteins are (at least partially) made of helical repeat motifs like tetratri-
copeptide repeats (TPR) or armadillo motifs [Groves and Barford, 1999]. Such helical repeats
possess an extended surface area and have a modular character: helical tandems can be struc-
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turally deformed and modified in their length and composition of surface residues while retaining
an overall stable fold. These tandems can act in a combinatorial manner to mediate interaction
with multiple proteins and thus their interfaces "provide not only a scaffolding function that
allows the assembly of multiprotein complexes, but also directly modulate the conformation and
biological behaviour of the proteins with which they interact" [Groves and Barford, 1999].
Interestingly, and in contrast to EDS1, SAG101 and PAD4 contain surface-exposed patches
of highly conserved amino acids within parts of the EP domain that are not covered by EDS1
in the heterodimers (see dotted circles in Fig. 4.11 that represent an area of ∼ 700 Å2). The
EP domains are thus candidates for rather transient interactions to TIR-NB-LRR R proteins,
effector proteins and other emerging EDS1 interactors.
Although TIR-NB-LRR R proteins have long been known to require the EDS1 family for
downstream signalling, it is unclear how a signal is transduced between them. In recent studies,
EDS1 has been shown by co-immunoprecipitation and bimolecular fluorescence complementation
to exist in a physical complex with TIR-NB-LRR proteins (RPS4, RPS6) and additionally effector
proteins (AvrRps4 and HopA1 that are recognised by RPS4 and RPS6, respectively) [Heidrich
et al., 2011; Bhattacharjee et al., 2011].
Intriguingly, RPS4, in turn, cooperates genetically with RRS1 (RESISTANCE TO R. SOLANA-
CEARUM1) in plant immunity and both genes are encoded in a head-to-head configuration,
separated by only 264 base pairs, in the Arabidopis genome [Narusaka et al., 2009]. RRS1 is
an atypical NB-LRR protein that contains a C-terminal WRKY domain [Deslandes et al., 2002].
The WRKY domain is able to bind DNA and the defining feature of WRKY transcription factors
that modulate numerous plant processes [Rushton et al., 2010]. Although both proteins have
yet not been shown to physically interact, EDS1 could act in concert with RPS4 and RRS1 as
an adaptor protein that connects recognition of an effector (e.g. AvrRps4) to transcriptional
reprogramming during an immune response [Bonardi and Dangl, 2012].
Beyond effector and NB-LRR proteins, EDS1 has been shown to physically interact with
another protein, SRFR1 (SUPPRESSOR OF rps4-RLD1). SRFR1 is a negative regulator of
effector-triggered immunity and Bhattacharjee et al. [2011] found that it exists in a complex
together with EDS1 and the TIR-NB-LRR R proteins RPS4 and RPS6. As the interaction of
SRFR1 to EDS1 was significantly reduced in the presence of the corresponding effector proteins
AvrRps4 and HopA1 (recognised by RPS4 and RPS6, respectively), the authors propose that
SRFR1 could set a threshold at which the R proteins are activated. Maybe coincidental, SRFR1
contains α-helical tetratricopeptide repeats [Kwon et al., 2009].
4.6. Conclusions and Future Perspectives
Structural information that I obtained during this thesis will help to explain the biochemical
functions of the immune-regulatory EDS1 plant protein family.
Despite being sequentially and structurally related to lipases, this is not the central key to
their understanding. We found that neither EDS1 nor PAD4 need critical residues from a
putative catalytic S-D-H triad in Arabidopis TIR-NB-LRR-mediated and basal resistance against
biotrophic pathogens. SAG101 misses critical lipase features and does definitely not act in the
hydrolysis of small molecules.
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Experimental and structural evidence further suggests that lipase-like EDS1 could likewise have
lost its enzymatic activity in general as the protein failed to hydrolyse typical hydrolase substrates
and the triad seems to be effectively shielded from the solvent.
While I can not ultimately rule out that either N-terminal EDS1 or PAD4 retained enzymatic
function in other signalling pathways, the lipase-like domains of EDS1, PAD4 and SAG101 have
co-evolved a function as the anchoring point for protein-protein interactions within the EDS1
family.
I analysed these interactions in vitro and in vivo and proposed structure-guided loss-of-interaction
variants of EDS1, SAG101 and PAD4. These were verified and preliminarily analysed in planta
by J. Stuttmann (MPIPZ, Köln) and provide an excellent basis to further separate between
biological functions of EDS1-requiring complexes and the single components in plant signalling.
They have already helped to emphasise the importance of protein-protein interactions within
the EDS1 family in TIR-NB-LRR-mediated immune signalling. Supported by genetic studies,
our analysis suggests that EDS1 therein functions solely in complex with SAG101 and PAD4.
Exchanges of hydrophobic residues to polar or charged side chains at the interface between the
proteins might suppress residual complex formation and should be used in a more comprehensive
analysis.
Instead of being transient, the large interaction interfaces within EDS1 heterodimers suggest
surprisingly stable complexes. A tight association between exclusively nuclear SAG101 and EDS1
could be required for EDS1 accumulation in the nucleus that is required for transcriptional
reprogramming during an immune response [García et al., 2010]. Transition between molecular
EDS1 states should be analysed, for instance, by competition assays using EDS1, SAG101 and
PAD4 variants that are expressed in planta and fused to different affinity tags.
Beyond the scope of Arabidopsis resistance against biotrophic pathogens that is discussed
in this thesis, the EDS1 protein family participates in the regulation of cell death upon photo-
oxidative stress [Mateo et al., 2004; Rustérucci et al., 2001; Straus et al., 2010], insect resistance
[Pegadaraju et al., 2007, 2005; Louis et al., 2012] and root growth arrest [Kim et al., 2012].
The herein characterised mutant variants, and the presented structural information in general,
will help to further understand the underlying signalling events.
The Elucidation of Further EDS1 Structures For a comprehensive structure-function rela-
tionship, further EDS1 states should be structurally elucidated. An EDS1 structure without
binding partner could, for instance, answer open questions concerning its ability to form homo-
mers.
Additionally, EDS1 can almost be assumed to adopt diverse conformations in different molec-
ular assemblies. Lo Conte et al. [1999] and Nooren and Thornton [2003b] consistently found,
when analysing larger sets of protein-protein interactions, that the assembly or disassembly of
complexes with large interaction interfaces (>1000Å2) is regularly associated with a conforma-
tional change. Thus, each functional EDS1 state adds a piece to the puzzle that connects EDS1
structure to function.
Without putting too much interpretation into these results, the NMSim webserver [Krüger
et al., 2012] introduced before gives an idea how such changes may look like (Fig. 4.12).
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Figure 4.12 | Simulation of large scale
conformational EDS1 changes. The NM-
Sim server has been described before (sec-
tion 4.2 and was used in "large scale mo-
tions" mode with isolated EDS1 as an input
structure (left-hand side). The final struc-
ture of the simulation reveals that not only
EDS1 α-helix αH changes its position, as de-
scribed in section 3.4.2, but additionally he-
lices within the C-terminal EP domain (pur-
ple) could fold back on the lipase-like domain
(blue). Hypothesising that the EP domain
represents a binding platform to other pro-
teins (section 4.5), such motions could dis-
criminate between functional EDS1 states in
various signalling pathways.
Lipase-like domain
(residues 1-384)
EP domain
(residues 385-623)
A further focus should lie on the preparation of PAD4. Although we used a PAD4 homology
model to characterise its interaction to EDS1, we are still unable to answer molecular details.
It would be interesting to see whether PAD4 contains a solvent-accessible triad that acts in sig-
nalling molecule hydrolysis. As attempts to produce it recombinantly in E. coli failed, eukaryotic
expression systems (e.g. yeast, insect cell culture or tobacco plants) should be considered.
In this context, the herein presented PAD4 homology model could and should be used to derive
domain fragments or introduce chemical modifications that potentially stabilise the protein.
Once a soluble variant is obtained, the homology model could assist structure-guided muta-
genesis of entropic surface residues that can be detrimental to crystallisation.
These approaches can be successfully combined as shown by Longenecker et al. [2001]. The
authors produced a domain fragment of a RhoGTPase nucleotide exchange factor (RhoGEF)
and exchanged lysine and glutamine residues that are statistically probable surface residues to
alanines. By replacing polar, flexible side chains that formed clusters in the primary sequence,
they created a binding region that allowed new intermolecular contacts and promoted protein
crystallisation.
This and numerous other approaches applicable to non-crystallising proteins including, (1)
hydrophobic to hydrophilic mutations on the protein surface, (2) deletion of potentially flexible
regions and (3) the use protein-fusions to enhance solubility and crystallisability are review by
Dale et al. [2003]. The authors further suggest to consider using orthologous proteins from
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different species that, in case of PAD4, should include such containing an N-terminal insertion
(Fig. 3.18).
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A.1. Appendix Tables
Table A.1 | Thermofluor screen composition table.
A1 50mM Sodium acetate, pH 4.5 E1 150mM Sodium bromide
A2 50mM Sodium citrate, pH 5.0 E2 150mM Sodium fluoride
A3 50mM Sodium citrate, pH 5.5 E3 150mM Sodium thiocyanate
A4 50mM Bis-Tris, pH 6.0 E4 1mM EDTA
A5 50mM MES, pH 6.5 E5 0.2% (w/v) Tween-80
A6 50mM Sodium phosphate, pH 7.0 E6 0.2% (v/v) Triton X-100
A7 50mM Potassium phosphate, pH 7.0 E7 150mM Glycine, pH 7.5
A8 50mM HEPES, pH 7.0 E8 50mM Glycylglycylglycine, pH 7.5
A9 50mM Tris, pH 7.5 E9 500mM Arginine, pH 7.5
A10 50mM HEPES, pH 7.5 E10 5% (v/v) Glycerol
A11 50mM TEA, pH 7.5 E11 10% (v/v) Glycerol
A12 50mM Bicine, pH 8.0 E12 20% (v/v) Glycerol
B1 50mM Tris, pH 8.0 F1 5% (w/v) D-Glucose
B2 50mM HEPES, pH 8.0 F2 5% (w/v) D-Fructose
B3 50mM Imidazole, pH 8.0 F3 5% (w/v) Sucrose
B4 50mM Tris, pH 8.5 F4 5% (w/v) D-D-sorbitol
B5 50mM CHES, pH 9.0 F5 5% (w/v) Trehalose dihydrate
B6 50mM CAPS, pH 10.0 F6 10 (v/v) Ethylenglycol
B7 A2 +50mM NaCl F7 1% (v/v) PEG400
B8 A2 +150mM NaCl F8 1% (w/v) PEG4000
B9 A2 +500mM NaCl F9 1% (w/v) PEG8000
B10 A4 +50mM NaCl F10 10mM urea
B11 A4 +150mM NaCl F11 10mM GuHCl
B12 A4 +500mM NaCl F12 3% (v/v) DMSO
C1 A10 +50mM NaCl G1 5% (v/v) MPD
C2 A10 +150mM NaCl G2 5% (w/v) Trimethyl-N-oxide
C3 A10 +500mM NaCl G3 1mM DTT
C4 B4 +50mM NaCl G4 5mM DTT
C5 B4 +150mM NaCl G5 1mM β-ME
C6 B4 +500mM NaCl G6 5mM β-ME
C7 150mM NaCl G7 1mM TCEP pH 7.5
C8 150mM KCl G8 5mM TCEP pH 7.5
C9 150mM CaCl2 G9 5% (w/v) DDAO
C10 150mM MgCl2 G10 10mM CHAPS
C11 150mM LiCl G11 Water
C12 10mM NH4Cl G12 5mM NAD
D1 10mM ZnCl2 H1 5mM NADH
D2 10mM NiCl2 H2 5mM ATP
D3 10mM CuCl2 H3 5mM ADP
D4 10mM CsCl H4 5mM AMP
D5 10mM MnSO4 H5 10mM cholic acid
D6 150mM Sodium citrate H6 5mM Salicylic acid in 10mM HEPES, pH 7.5
D7 150mM Sodium acetate H7 5mM 2,3 DHBA in 10mM HEPES, pH 7.5
D8 150mM Sodium sulfate H8 5mM 2,5 DHBA in 10mM HEPES, pH 7.5
D9 150mM Sodium dihydrogenphosphate, pH 7.0 H9 4% (v/v) Ethanol
D10 150mM Sodium nitrate H10 4% (v/v) Acetonitrile
D11 150mM Sodium tartrate H11 4% (v/v) 2-Propanol
D12 150mM Sodium iodide H12 4% (v/v) Methanol
112
A. Appendix
Table A.2 | Effects of mutations within SAG101 as tested in the yeast two-hybrid assay.
Mutation in BD-SAG101 Effect against AD-EDS11-384 Effect against AD-EDS1
L12A no effect no effect
L12S no effect no effect
L15A protein instability protein instability
L21A no effect no effect
L21S partial loss-of-interaction no effect
I141A partial loss-of-interaction no effect
R169E protein instability protein instability
L171A no effect no effect
L199A no effect no effect
L12A/L21A partial loss-of-interaction no effect
L12S/L21S protein instability protein instability
L12A/L21A/I141A loss-of-interaction no effect
R169E/L171A protein instability protein instability
N298A not tested no effect
I302A not tested no effect
Y306A not tested no effect
W309A not tested no effect
L12A/L21A/N298A not tested no effect
L12A/L21A/I302A not tested no effect
L12A/L21A/Y306A not tested no effect
L12A/L21A/W309A not tested protein instability
L12A/L21A/R428E not tested no effect
L12A/L21A/I141A/N298A not tested no effect
L12A/L21A/I141A/I302A not tested protein instability
L12A/L21A/I141A/Y306A not tested loss-of-interaction
L12A/L21A/I141A/R428E not tested no effect
Table A.3 | Effects of mutations within EDS11-384 as tested in the yeast two-hybrid assay.
Mutation in AD-EDS11-384 Effect against BD-SAG101
R234E partial loss-of-interaction
C245A no effect
I254A loss-of-interaction
E256K no effect
T257A no effect
L258A loss-of-interaction
F261A loss-of-interaction
L262A loss-of-interaction
W306A no effect
R353E no effect
Y357A no effect
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Table A.4 | Effects of mutations within EDS1 as tested in the yeast two-hybrid assay.
Mutation in AD-EDS1 Effect against BD-SAG101
I254A no effect
L258A no effect
F261A no effect
L262A no effect
L258A/L262A no effect
I254A/L258A/L262A partial loss-of-interaction
I254A/L258A/F261A/L262A loss-of-interaction
I254A/L258A/F261A/L262A/E416K no additional loss-of-interaction
I254A/L258A/F261A/L262A/F419A no additional loss-of-interaction
I254A/L258A/F261A/L262A/N422A no additional loss-of-interaction
I254A/L258A/F261A/L262A/V423A no additional loss-of-interaction
I254A/L258A/F261A/L262A/V423S no additional loss-of-interaction
I254A/L258A/F261A/L262A/E427A no additional loss-of-interaction
I254A/L258A/F261A/L262A/R475E no additional loss-of-interaction
I254A/L258A/F261A/L262A/D481K no additional loss-of-interaction
I254A/L258A/F261A/L262A/V423S/E427A no additional loss-of-interaction
Table A.5 | Effects of mutations within PAD4 as tested in the yeast two-hybrid assay.
Mutation in BD-PAD4 Effect against AD-EDS1
L11A no effect
L11S no effect
Q12E no effect
V15A no effect
V15S no effect
M16A partial loss-of-interaction
L21A no effect
L21S partial loss-of-interaction
F143A partial loss-of-interaction
R247E no effect
L315S no effect
W319S no effect
M16A/L21A partial loss-of-interaction
M16A/L21S loss-of-interaction
M16A/L21A/F143A partial loss-of-interaction
M16A/L21S/F143A loss-of-interaction
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Figure A.1 | Phylogenetic tree of the EDS1 protein family. The sequences were retrieved and clustered
in a phylogenetic tree as described in section 3.1. Annotated sequences of Arabidopsis thaliana EDS1,
PAD4 and SAG101 are marked within each cluster. Bootstrap values are given in percentages for each
branch. The scale bar equals a distance of 20 changes per 100 amino acid positions.
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Figure A.2 | Thermufluor melting curves. EDS1 and EDS11-384 were thermally unfolded in the same
sodium phosphate buffer, pH 7.5 and in presence of SYPRO® Orange dye. Unfolding events lead to an
increase of fluorescence as the dye emits of a distinct wavelength upon binding to hydrophobic patches
that become accessible upon protein denaturation. The maximum value of the first derivative curve
equals the protein’s melting point Tm.
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Figure A.3 | Flexibility of EDS1 helix αH. Full length EDS1 without bound SAG101 was used as input
structure for the calculation of "large scale motions" using the NMSim server [Krüger et al., 2012]
(refer to section 4.2.1 for details). Here, the lipase-like EDS1 domain is coloured according to structural
flexibility. Analogous to Figure 3.17, helices αF,G,H within the N-terminal EDS1 insertion are marked.
The triad position, where a small molecule ligand or a substrate could bind, is indicated by a yellow
sphere.
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Figure A.4 | The EDS1 triad does not bind a small molecule in TIR-NB-LRR-mediated resistance.
Complementation of lines that express the depicted amounts of protein was tested as described for
Figure 3.20. All protein variants were expressed under the native EDS1 promoter (pEDS1)
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Figure A.5 | The N-terminal EDS1 domain does not complement for the loss of full length EDS1.
Upper panel: localisation of the indicated protein fusions upon 35S-driven expression in transgenic Ara-
bidopsis eds1-2 plants (T2). Full length EDS1 and the N-terminal domain localise to plant nuclei and the
cytoplasm. The C-terminal domain, in contrast, never was visible in nuclei. Guard cell autofluorescence
appears very bright due to generally lower expression/fluorescence of the C-terminal construct. Lower
panel: infection phenotypes of the same lines upon infection with the incompatible Hyaloperonospora
isolate Cala2. Infected leaves were stained with Trypan Blue 7 days after inoculation and analysed under
a microscope.
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Figure A.6 | The flexible SAG101 loop. Sequence alignment of SAG101 orthologs from different plant
species was carried out using SeaView [Gouy et al., 2010] and presented using ESPript [Gouet et al.,
1999]. The positions of AtSAG101 Proline 35 and Aspartate 53, which represent the borders of a loop
that could not been modelled in the EDS1/SAG101 crystal structure due to high structural flexibility,
are indicated.
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Figure A.7 | Full length and lipase-like EDS1 co-purifications with SAG101 variants. EDS1,
EDS11-384 and SAG101 loss-of-interaction variants were expressed separately in E. coli. E. coli cells
that expressed each of the SAG101 variant were lysed together with cells expressing an excess of either
untagged EDS1 or EDS11-384. His-tagged SAG101 (and interacting EDS1 or EDS11-384, respectively)
was purified by IMAC and the elution fractions were separated by SDS-PAGE. Bands corresponding to
each protein are indicated on the right.
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A.3. Definition of Crystallographic R-Factors
The Rmeas value was defined by Diederichs and Karplus [1997] and should be used as a measure
of X-ray diffraction data quality instead of Rsym and Rmerge that both depend on the multiplicity
of collected data. It is defined as:
Rmeas=
∑
h
√
nh
nh − 1
nh∑
i
|Iˆh − Ih,i |
∑
h
nh∑
i
Ih,i
where Îh=
1
nh
nh∑
i
Ih,i (the mean intensity for all observations i of reflection h) and nh is its
multiplicity (the total number of observations).
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